MPT Operating Partnership 10-K 29 Feb 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Feb. 26, 2016	Jun. 30, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Trading Symbol	MPW
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	1,287,865
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		237,846,536
Entity Public Float			$ 2,741,148,898
MPT Operating Partnership, L.P. [Member]
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Registrant Name	MPT OPERATING PARTNERSHIP, L.P.
Entity Central Index Key	1,524,607
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Real estate assets
Land	$ 315,787	$ 192,551
Buildings and improvements	2,675,803	1,848,176
Construction in progress and other	49,165	23,163
Intangible lease assets	256,950	108,885
Net investment in direct financing leases	626,996	439,516
Mortgage loans	757,581	397,594
Gross investment in real estate assets	4,682,282	3,009,885
Accumulated depreciation	(232,675)	(181,441)
Accumulated amortization	(25,253)	(21,186)
Net investment in real estate assets	4,424,354	2,807,258
Cash and cash equivalents	195,541	144,541
Interest and rent receivables	46,939	41,137
Straight-line rent receivables	82,155	59,128
Other loans	664,822	573,167
Other assets	195,540	95,099
Total Assets	5,609,351	3,720,330
Liabilities
Debt, net	3,322,541	2,174,648
Accounts payable and accrued expenses	137,356	112,623
Deferred revenue	29,358	27,207
Lease deposits and other obligations to tenants	12,831	23,805
Total liabilities	$ 3,502,086	$ 2,338,283
Commitments and Contingencies
Equity / Capital
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 236,744 shares at December 31, 2015 and 172,743 shares at December 31, 2014	$ 237	$ 172
Limited Partners:
Additional paid-in capital	2,593,827	1,765,381
Distributions in excess of net income	(418,650)	(361,330)
Accumulated other comprehensive loss	(72,884)	(21,914)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust Equity / Capital	2,102,268	1,382,047
Non-controlling interests	4,997
Total Equity / Capital	2,107,265	1,382,047
Total Liabilities and Equity / Capital	5,609,351	3,720,330
Common Units [Member]
Limited Partners:
Total Equity / Capital	237	172
MPT Operating Partnership, L.P. [Member]
Real estate assets
Land	315,787	192,551
Buildings and improvements	2,675,803	1,848,176
Construction in progress and other	49,165	23,163
Intangible lease assets	256,950	108,885
Net investment in direct financing leases	626,996	439,516
Mortgage loans	757,581	397,594
Gross investment in real estate assets	4,682,282	3,009,885
Accumulated depreciation	(232,675)	(181,441)
Accumulated amortization	(25,253)	(21,186)
Net investment in real estate assets	4,424,354	2,807,258
Cash and cash equivalents	195,541	144,541
Interest and rent receivables	46,939	41,137
Straight-line rent receivables	82,155	59,128
Other loans	664,822	573,167
Other assets	195,540	95,099
Total Assets	5,609,351	3,720,330
Liabilities
Debt, net	3,322,541	2,174,648
Accounts payable and accrued expenses	84,628	74,195
Deferred revenue	29,358	27,207
Lease deposits and other obligations to tenants	12,831	23,805
Payable due to Medical Properties Trust, Inc.	52,338	38,038
Total liabilities	$ 3,501,696	$ 2,337,893
Commitments and Contingencies
Limited Partners:
Accumulated other comprehensive loss	$ (72,884)	$ (21,914)
Total Medical Properties Trust Equity / Capital	2,102,658	1,382,437
Non-controlling interests	4,997
Total Equity / Capital	2,107,655	1,382,437
Total Liabilities and Equity / Capital	5,609,351	3,720,330
MPT Operating Partnership, L.P. [Member] | Common Units [Member]
Limited Partners:
Limited Partners Capital	2,153,769	1,390,296
MPT Operating Partnership, L.P. [Member] | General Partner [Member]
Equity / Capital
General partner - issued and outstanding - 2,363 units at December 31, 2015 and 1,722 units at December 31, 2014	21,773	14,055
Limited Partners:
Total Equity / Capital	$ 21,773	$ 14,055

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	236,744,000	172,743,000
Common stock, shares outstanding	236,744,000	172,743,000
Common Units [Member] | MPT Operating Partnership, L.P. [Member]
Limited Partners, units issued	234,381,000	171,021,000
Limited Partners, units outstanding	234,381,000	171,021,000
General Partner [Member] | MPT Operating Partnership, L.P. [Member]
General partner, units issued	2,363,000	1,722,000
General partner, units outstanding	2,363,000	1,722,000
LTIP Units [Member] | MPT Operating Partnership, L.P. [Member]
LTIP Units, shares issued	292,000	292,000
LTIP Units, shares outstanding	292,000	292,000

Consolidated Statements of Net

Consolidated Statements of Net Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues
Rent billed	$ 247,604	$ 187,018	$ 132,578
Straight-line rent	23,375	13,507	10,706
Income from direct financing leases	58,715	49,155	40,830
Interest and fee income	112,184	62,852	58,409
Total revenues	441,878	312,532	242,523
Expenses
Real estate depreciation and amortization	69,867	53,938	36,978
Impairment charges		50,128
Property-related	3,792	1,851	2,450
Acquisition expenses	61,342	26,389	19,494
General and administrative	43,639	37,274	30,063
Total operating expenses	178,640	169,580	88,985
Operating income	263,238	142,952	153,538
Other income (expense)
Interest and other income (expense)	595	5,481	(319)
Earnings from equity and other interests	2,849	2,559	3,554
Debt refinancing and unutilized financings expense	(4,368)	(1,698)
Interest expense	(120,884)	(98,156)	(66,746)
Income tax expense	(1,503)	(340)	(726)
Net other expenses	(123,311)	(92,154)	(64,237)
Income from continuing operations	139,927	50,798	89,301
Income (loss) from discontinued operations		(2)	7,914
Net income	139,927	50,796	97,215
Net income attributable to non-controlling interests	(329)	(274)	(224)
Net income attributable to MPT common stockholders	$ 139,598	$ 50,522	$ 96,991
Earnings per share / unit - basic
Income from continuing operations attributable to MPT common stockholders	$ 0.64	$ 0.29	$ 0.59
Income from discontinued operations attributable to MPT common stockholders			0.05
Net income attributable to MPT common stockholders	$ 0.64	$ 0.29	$ 0.64
Weighted average shares (units) outstanding - basic	217,997	169,999	151,439
Earnings per share / unit - diluted
Income from continuing operations attributable to MPT common stockholders	$ 0.63	$ 0.29	$ 0.58
Income from discontinued operations attributable to MPT common stockholders			0.05
Net income attributable to MPT common stockholders	$ 0.63	$ 0.29	$ 0.63
Weighted average shares (units) outstanding - diluted	218,304	170,540	152,598
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 247,604	$ 187,018	$ 132,578
Straight-line rent	23,375	13,507	10,706
Income from direct financing leases	58,715	49,155	40,830
Interest and fee income	112,184	62,852	58,409
Total revenues	441,878	312,532	242,523
Expenses
Real estate depreciation and amortization	69,867	53,938	36,978
Impairment charges		50,128
Property-related	3,792	1,851	2,450
Acquisition expenses	61,342	26,389	19,494
General and administrative	43,639	37,274	30,063
Total operating expenses	178,640	169,580	88,985
Operating income	263,238	142,952	153,538
Other income (expense)
Interest and other income (expense)	595	5,481	(319)
Earnings from equity and other interests	2,849	2,559	3,554
Debt refinancing and unutilized financings expense	(4,368)	(1,698)
Interest expense	(120,884)	(98,156)	(66,746)
Income tax expense	(1,503)	(340)	(726)
Net other expenses	(123,311)	(92,154)	(64,237)
Income from continuing operations	139,927	50,798	89,301
Income (loss) from discontinued operations		(2)	7,914
Net income	139,927	50,796	97,215
Net income attributable to non-controlling interests	(329)	(274)	(224)
Net income attributable to MPT common stockholders	$ 139,598	$ 50,522	$ 96,991
Earnings per share / unit - basic
Income from continuing operations attributable to MPT common stockholders	$ 0.64	$ 0.29	$ 0.59
Income from discontinued operations attributable to MPT common stockholders			0.05
Net income attributable to MPT common stockholders	$ 0.64	$ 0.29	$ 0.64
Weighted average shares (units) outstanding - basic	217,997	169,999	151,439
Earnings per share / unit - diluted
Income from continuing operations attributable to MPT common stockholders	$ 0.63	$ 0.29	$ 0.58
Income from discontinued operations attributable to MPT common stockholders			0.05
Net income attributable to MPT common stockholders	$ 0.63	$ 0.29	$ 0.63
Weighted average shares (units) outstanding - diluted	218,304	170,540	152,598

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net income	$ 139,927	$ 50,796	$ 97,215
Other comprehensive income (loss):
Unrealized gain on interest rate swap	3,139	2,964	3,474
Foreign currency translation (loss) gain	(54,109)	(15,937)	67
Total comprehensive income	88,957	37,823	100,756
Comprehensive income attributable to non-controlling interests	(329)	(274)	(224)
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	88,628	37,549	100,532
MPT Operating Partnership, L.P. [Member]
Net income	139,927	50,796	97,215
Other comprehensive income (loss):
Unrealized gain on interest rate swap	3,139	2,964	3,474
Foreign currency translation (loss) gain	(54,109)	(15,937)	67
Total comprehensive income	88,957	37,823	100,756
Comprehensive income attributable to non-controlling interests	(329)	(274)	(224)
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	$ 88,628	$ 37,549	$ 100,532

Consolidated Statements of Equi

Consolidated Statements of Equity / Capital - USD ($) shares in Thousands, $ in Thousands	Total	Additional Paid-in Capital [Member]	Distributions in Excess of Net Income [Member]	Treasury Stock [Member]	Common Par Value [Member]	Accumulated Other Comprehensive Loss [Member]	Non- Controlling Interests [Member]	MPT Operating Partnership, L.P. [Member]	MPT Operating Partnership, L.P. [Member]Accumulated Other Comprehensive Loss [Member]	MPT Operating Partnership, L.P. [Member]Non- Controlling Interests [Member]	MPT Operating Partnership, L.P. [Member]General Partner [Member]	MPT Operating Partnership, L.P. [Member]Limited Partner [Member]Common Par Value [Member]	MPT Operating Partnership, L.P. [Member]Limited Partner [Member]Long Term Incentive Plan [Member]
Beginning balance at Dec. 31, 2012	$ 1,049,814	$ 1,295,916	$ (233,494)	$ (262)	$ 136	$ (12,482)		$ 1,050,204	$ (12,482)		$ 10,630	$ 1,052,056
Beginning balance (in shares) at Dec. 31, 2012					136,335						1,357	134,978	221
Net income	97,215		96,991				$ 224	97,215		$ 224	$ 972	$ 95,748	$ 271
Unrealized gain on interest rate swaps	3,474					3,474		3,474	3,474
Foreign currency translation gain (loss)	67					67		67	67
Stock (Unit) vesting and amortization of stock (unit)-based compensation	8,833	8,832			$ 1			8,833			$ 88	$ 8,745
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)					811						9	802	71
Distributions to non-controlling interests	(224)						(224)	(224)		(224)
Proceeds from offering (net of offering costs)	313,330	313,306			$ 24			313,330			$ 3,133	$ 310,197
Proceeds from offering (net of offering costs) (shares)					24,164						242	23,922
Dividends (Distributions) declared ($0.81 in 2013, 0.84 in 2014 and 0.88 in 2015 per common share/ unit)	(128,301)		(128,301)					(128,301)			$ (1,282)	$ (126,748)	$ (271)
Ending balance at Dec. 31, 2013	1,344,208	1,618,054	(264,804)	(262)	$ 161	(8,941)		1,344,598	(8,941)		$ 13,541	$ 1,339,998
Ending balance (in shares) at Dec. 31, 2013					161,310						1,608	159,702	292
Net income	50,796		50,522				274	50,796		274	$ 508	$ 49,769	$ 245
Unrealized gain on interest rate swaps	2,964					2,964		2,964	2,964
Foreign currency translation gain (loss)	(15,937)					(15,937)		(15,937)	(15,937)
Stock (Unit) vesting and amortization of stock (unit)-based compensation	9,165	9,165						9,165			$ 92	$ 9,073
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)					777						8	769
Distributions to non-controlling interests	(274)						(274)	(274)		(274)
Proceeds from offering (net of offering costs)	138,173	138,162			$ 11			138,173			$ 1,382	$ 136,791
Proceeds from offering (net of offering costs) (shares)					10,656						106	10,550
Dividends (Distributions) declared ($0.81 in 2013, 0.84 in 2014 and 0.88 in 2015 per common share/ unit)	(147,048)		(147,048)					(147,048)			$ (1,468)	$ (145,335)	$ (245)
Ending balance at Dec. 31, 2014	1,382,047	1,765,381	(361,330)	(262)	$ 172	(21,914)		1,382,437	(21,914)		$ 14,055	$ 1,390,296
Ending balance (in shares) at Dec. 31, 2014					172,743						1,722	171,021	292
Net income	139,927		139,598				329	139,927		329	$ 1,399	$ 138,199
Sale of non-controlling interests	5,000						5,000
Sale of non-controlling interests								5,000		5,000
Unrealized gain on interest rate swaps	3,139					3,139		3,139	3,139
Foreign currency translation gain (loss)	(54,109)					(54,109)		(54,109)	(54,109)
Stock (Unit) vesting and amortization of stock (unit)-based compensation	11,122	11,120			$ 2			11,122			$ 111	$ 11,011
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)					751						8	743
Distributions to non-controlling interests	(332)						(332)	(332)		(332)
Proceeds from offering (net of offering costs)	817,389	817,326			$ 63			817,389			$ 8,175	$ 809,214
Proceeds from offering (net of offering costs) (shares)					63,250						633	62,617
Dividends (Distributions) declared ($0.81 in 2013, 0.84 in 2014 and 0.88 in 2015 per common share/ unit)	(196,918)		(196,918)					(196,918)			$ (1,967)	$ (194,951)
Ending balance at Dec. 31, 2015	$ 2,107,265	$ 2,593,827	$ (418,650)	$ (262)	$ 237	$ (72,884)	$ 4,997	$ 2,107,655	$ (72,884)	$ 4,997	$ 21,773	$ 2,153,769
Ending balance (in shares) at Dec. 31, 2015					236,744						2,363	234,381	292

Consolidated Statements of Equ7

Consolidated Statements of Equity / Capital (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Dividends (Distributions) declared per common share / unit	$ 0.88	$ 0.84	$ 0.81
MPT Operating Partnership, L.P. [Member]
Dividends (Distributions) declared per common share / unit	$ 0.88	$ 0.84	$ 0.81

Consolidated Statements of Cash

Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Operating activities
Net income	$ 139,927	$ 50,796	$ 97,215
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	71,827	55,162	38,818
Amortization and write-off of deferred financing costs and debt discount	6,085	5,105	3,559
Direct financing lease interest accretion	(8,032)	(6,701)	(5,774)
Straight-line rent revenue	(26,187)	(16,325)	(11,265)
Share / (Unit)-based compensation expense	11,122	9,165	8,833
Gain from sale of real estate	(3,268)	(2,857)	(7,659)
Impairment charges		50,128
Straight-line rent write-off	2,812	2,818	1,457
Other adjustments	(1,967)	520	(70)
Decrease (increase) in:
Interest and rent receivable	(5,599)	(3,856)	(13,211)
Other assets	(8,297)	764	1,855
Accounts payable and accrued expenses	26,540	6,209	23,867
Deferred revenue	2,033	(485)	3,177
Net cash provided by operating activities	206,996	150,443	140,802
Investing activities
Cash paid for acquisitions and other related investments	(2,218,869)	(767,696)	(654,922)
Net proceeds from sale of real estate	19,175	34,649	32,409
Principal received on loans receivable	771,785	11,265	7,249
Investment in loans receivable	(354,001)	(12,782)	(3,746)
Construction in progress	(146,372)	(102,333)	(41,452)
Other investments, net	(17,339)	(13,126)	(52,115)
Net cash used for investing activities	(1,945,621)	(850,023)	(712,577)
Financing activities
Additions to term debt	681,000	425,000	424,580
Payments of term debt	(283)	(100,266)	(11,249)
Payment of deferred financing costs	(7,686)	(14,496)	(9,760)
Revolving credit facilities, net	509,415	490,625	(20,000)
Distributions paid	(182,980)	(144,365)	(120,309)
Lease deposits and other obligations to tenants	(10,839)	7,892	3,231
Proceeds from sale of common shares / units, net of offering costs	817,389	138,173	313,330
Other financing activities	(5,326)
Net cash provided by financing activities	1,800,690	802,563	579,823
Increase in cash and cash equivalents for the year	62,065	102,983	8,048
Effect of exchange rate changes	(11,065)	(4,421)	620
Cash and cash equivalents at beginning of year	144,541	45,979	37,311
Cash and cash equivalents at end of year	195,541	144,541	45,979
Interest paid, including capitalized interest of $1,425 in 2015, $1,860 in 2014, and $1,729 in 2013	107,228	91,890	58,110
Supplemental schedule of non-cash investing activities:
Mortgage loan issued from sale of real estate		12,500
Supplemental schedule of non-cash financing activities:
Dividends declared, not paid	52,402	38,461	35,778
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	139,927	50,796	97,215
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	71,827	55,162	38,818
Amortization and write-off of deferred financing costs and debt discount	6,085	5,105	3,559
Direct financing lease interest accretion	(8,032)	(6,701)	(5,774)
Straight-line rent revenue	(26,187)	(16,325)	(11,265)
Share / (Unit)-based compensation expense	11,122	9,165	8,833
Gain from sale of real estate	(3,268)	(2,857)	(7,659)
Impairment charges		50,128
Straight-line rent write-off	2,812	2,818	1,457
Other adjustments	(1,967)	520	(70)
Decrease (increase) in:
Interest and rent receivable	(5,599)	(3,856)	(13,211)
Other assets	(8,297)	764	1,855
Accounts payable and accrued expenses	26,540	6,209	23,867
Deferred revenue	2,033	(485)	3,177
Net cash provided by operating activities	206,996	150,443	140,802
Investing activities
Cash paid for acquisitions and other related investments	(2,218,869)	(767,696)	(654,922)
Net proceeds from sale of real estate	19,175	34,649	32,409
Principal received on loans receivable	771,785	11,265	7,249
Investment in loans receivable	(354,001)	(12,782)	(3,746)
Construction in progress	(146,372)	(102,333)	(41,452)
Other investments, net	(17,339)	(13,126)	(52,115)
Net cash used for investing activities	(1,945,621)	(850,023)	(712,577)
Financing activities
Additions to term debt	681,100	425,000	424,580
Payments of term debt	(283)	(100,266)	(11,249)
Payment of deferred financing costs	(7,686)	(14,496)	(9,760)
Revolving credit facilities, net	509,415	490,625	(20,000)
Distributions paid	(182,980)	(144,365)	(120,309)
Lease deposits and other obligations to tenants	(10,839)	7,892	3,231
Proceeds from sale of common shares / units, net of offering costs	817,389	138,173	313,330
Other financing activities	(5,326)
Net cash provided by financing activities	1,800,690	802,563	579,823
Increase in cash and cash equivalents for the year	62,065	102,983	8,048
Effect of exchange rate changes	(11,065)	(4,421)	620
Cash and cash equivalents at beginning of year	144,541	45,979	37,311
Cash and cash equivalents at end of year	195,541	144,541	45,979
Interest paid, including capitalized interest of $1,425 in 2015, $1,860 in 2014, and $1,729 in 2013	107,228	91,890	58,110
Supplemental schedule of non-cash investing activities:
Mortgage loan issued from sale of real estate		12,500
Supplemental schedule of non-cash financing activities:
Dividends declared, not paid	$ 52,402	$ 38,461	$ 35,778

Consolidated Statements of Cas9

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Interest paid, capitalized	$ 1,425	$ 1,860	$ 1,729
MPT Operating Partnership, L.P. [Member]
Interest paid, capitalized	$ 1,425	$ 1,860	$ 1,729

Organization

Organization	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing healthcare real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist. We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will generally not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are located in the United States and Europe.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Use of Estimates: Principles of Consolidation: We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity (“VIE”). If we determine that we have a variable interest in a VIE, we then evaluate if we are the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a VIE that most significantly impact the entity’s economic performance. We consolidate each VIE in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2015, we had loans and/or equity investments in certain VIEs, which are also tenants of our facilities (including but not limited to Ernest, Capella and Vibra). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2015 (in thousands): VIE Type Maximum Loss Asset Type Carrying Amount(2) Loans, net $ 984,512 Mortgage and other loans $ 921,930 Equity investments $ 54,033 Other assets $ 6,232 (1) Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities. (2) Carrying amount reflects the net book value of our loan or equity interest only in the VIE. For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of December 31, 2015, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls). Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower. See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein. Investments in Unconsolidated Entities: Cash and Cash Equivalents: Revenue Recognition: Certain leases may provide for additional rents contingent upon a percentage of the tenant’s revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index or when the consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as rent billed revenue in the period earned. We use DFL accounting to record rent on certain leases deemed to be financing leases, per accounting rules, rather than operating leases. For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income. In instances where we have a profits or equity interest in our tenant’s operations, we record income equal to our percentage interest of the tenant’s profits, as defined in the lease or tenant’s operating agreements, once annual thresholds, if any, are met. We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the remaining term of the lease. We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. Tenant payments for certain taxes, insurance, and other operating expenses related to our facilities (most of which are paid directly by our tenants to the government or appropriate third party vendor) are recorded net of the respective expense as generally our leases are “triple-net” leases, with terms requiring such expenses to be paid by our tenants. Failure on the part of our tenants to pay such expense or to pay late would result in a violation of the lease agreement, which could lead to an event of default, if not cured. Acquired Real Estate Purchase Price Allocation: We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of these intangible assets to expense over the initial term of the respective leases. If a lease is terminated, the unamortized portion of the lease intangibles are charged to expense. Goodwill: Real Estate and Depreciation: Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2015 are as follows: Buildings and improvements 38.9 years Tenant lease intangibles 25.6 years Leasehold improvements 22.1 years Furniture, equipment and other 9.3 years Losses from Rent Receivables: Losses from Operating Lease Receivables: Losses on DFL Receivables: Loans: Earnings Per Share/Units: Our unvested restricted stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit. Income Taxes: Our financial statements include the operations of taxable REIT subsidiaries (“TRS”), including MPT Development Services, Inc. (“MDS”) and MPT Covington TRS, Inc. (“CVT”), along with many other entities, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. Our TRS entities are not entitled to a dividends paid deduction and are subject to federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and they make loans to and/or investments in our lessees. With the property acquisitions and investments in Europe, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes in the United States as such income from our international properties will flow through our REIT income tax returns. For our TRS and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax receivables/liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is reflected in our tax provision when such changes occur. Stock-Based Compensation: Deferred Costs: Deferred Financing Costs: Foreign Currency Translation and Transactions: Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in foreign currency from time to time. Gains or losses resulting from these foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses on our short-term transactions are included in other income in the consolidated statements of income, while the translation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. Derivative Financial Investments and Hedging Activities: To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur. Fair Value Measurement: • Level 1 identical • Level 2 similar • Level 3 unobservable We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Monte Carlo valuation models. We also consider our counterparty’s and own credit risk on derivatives and other liabilities measured at their estimated fair value. Fair Value Option Election: Recent Accounting Developments: Presentation of Debt Issuance Costs In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. Also in August 2015, the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated With Line-of-Credit Arrangements” which clarifies the SEC staff’s position not objecting to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing such costs, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. We adopted these standards for the quarter ended December 31, 2015. There were deferred financing costs of $28.4 million and $27.0 million as of December 31, 2015 and 2014, respectively that are now classified within Debt, net on our consolidated balance sheets. Measurement-Period Adjustments for Business Combinations In September 2015, the FASB issued ASU 2015-16, “Simplifying the Accounting for Measurement-Period Adjustments” to simplify the accounting for business combinations, specifically as it relates to measurement-period adjustments. Acquiring entities in a business combination must recognize measurement-period adjustments in the reporting period in which the adjustment amounts are determined. Also, ASU 2015-16 requires entities to present separately on the face of the income statement (or disclose in the notes to the financial statements) the portion of the amount recorded in the current period earnings, by line item, that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. ASU 2015-16 is effective for us beginning in the 2015 fourth quarter and is to be applied prospectively to measurement-period adjustments that occur after the effective date. We do not expect the adoption of this ASU to have a significant impact on our consolidated financial statements. Revenue from Contracts with Customers In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers.” Under the new standard, revenue is recognized at the time a good or service is transferred to a customer for the amount of consideration received for that specific good or service. Entities may use a full retrospective approach or report the cumulative effect as of the date of adoption. On April 1, 2015, the FASB proposed deferring the effective date of this standard by one year to December 15, 2017, for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. We do not expect this standard to have a significant impact on our financial results, as a substantial portion of our revenue consists of rental income from leasing arrangements, which are specifically excluded from ASU No. 2014-09. Amendments to the Consolidation Analysis In February 2015, the FASB issued ASU 2015-02 that modifies the evaluation of whether limited partnerships and similar legal entities are VIEs, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. We do not believe this proposed standard will have a significant impact on us. This ASU is effective for fiscal years beginning after December 15, 2015. Leases In February 2016, the FASB issued ASU 2016-02 - Leases

Real Estate and Loans Receivabl

Real Estate and Loans Receivable	12 Months Ended
	Dec. 31, 2015
Text Block [Abstract]
Real Estate and Loans Receivable	3. Real Estate and Loans Receivable Acquisitions We acquired the following assets: 2015 2014 2013 Assets Acquired (in thousands) Land $ 126,336 $ 22,569 $ 41,473 Building 758,009 241,242 439,030 Intangible lease assets — subject to amortization (weighted average useful life of 30.4 years in 2015, 18.2 years in 2014 and 21.0 years in 2013) 154,719 22,513 38,589 Net investments in direct financing leases 174,801 — 110,580 Mortgage loans 380,000 — 20,000 Other loans 523,605 447,664 5,250 Equity investments and other assets 101,716 33,708 — Liabilities (317 ) — — Total assets acquired $ 2,218,869 $ 767,696 $ 654,922 Loans repaid(1) (385,851 ) — — Total net assets acquired $ 1,833,018 $ 767,696 $ 654,922 (1) Loans advanced to MEDIAN in 2014 and repaid in 2015 as part of step 2 of the MEDIAN transaction. See below for details. 2015 Activity Acquisition of Capella Healthcare Hospital Portfolio In July 2015, we entered into definitive agreements to acquire a portfolio of seven acute care hospitals owned and operated by Capella for a combined purchase price and investment of approximately $900 million, adjusted for any cash on hand. The transaction includes our investments in seven acute care hospitals (two of which are in the form of mortgage loans) for an aggregate investment of approximately $600 million, an acquisition loan for approximately $290 million and a 49% equity interest in the ongoing operator of the facilities. In conjunction with the acquisition, MPT Camaro Opco, LLC, a wholly-owned subsidiary of MDS, formed a joint venture limited liability company, Capella Health Holdings, LLC (“Capella Holdings”), with an entity affiliated with the current senior management of Capella (“ManageCo”). MPT Camaro Opco, LLC holds 49% of the equity interests in Capella Holdings and the ManageCo holds the remaining 51%. Capella and its operating subsidiaries are managed and operated by ManageCo pursuant to the terms of one or more management agreements, the terms of which include base management fees payable to ManageCo and incentive payments tied to agreed benchmarks. Pursuant to the limited liability company agreement of Capella Holdings, ManageCo and MPT Camaro Opco, LLC will share profits and distributions from Capella Holdings according to a distribution waterfall under which, if certain benchmarks are met, after taking into account interest paid on the acquisition loan, ManageCo and MPT Camaro Opco, LLC will share in cash generated by Capella Holdings in a ratio of 35% to ManageCo and 65% to MPT Camaro Opco, LLC. The limited liability company agreement provides that ManageCo will manage Capella Holdings and MPT Camaro Opco, LLC will have no management authority or control except for certain protective rights consistent with a passive ownership interest, such as a limited right to approve certain components of the annual budgets and the right to approve extraordinary transactions. On August 31, 2015, we closed on six of the seven Capella properties, two of which were in the form of mortgage loans, and expect to close on the seventh property in 2016. We entered into a master lease and mortgage loans for the acquired properties providing for 15-year terms with four 5-year extension options, plus consumer price-indexed increases, limited to a 2% floor and a 4% ceiling annually. The acquisition loan has a 15-year term and carries a fixed interest rate of 8%. On October 30, 2015, we acquired an additional acute hospital in Camden, South Carolina for an aggregate purchase price of $25.8 million. We leased this hospital to Capella pursuant to the 2015 master lease. In connection with the transaction, we funded an additional acquisition loan to Capella of $9.2 million. As of December 31, 2015, our acquisition loan is $487.7 million, of which $100 million is related to the funding of the eighth property that is expected to close in 2016. MEDIAN Transaction Update During early 2015, we made additional loans of approximately €240 million on behalf of MEDIAN, a German provider of post-acute and acute rehabilitation services, to complete step one of a two step process to acquire the healthcare real estate of MEDIAN. On April 29, 2015, we entered into a series of definitive agreements with MEDIAN to complete the acquisition of the real estate assets of 32 hospitals owned by MEDIAN for an aggregate purchase price of approximately €688 million. Upon acquisition, each property became subject to a master lease between us and MEDIAN providing for the leaseback of the property to MEDIAN. The master lease has an initial term of 27 years and provides for annual escalations of rent at the greater of one percent or 70% of the German consumer price index. MEDIAN is owned by an affiliate of Waterland Private Equity Fund V C.V. (“Waterland”), which acquired 94.9% of the outstanding equity interests in MEDIAN, and by a subsidiary of our Operating Partnership, which acquired the remaining 5.1% of the outstanding equity interests in MEDIAN, each in December 2014. See “2014 Activity” for further details of our 2014 activity with MEDIAN. At each closing, the purchase price for each facility has been reduced and offset against the interim loans made to affiliates of Waterland and MEDIAN and against the amount of any debt assumed or repaid by us in connection with the closing. As part of this transaction, we incurred approximately $37 million of real estate transfer tax in 2015. As of December 31, 2015, we have closed on 31 of the 32 properties for an aggregate amount of €646 million. As of December 31, 2015, we have no loans outstanding to MEDIAN. An affiliate of Waterland controls RHM Klinik-und Altenheimbetriebe GmbH & Co. KG (“RHM”), the operator and lessee of the other German facilities that we own. MEDIAN and RHM merged in December 2015. For concentration disclosures that follow in this Note 3, we will show MEDIAN and RHM on a combined basis as MEDIAN. Other Acquisitions On December 3, 2015, we acquired a 266-bed outpatient rehabilitation clinic located in Hannover, Germany from RHM for €18.7 million. Upon acquisition, the facility was leased back under our existing master lease with RHM, providing for a remaining term of 25 years and annual rent increases of 2.0% in 2017 and 0.5% thereafter. On December 31, 2020 and every three years thereafter, rent will also be increased to reflect 70% of cumulative increases in the German consumer price index. On November 18, 2015, we acquired seven acute care hospitals and a freestanding clinic in northern Italy for an aggregate purchase price to us of approximately €90 million. The acquisition was effected through a newly-formed joint venture between us and affiliates of AXA Real Estate, in which we own a 50% interest. The facilities are leased to an Italian acute care hospital operator, pursuant to a long-term master lease. We are accounting for our 50% interest in this joint venture under the equity method. On September 30, 2015, we provided a $100 million mortgage financing to Prime for three general acute care hospitals and one free-standing emergency department and health center in New Jersey. The loan has a five-year term and provides for consumer-priced indexed interest increases, subject to a floor. On September 9, 2015, we acquired the real estate of a general acute care hospital under development located in Valencia, Spain The acquisition was effected through a newly-formed joint venture between us and clients of AXA Real Estate, in which we will own a 50% interest. Our expected share of the aggregate purchase and development price is €21.4 million. Upon completion, the facility will be leased to a Spanish operator of acute care hospitals, pursuant to a long-term lease. We are accounting for our 50% interest in this joint venture under the equity method. On August 31, 2015, we closed on a $30 million mortgage loan transaction with Prime for the acquisition of Lake Huron Medical Center, a 144-bed general acute care hospital located in Port Huron, Michigan. The loan provides for consumer-priced indexed interest increases, subject to a floor. On December 31, 2015, we acquired the real estate of Lake Huron Medical Center for $20 million, which reduced the mortgage loan accordingly. The facility is being leased to Prime under our master lease agreement. On June 16, 2015, we acquired the real estate of two facilities in Lubbock, Texas, a 60-bed inpatient rehabilitation hospital and a 37-bed long-term acute care hospital, for an aggregate purchase price of $31.5 million. We entered into a 20-year lease with Ernest for the rehabilitation hospital, which provides for three five-year extension options, and separately entered into a lease with Ernest for the long-term acute care hospital that has a final term ending December 31, 2034. In connection with the transaction, we funded an acquisition loan to Ernest of approximately $12.0 million. Ernest will operate the rehabilitation hospital in a joint venture with Covenant Health System, while the long-term acute care hospital will continue to be operated by Fundamental Health under a new sublease with Ernest. On February 27, 2015, we acquired an inpatient rehabilitation hospital in Weslaco, Texas for $10.7 million. We have leased this hospital to Ernest pursuant to the 2012 master lease, which has a remaining 17-year fixed term and three extension options of five years each. This lease provides for consumer-priced-indexed annual rent increases, subject to a floor and a cap. In addition, we funded an acquisition loan in the amount of $5 million. On February 13, 2015, we acquired two general acute care hospitals in the Kansas City area for $110 million. Prime is the tenant and operator pursuant to a new master lease that has similar terms and security enhancements as the other master lease agreements entered into in 2013. This master lease has a 10-year initial fixed term with two extension options of five years each. The lease provides for consumer-price-indexed annual rent increases, subject to a specified floor. In addition, we funded a mortgage loan in the amount of $40 million, which has a 10-year term. From the respective acquisition dates, the properties and mortgage loans acquired in 2015 contributed $102.4 million and $69.3 million of revenue and income (excluding related acquisition expenses), respectively, for the year ended December 31, 2015. In addition, we incurred $58 million of acquisition related costs on the 2015 acquisitions for the year ended December 31, 2015. The majority of the purchase price allocations attributable to the 2015 acquisitions are preliminary. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition dates that, if known, would have affected the measurement of the amounts recognized as of those dates. 2014 Activity MEDIAN Transaction On October 15, 2014, we entered into definitive agreements pursuant to which we would acquire substantially all the real estate assets of MEDIAN. The transaction was structured using a two step process in partnership with affiliates of Waterland. In the first step, an affiliate of Waterland acquired 94.9% of the outstanding equity interest in MEDIAN pursuant to a stock purchase agreement with MEDIAN’s current owners. We indirectly acquired the remaining 5.1% of the outstanding equity interest and provided or committed to provide interim acquisition loans to Waterland and MEDIAN in aggregate amounts of approximately €425 million, of which €349 million had been advanced at December 31, 2014. These interim loans bore interest at a rate similar to the initial lease rate under the planned sale and leaseback transactions. See “2015 Activity” for an update on the second step of this transaction — the sale-leaseback of the real estate. Other Acquisitions In the fourth quarter of 2014, we acquired three RHM rehabilitation facilities in Germany for an aggregate purchase price of €63.6 million (approximately $81 million) including approximately €3.0 million (or approximately $3.6 million) of transfer and other taxes that have been expensed as acquisition costs. These facilities include: Bad Mergentheim (211 beds), Bad Tolz (248 beds), and Bad Liebenstein (271 beds). All three properties are included under our 2013 master lease agreement with RHM as described below. On October 31, 2014, we acquired a 237-bed acute care hospital, associated medical office buildings, and a behavioral health facility in Sherman, Texas for $32.5 million. Alecto is the tenant and operator pursuant to a 15-year lease agreement with three five-year extension options. In addition, we funded a working capital loan of $7.5 million, and we obtained a 20% interest in the operator of the facility. On September 19, 2014, we acquired an acute care hospital in Fairmont, West Virginia for an aggregate purchase price of $15 million from Alecto. The facility was simultaneously leased back to the seller under a 15-year On July 1, 2014, we acquired an acute care hospital in Peasedown St. John, United Kingdom from Circle Health Ltd., through its subsidiary Circle Hospital (Bath) Ltd. The sale/leaseback transaction, excluding any transfer taxes, is valued at approximately £28.3 million (or approximately $48.0 million based on exchange rates at that time). The lease has an initial term of 15-years with a tenant option to extend the lease for an additional 15 years. The lease includes annual rent increases, which will equal the year-over-year change in the retail price index with a floor of 2% and a cap of 5%. With the transaction, we incurred approximately £1.1 million (approximately $1.9 million) of transfer and other taxes that have been expensed as acquisition costs. On March 31, 2014, we acquired a general acute care hospital and an adjacent parcel of land for an aggregate purchase price of $115 million from a joint venture of LHP Hospital Group, Inc. and Hackensack University Medical Center Mountainside. The facility was simultaneously leased back to the seller under a lease with a 15-year initial term with a 3-year extension option, followed by a further 12-year extension option at fair market value. The lease provides for consumer price-indexed annual rent increases, subject to a specified floor and ceiling. The lease includes a customary right of first refusal with respect to a subsequent proposed sale of the facility. From the respective acquisition dates in 2014 through that year end, the 2014 acquisitions contributed $12.4 million and $8.7 million of revenue and income (excluding related acquisition and financing expenses) for the period ended December 31, 2014. In addition, we incurred $26.4 million of acquisition related expenses in 2014, of which $25.2 million (including $5.8 million in transfer taxes as part of our RHM, Circle, and MEDIAN transactions) related to acquisitions consummated as of December 31, 2014. 2013 Activity RHM Portfolio Acquisition On November 29, 2013, we acquired 11 rehabilitation facilities in the Federal Republic of Germany from RHM for an aggregate purchase price, excluding €9 million applicable transfer taxes, of €175 million (or $237.8 million based on exchange rates at that time). Each of the facilities are leased to RHM under a master lease providing for a term of 27 years and for annual rent increases of 2.0% from 2015 through 2017, and of 0.5% thereafter. On December 31, 2020 and every three years thereafter, rent will be increased to reflect 70% of cumulative increases in the German consumer price index. Other Acquisitions On December 12, 2013, we acquired the real estate of Dallas Medical Center in Dallas, Texas from affiliates of Prime for a purchase price of $25 million and leased the facility to Prime with an initial 10-year lease term under the master lease agreement, plus two renewal options of five years each. This lease is accounted for as a direct financing lease. On September 26, 2013, we acquired three general acute care hospitals from affiliates of IASIS for a combined purchase price of $281.3 million. Each of the facilities were leased back to IASIS under leases with initial 15-year terms plus two renewal options of five years each, and consumer price-indexed rent increases limited to a 2.5% ceiling annually. The lessees have a right of first refusal option with respect to subsequent proposed sales of the facilities. All of our leases with affiliates of IASIS are cross-defaulted with each other. In addition to the IASIS acquisitions transactions, we amended our lease with IASIS for the Pioneer Valley Hospital in West Valley City, Utah, which extended the lease to 2028 from 2019 and adjusted the rent. On July 18, 2013, we acquired the real estate of Esplanade Rehab Hospital in Corpus Christi, Texas (now operating as Corpus Christi Rehabilitation Hospital). The total purchase price was $10.5 million including $0.5 million for adjacent land. The facility is leased to an affiliate of Ernest under the master lease agreement entered into in 2012 that initially provided for a 20-year term with three five-year extension options, plus consumer price-indexed rent increases, limited to a 2% floor and 5% ceiling annually. This lease is accounted for as a DFL. In addition, we made a $5.3 million loan on this property with terms similar to the lease terms. On June 11, 2013, we acquired the real estate of two acute care hospitals in Kansas from affiliates of Prime for a combined purchase price of $75 million and leased the facilities to the operator under a master lease agreement. The master lease is for 10 years and contains two renewal options of five years each, and the rent increases annually based on the greater of the consumer price-index or 2%. This lease is accounted for as a DFL. On December 31, 2013, we provided a $20 million mortgage financing to Alecto for the 204-bed Olympia Medical Center. From the respective acquisition dates, in 2013 through that year-end, the 2013 acquisitions contributed $13.6 million and $10.6 million of revenue and income (excluding related acquisition and financing expenses) for the period ended December 31, 2013. In addition, we incurred $19.5 million of acquisition related expenses in 2013, of which $18.0 million (including $12 million in transfer taxes as a part of the RHM acquisition) related to acquisitions consummated as of December 31, 2013. Pro Forma Information The following unaudited supplemental pro forma operating data is presented below as if each acquisition was completed on January 1, 2014 and January 1, 2013 for the year ended December 31, 2015 and 2014, respectively. The unaudited supplemental pro forma operating data is not necessarily indicative of what the actual results of operations would have been assuming the transactions had been completed as set forth above, nor do they purport to represent our results of operations for future periods (in thousands, except per share/unit amounts). For the Year Ended December 31, 2015 2014 Total revenues $ 542,763 $ 531,549 Net income 240,783 220,181 Net income per share/unit $ 1.02 $ 0.93 Development Activities 2015 Activity During 2015, we completed construction and began recording rental income on the following facilities: • First Choice ER (a subsidiary of Adeptus Health) – We completed 17 acute care facilities for this tenant during 2015 totaling $102.6 million. Fourteen of these facilities are leased pursuant to the master lease entered into in 2014 and are cross-defaulted with the original master lease executed with First Choice ER in 2013. Three properties are leased pursuant to the master lease entered into in 2015 and are cross-defaulted with the master leases entered into in 2014 and 2013. • UAB Medical West — This $8.6 million acute care facility and medical office building located in Birmingham, Alabama is leased to Medical West, an affiliate of The University of Alabama at Birmingham, for 15 years and contains four renewal options of five years each. The rent increases 2% annually. On May 5, 2015, we entered into an agreement to finance the development of and lease an inpatient rehabilitation facility in Toledo, Ohio for $19.2 million, which will be leased to Ernest under the 2012 master lease. The facility is expected to be completed in the second quarter of 2016. In April 2015, we executed an agreement with Adeptus Health that provides for the acquisition and development of general acute care hospitals and free standing emergency facilities with an aggregate commitment of $250 million. These facilities will be leased to Adeptus Health pursuant to the terms of the 2014 master lease agreement that has a 15-year initial term with three extension options of five years each that provides for annual rent increases based on changes in the consumer price index with a 2% minimum. With this commitment, along with similar agreements entered into in 2014 and 2013, we have committed to fund up to $500 million in acute care facilities with Adeptus Health. At December 31, 2015, we have funded $217.5 million that includes 35 completed and open facilities and 8 still under construction. 2014 Activity During 2014, we completed construction and began recording rental income on the following facilities: • Northern Utah Rehabilitation Hospital — This $19 million inpatient rehabilitation facility located in South Ogden, Utah is leased to Ernest pursuant to the 2012 master lease. • Oakleaf Surgical Hospital — This approximately $30 million acute care facility located in Altoona, Wisconsin. This facility is leased to National Surgical Hospitals for 15 years and contains two renewal options of five years each plus an additional option for nearly another five years, and the rent increases annually based on changes in the consumer price-index. • First Choice ER (a subsidiary of Adeptus Health) — We completed 17 acute care facilities for this tenant during 2014 totaling approximately $83.0 million. These facilities are leased pursuant to the master lease entered into in 2013. See table below for a status update on our current development projects (in thousands): Property Location Property Type Operator Commitment Costs Incurred Estimated First Choice ER — Houston(2) Houston, TX Acute Care Hospital Adeptus Health $ 5,257 $ 2,535 1Q 2016 First Choice ER- Denver(2) Denver, CO Acute Care Hospital Adeptus Health 5,300 2,435 2Q 2016 First Choice ER- Phoenix(2) Phoenix, AZ Acute Care Hospital Adeptus Health 6,728 3,275 2Q 2016 First Choice ER- San Antonio(2) San Antonio, TX Acute Care Hospital Adeptus Health 7,530 3,690 2Q 2016 First Choice ER- Texas Acute Care Hospital Adeptus Health 16,422 3,924 2Q 2016 Rehabilitation Hospital of Northwestern Ohio Toledo, OH Inpatient Rehabilitation Hospital Ernest Health 19,212 13,693 2Q 2016 First Choice ER- Houston Houston, TX Acute Care Hospital Adeptus Health 45,961 19,613 3Q 2016 First Choice Emergency Rooms Various Acute Care Hospital Adeptus Health 200,090 — Various $ 306,500 $ 49,165 (1) Includes three acute care facilities. (2) Freestanding emergency room. Disposals 2015 Activity On July 30, 2015, we sold a long-term acute care facility in Luling, Texas for approximately $9.7 million, resulting in a gain of $1.5 million. Due to this sale, we wrote off $0.9 million of straight-line receivables. On August 5, 2015, we sold six wellness centers in the United States for total proceeds of approximately $9.5 million (of which $1.5 million is in the form of a promissory note), resulting in a gain of $1.7 million. Due to this sale, we wrote off $0.9 million of billed rent receivables. With these disposals, we accelerated the amortization of the related lease intangible assets resulting in approximately $0.7 million of additional expense. The sale of the Luling facility and the six wellness centers were not strategic shifts in our operations, and therefore the results of operations related to these facilities have not been reclassified as discontinued operations. 2014 Activity On December 31, 2014, we sold our La Palma facility for $12.5 million, resulting in a gain of $2.9 million. Due to this sale, we wrote-off $1.3 million of straight-line rent receivables. On May 20, 2014, the tenant of our Bucks facility gave notice of their intent to exercise the lease’s purchase option. Pursuant to this purchase option, the tenant acquired the facility on August 6, 2014 for $35 million. We wrote down this facility to fair market value less cost to sell, resulting in a $3.1 million real estate impairment charge in the 2014 second quarter. The sale of the Bucks and La Palma facilities was not a strategic shift in our operations, and therefore the results of the Bucks and La Palma operations have not been reclassified as discontinued operations. 2013 Activity On November 27, 2013, we sold the real estate of an inpatient rehabilitation facility, Warm Springs Rehabilitation Hospital of San Antonio, for $14 million, resulting in a gain on sale of $5.6 million. On April 17, 2013, we sold two long-term acute care hospitals, Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas, for total proceeds of $18.5 million, resulting in a gain of $2.1 million. Intangible Assets At December 31, 2015 and 2014, our intangible lease assets were $257.0 million ($231.7 million, net of accumulated amortization) and $108.9 million ($87.7 million, net of accumulated amortization), respectively. We recorded amortization expense related to intangible lease assets of $9.1 million, $7.0 million, and $4.0 million in 2015, 2014, and 2013, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows: (amounts in thousands) For the Year Ended December 31: 2016 $ 10,204 2017 10,194 2018 10,133 2019 10,085 2020 9,882 As of December 31, 2015, capitalized lease intangibles have a weighted average remaining life of 24.0 years. Leasing Operations All of our leases are accounted for as operating leases except we are accounting for 15 Ernest facilities, five Prime facilities, and four Capella facilities as DFLs. The components of our net investment in DFLs consisted of the following (dollars in thousands): As of December 31, As of December 31, Minimum lease payments receivable $ 2,587,912 $ 1,607,024 Estimated residual values 393,097 211,888 Less unearned income (2,354,013 ) (1,379,396 ) Net investment in direct financing leases $ 626,996 $ 439,516 Minimum rental payments due to us in future periods under operating leases and DFLs, which have non-cancelable terms extending beyond one year at December 31, 2015, are as follows: (amounts in thousands) Total Under Total Under Total 2016 $ 295,839 $ 65,097 $ 360,936 2017 297,671 66,399 364,070 2018 299,662 67,727 367,389 2019 301,040 69,081 370,121 2020 301,460 70,463 371,923 Thereafter 4,847,165 2,039,146 6,886,311 $ 6,342,837 $ 2,377,913 $ 8,720,750 Hoboken Facility In the 2015 third quarter, a subsidiary of the operator of our Hoboken facility acquired 10% of our subsidiary that owns the real estate for $5 million, which is reflected in the non-controlling interest line of our consolidated balance sheet at December 31, 2015. Twelve Oaks Facility In the third quarter of 2015, we sent notice of termination of the lease to the tenant at our Twelve Oaks facility. As a result of the lease terminating, we recorded a charge of $1.9 million to reserve against the straight-line rent receivables. In addition, we accelerated the amortization of the related lease intangible asset resulting in $0.5 million of additional expense during 2015. At December 31, 2015, we have approximately $1 million of exposure outstanding with this tenant, but we received $0.8 million in payments subsequent to year-end. In addition, we have a letter of credit for approximately $0.5 million to cover any rent and other monetary payments not paid. Although no assurances can be made that we will not have any impairment charges or write-offs of receivables in the future, we believe our investment in Twelve Oaks at December 31, 2015 is fully recoverable. Monroe Facility During 2014, the previous operator of our Monroe facility continued to underperform and became further behind on payments to us as required by the real estate lease agreement and working capital loan agreement. In August 2014, this operator filed for bankruptcy. Based on these developments and the fair value of our real estate and the underlying collateral of our loan (using Level 2 inputs), we recorded a $47.0 million impairment charge in 2014. Effective December 31, 2014, the bankruptcy court approved the purchase by Prime of the assets of the prior operator. Prime leases the facility from us pursuant to terms under an existing master lease. The initial annual lease payment was approximately $2.5 million, and Prime has been current on its rent since lease inception. At December 31, 2015, our investment in Monroe is approximately $36 million, which we believe is fully recoverable. Florence Facility On March 6, 2013, the tenant of our facility in Phoenix, Arizona filed for Chapter 11 bankruptcy. At December 31, 2015, we have approximately $0.9 million of receivables outstanding, but the tenant continues to pay us in accordance with bankruptcy orders. In addition, we have a letter of credit for approximately $1.2 million to cover any rent and other monetary payments not paid. Although no assurances can be made that we will not have any impairment charges in the future, we believe our investment in Florence of $26.7 million at December 31, 2015, is fully recoverable. Loans The following is a summary of our loans ($ amounts in thousands): As of December 31, 2015 As of December 31, 2014 Balance Weighted Average Balance Weighted Average Mortgage loans $ 757,581 9.5 % $ 397,594 10.5 % Acquisition loans 610,469 9.1 % 525,136 9.3 % Working capital and other loans 54,353 10.2 % 48,031 10.4 % $ 1,422,403 $ 970,761 Our mortgage loans cover 14 of our properties with four operators. The increase in mortgage loans relates to the two loans for $210 million made to Capella with the remainder to Prime — See “2015 Activity” under the Acquisition section for more details. Other loans typically consist of loans to our tenants for acquisitions and working capital purposes. At December 31, 2015, acquisition loans include our $114.4 million of loans to Ernest plus $487.7 million related to the Capella transaction. The new Capella acquisition loans more than offset the MEDIAN loans that were converted to real estate in 2015 — See “2015 Activity” under the Acquisition section for more details. On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At December 31, 2015, $3.3 million remains outstanding on the convertible note, and we retain the option to convert this remainder into an additional 15.1% equity interest in the operator. Concentration of Credit Risks Investments and Revenue by Operator As of December 31, 2015: (Dollar amounts in thousands) Operators Total Assets Percentage of Total Total Percentage of Prime $ 1,032,353 18.4 % $ 104,325 23.6 % Capella 1,015,914 18.1 % 28,567 6.4 % MEDIAN 978,529 17.4 % 78,540 17.8 % Ernest 569,375 10.2 % 61,988 14.0 % As of December 31, 2014: (Dollar amounts in thousands) Operators Total Assets Percentage of Total Total Percentage of Prime $ 749,553 20.1 % $ 84,038 26.9 % MEDIAN 707,437 19.0 % 23,663 7.6 % Ernest 486,758 13.1 % 57,315 18.3 % Investments and Revenue by U.S. State and Country As of December 31, 2015: (Dollar amounts in thousands) U.S. States and Other Countries Total Assets Percentage of Total Total Percentage of Texas $ 917,314 16.4 % $ 87,541 19.8 % California 547,085 9.8 % 66,120 15.0 % Germany 978,529 17.4 % 78,540 17.8 % Italy, Spain, and the U.K. 152,661 2.7 % 4,476 1.0 % As of December 31, 2014: (Dollar amounts in thousands) U.S. States and Other Countries Total Assets Percentage of Total Total Percentage of Total Texas $ 776,017 20.9 % $ 74,044 23.7 % California 547,098 14.7 % 64,268 20.5 % Germany 707,437 19.0 % 23,663 7.6 % U.K. 44,005 1.2 % 2,322 0.7 % On an individual property basis, we had no investment of any single property greater than 2% of our total assets as of December 31, 2015. From a global geographic perspective, approximately 80% of our total assets are in the United States while 20% reside in Europe as of December 31, 2015 and 2014. Revenue from our European investments was $83.0 million and $26.0 million in 2015

Debt

Debt	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Debt	4. Debt The following is a summary of debt ($ amounts in thousands): As of December 31, 2015 As of December 31, 2014 Balance Interest Rate Balance Interest Rate Revolving credit facility $ 1,100,000 Variable $ 593,490 Variable 2006 Senior Unsecured Notes 125,000 Various 125,000 Various 2011 Senior Unsecured Notes 450,000 6.875 % 450,000 6.875 % 2012 Senior Unsecured Notes: Principal amount 350,000 6.375 % 350,000 6.375 % Unamortized premium 2,168 2,522 352,168 352,522 2013 Senior Unsecured Notes(A) 217,240 5.75 % 241,960 5.75 % 2014 Senior Unsecured Notes 300,000 5.50 % 300,000 5.50 % 2015 Senior Unsecured Notes(A) 543,100 4.00 % — — Term loans 263,400 Various 138,682 Various $ 3,350,908 $ 2,201,654 Debt issue costs, net (28,367 ) (27,006 ) $ 3,322,541 $ 2,174,648 As of December 31, 2015, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows: 2016 $ 125,299 2017 320 2018 1,112,781 2019 250,000 2020 217,240 Thereafter 1,643,100 Total $ 3,348,740 (A) These notes are Euro-denominated and reflect the exchange rates at December 31, 2015 and 2014, respectively. Revolving Credit Facility On June 19, 2014, we closed on a $900 million senior unsecured credit facility (the “Credit Facility”). The Credit Facility was comprised of a $775 million senior unsecured revolving credit facility (the “Revolving credit facility”) and a $125 million senior unsecured term loan facility (the “Term Loan”). The Credit Facility had an accordion feature that allowed us to expand the size of the facility by up to $250 million through increases to the Revolving credit facility, Term Loan, both or as a separate term loan tranche. The Credit Facility replaced our previous $400 million unsecured revolving credit facility and $100 million unsecured term loan. This transaction resulted in a refinancing charge of approximately $0.3 million in the 2014 second quarter. On October 17, 2014, we entered into an amendment to our Credit Facility to exercise the $250 million accordion on the Revolving credit facility. This amendment increased the Credit Facility to $1.15 billion and added a new accordion feature that allowed us to expand our credit facility by another $400 million. On August 4, 2015, we entered into an amendment to our Revolving credit facility and Term Loan agreement to increase the current aggregate committed size to $1.25 billion and amend certain covenants in order to permit us to consummate and finance the acquisition of Capella. On September 30, 2015, we further amended our Credit Facility to, among other things, increase the aggregate commitment under our Revolving credit facility to $1.3 billion and increase the Term Loan portion to $250 million. In addition, this amendment includes a new accordion feature that allows us to expand our credit facility by another $400 million for a total commitment of $1.95 billion. This amendment resulted in a $0.1 million expense in the 2015 third quarter. The Revolving credit facility matures in June 2018 and can be extended for an additional 12 months at our option. The Revolving credit facility’s interest rate was originally set as (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Eurodollar rate plus 1.00%, plus a spread that was adjustable from 0.70% to 1.25% based on current total leverage, or (2) LIBOR plus a spread that was adjustable from 1.70% to 2.25% based on current total leverage. In addition to interest expense, we were required to pay a quarterly commitment fee on the undrawn portion of the revolving credit facility, ranging from 0.25% to 0.35% per year. In November 2014, we received an upgrade to our credit rating resulting in an improvement in our interest rate spreads and commitment fee rates. Effective December 10, 2014, the Revolving credit facility’s interest rate is (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Eurodollar rate plus 1.00% plus a fixed spread of 0.40% or (2) LIBOR plus a fixed spread of 1.40%. In regards to commitment fees, we now pay based on the total facility at a rate of 0.30% per year. At December 31, 2015 and 2014, we had $1.1 billion and $593.5 million, respectively, outstanding on the Revolving credit facility. At December 31, 2015, our availability under our Revolving credit facility was $200 million. The weighted average interest rate on this facility was 1.7% and 2.2% for 2015 and 2014, respectively. 2015 Senior Unsecured Notes On August 19, 2015, we completed a €500 million senior unsecured notes offering (“2015 Senior Unsecured Notes”), proceeds of which were used to repay Euro-denominated borrowings under our Revolving credit facility and to fund our European investments. Interest on the notes will be payable annually on August 19 of each year, commencing on August 19, 2016. The 2015 Senior Unsecured Notes will pay interest in cash at a rate of 4.00% per year. The notes mature on August 19, 2022. We may redeem some or all of the 2015 Senior Unsecured Notes at any time. If the notes are redeemed prior to 90 days before maturity, the redemption price will be 100% of their principal amount, plus a make-whole premium, plus accrued and unpaid interest to, but excluding, the applicable redemption date. Within the period beginning on or after 90 days before maturity, the notes may be redeemed, in whole or in part, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the applicable redemption date. The 2015 Senior Unsecured Notes are fully and unconditionally guaranteed on an unsecured basis by the Company. In the event of a change of control, each holder of the notes may require us to repurchase some or all of our notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of the purchase. 2014 Senior Unsecured Notes On April 17, 2014, we completed a $300 million senior unsecured notes offering (“2014 Senior Unsecured Notes”). Interest on the notes is payable semi-annually on May 1 and November 1 of each year. The 2014 Senior Unsecured Notes pay interest in cash at a rate of 5.50% per year. The notes mature on May 1, 2024. We may redeem some or all of the 2014 Senior Unsecured Notes at any time prior to May 1, 2019 at a “make-whole” redemption price. On or after May 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to May 1, 2017, we may redeem up to 35% of the aggregate principal amount of the 2014 Senior Unsecured Notes using the proceeds of one or more equity offerings. In the event of a change of control, each holder of the 2014 Senior Unsecured Notes may require us to repurchase some or all of our 2014 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount of the 2014 Senior Unsecured Notes plus accrued and unpaid interest to the date of purchase. 2013 Senior Unsecured Notes On October 10, 2013, we completed the 2013 Senior Unsecured Notes offering for €200 million. Interest on the notes is payable semi-annually on April 1 and October 1 of each year. The 2013 Senior Unsecured Notes pay interest in cash at a rate of 5.750% per year. The notes mature on October 1, 2020. We may redeem some or all of the 2013 Senior Unsecured Notes at any time prior to October 1, 2016 at a “make-whole” redemption price. On or after October 1, 2016, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to October 1, 2016, we may redeem up to 35% of the aggregate principal amount of the 2013 Senior Unsecured Notes using the proceeds of one or more equity offerings. In the event of a change of control, each holder of the 2013 Senior Unsecured Notes may require us to repurchase some or all of our 2013 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount of the 2013 Senior Unsecured Notes plus accrued and unpaid interest to the date of purchase. 2012 Senior Unsecured Notes On February 17, 2012, we completed a $200 million offering of senior unsecured notes (“2012 Senior Unsecured Notes”) (resulting in net proceeds of $196.5 million, after underwriting discount). On August 20, 2013, we completed a $150 million tack on to the notes (resulting in net proceeds of $150.4 million, after underwriting discount). These 2012 Senior Unsecured Notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2013 tack on offering, was issued at a premium (price of 102%), resulting in an effective rate of 5.998%. Interest on these notes is payable semi-annually on February 15 and August 15 of each year. We may redeem some or all of the 2012 Senior Unsecured Notes at any time prior to February 15, 2017 at a “make-whole” redemption price. On or after February 15, 2017, we may redeem some or all of the 2012 Senior Unsecured Notes at a premium that will decrease over time, plus accrued and unpaid interest to, but not including, the redemption date. In the event of a change of control, each holder of the 2012 Senior Unsecured Notes may require us to repurchase some or all of its 2012 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount plus accrued and unpaid interest to the date of purchase. 2011 Senior Unsecured Notes On April 26, 2011, we closed on a private placement of $450 million senior notes (the “2011 Senior Unsecured Notes”) to qualified institutional buyers in reliance on Rule 144A under the Securities Act. The 2011 Senior Unsecured Notes were subsequently registered under the Securities Act pursuant to an exchange offer. Interest on the 2011 Senior Unsecured Notes is payable semi-annually on May 1 and November 1 of each year. The 2011 Senior Unsecured Notes pay interest in cash at a rate of 6.875% per year and mature on May 1, 2021. We may redeem some or all of the 2011 Senior Unsecured Notes at any time prior to May 1, 2016 at a “make-whole” redemption price. On or after May 1, 2016, we may redeem some or all of the 2011 Senior Unsecured Notes at a premium that will decrease over time, plus accrued and unpaid interest to, but not including, the redemption date. In the event of a change of control, each holder of the 2011 Senior Unsecured Notes may require us to repurchase some or all of its 2011 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount plus accrued and unpaid interest to the date of purchase. 2006 Senior Unsecured Notes During 2006, we issued $125.0 million of Senior Unsecured Notes (the “2006 Senior Unsecured Notes”). The 2006 Senior Unsecured Notes were placed in private transactions exempt from registration under the Securities Act. One of the issuances of the 2006 Senior Unsecured Notes totaling $65.0 million pays interest quarterly at a floating annual rate of three-month LIBOR plus 2.30% and can be called at par value by us at any time. This portion of the 2006 Senior Unsecured Notes matures in July 2016. The remaining issuances of 2006 Senior Unsecured Notes pays interest quarterly at a floating annual rate of three-month LIBOR plus 2.30% and can also be called at par value by us at any time. These remaining notes mature in October 2016. During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our $125 million 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At December 31, 2015 and 2014, the fair value of the interest rate swaps was $2.9 million and $6.0 million, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets. We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effects earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness from inception of our interest rate swaps through December 31, 2015 and therefore, there was no income statement effect recorded during the years ended December 31, 2015, 2014, and 2013. We do expect the current losses included in accumulated other comprehensive loss to be reclassified into earnings between now and the maturity of the related debt in July and October 2016. At December 31, 2015 and 2014, we have posted $1.7 million and $3.3 million of collateral related to our interest rate swaps, respectively, which is reflected in other assets on our consolidated balance sheets. Term Loans As noted previously under the Revolving Credit Facility section, we closed on the Term Loan for $125 million in the second quarter of 2014. Furthermore, as noted above, we amended the credit facility to increase the Term Loan portion to $250 million in the third quarter of 2015. The Term Loan matures in June 2019. The Term Loan’s initial interest rate was (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Eurodollar rate plus 1.00%, plus a spread that was adjustable from 0.60% to 1.20% based on current total leverage, or (2) LIBOR plus a spread that was adjustable from 1.60% to 2.20% based on current total leverage. With the upgrade to our credit rating as discussed above, the Term Loan’s interest rate, effective December 10, 2014, improved to (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Euro dollar rate plus 1.00% plus a fixed spread of 0.65%, or (2) LIBOR plus a fixed spread of 1.65%. At December 31, 2015 and 2014, the interest rate in effect on the Term Loan was 2.05% and 1.82%, respectively. In connection with our acquisition of the Northland LTACH Hospital on February 14, 2011, we assumed a $14.6 million mortgage. The Northland mortgage loan requires monthly principal and interest payments based on a 30-year amortization period. The Northland mortgage loan has a fixed interest rate of 6.2%, matures on January 1, 2018 and can be prepaid, subject to a certain prepayment premium. At December 31, 2015, the remaining balance on this term loan was $13.4 million. The loan is collateralized by the real estate of the Northland LTACH Hospital, which had a net book value of $16.9 million and $17.5 million at December 31, 2015 and 2014, respectively. Other Financing On July 27, 2015, we received a commitment to provide a senior unsecured bridge loan facility in the original principal amount of $1.0 billion to fund the acquisition of Capella pursuant to a commitment letter from JPMorgan Chase Bank, N.A. and Goldman, Sachs & Co. Funding under the bridge facility was not necessary as we funded the acquisition through a combination of an equity issuance and other borrowings. We incurred and expensed certain customary structuring and underwriting fees of $3.9 million in the 2015 third quarter related to the bridge commitment. Covenants Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our Credit Facility limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. At December 31, 2015, the dividend restriction was 95% of normalized adjusted FFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness. In addition to these restrictions, the Credit Facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, consolidated adjusted net worth, unsecured leverage ratio, and unsecured interest coverage ratio. This Credit Facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the Credit Facility, the entire outstanding balance may become immediately due and payable. At December 31, 2015, we were in compliance with all such financial and operating covenants. At December 31, 2015, the total leverage ratio covenant in our Credit Facility was 70% and the unsecured leverage ratio covenant was 77.5%. In June 2016, the total leverage ratio will reset to 60%, and in September 2016, the unsecured leverage ratio will reset to 65%. We expect to comply with these reset leverage requirements by reducing debt through asset sales, retention of cash generated from our monthly rent and interest receipts, and other access to capital through joint ventures, our at-the-market equity offering program and equity offerings. We may also seek to extend the covenant reset dates; however, no assurances can be made that such extensions will be approved by our lenders. If an event of default occurs and is continuing under the Credit Facility, the entire outstanding balance may become immediately due and payable which could have a material adverse impact to the Company.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	5. Income Taxes Medical Properties Trust, Inc. We have maintained and intend to maintain our election as a REIT under the Internal Revenue Code of 1986, as amended. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable income to our stockholders. As a REIT, we generally will not be subject to federal income tax if we distribute 100% of our taxable income to our stockholders and satisfy certain other requirements. Income tax is paid directly by our stockholders on the dividends distributed to them. If our taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax. Taxable income from non-REIT activities managed through our taxable REIT subsidiaries is subject to applicable United States federal, state and local income taxes. Our international subsidiaries are also subject to income taxes in the jurisdictions in which they operate. From our taxable REIT subsidiaries and our foreign operations, we incurred income tax expenses as follows (in thousands): For the years ended December 31, 2015 2014 2013 Current income tax expense: Domestic $ 147 $ 114 $ 358 Foreign 1,614 225 158 1,761 339 516 Deferred income tax (benefit) expense: Domestic (360 ) (23 ) 210 Foreign 102 24 — (258 ) 1 210 Income tax expense $ 1,503 $ 340 $ 726 The foreign provision (benefit) for income taxes is based on foreign loss before income taxes of $29.4 million in 2015 as compared with foreign loss before income taxes of $7.5 million in 2014, and foreign loss before income taxes of $12.9 million in 2013. The domestic provision (benefit) for income taxes is based on income before income taxes of $7.1 million in 2015 from our taxable REIT subsidiaries as compared with loss before income taxes of $20.9 million in 2014 from our taxable REIT subsidiaries, and income before income taxes of $7.6 million in 2013 from our taxable REIT subsidiaries. At December 31, 2015 and 2014, components of our deferred tax assets and liabilities were as follows (in thousands): 2015 2014 Deferred tax liabilities: Property and equipment $ (1,636 ) $ — Unbilled rent (4,495 ) (2,070 ) Partnership investments (3,362 ) (3,468 ) Other (6,141 ) (3,759 ) Total deferred tax liabilities $ (15,634 ) $ (9,297 ) Deferred tax assets: Operating loss and interest deduction carry forwards $ 19,016 $ 19,546 Property and equipment — 2,373 Other 10,314 3,971 Total deferred tax assets 29,330 25,890 Valuation allowance (23,005 ) (16,831 ) Total net deferred tax assets $ 6,325 $ 9,059 Net deferred tax (liability) $ (9,309 ) $ (238 ) At December 31, 2015, we had U.S. federal and state NOLs of $41.4 million and $107.7 million, respectively, that expire in 2021 through 2034. At December 31, 2015, we had foreign NOLs of $10.8 million that may be carried forward indefinitely. At December 31, 2015, we had U.S. federal alternative minimum tax credits of $0.3 million that may be carried forward indefinitely. At December 31, 2015, we had U.S. federal foreign tax credits of $0.6 million that expire in 2025. In 2015, our valuation allowance increased by $6.2 million as a result of book losses sustained by our foreign subsidiaries as the result of significant acquisition expenses incurred. We believe (based on cumulative losses and potential of future taxable income) that we should reserve for our net deferred tax assets. We will continue to monitor this valuation allowance and, if circumstances change (such as entering into new transactions including working capital loans, equity investments, etc.), we will adjust this valuation allowance accordingly. A reconciliation of the income tax expense at the statutory income tax rate and the effective tax rate for income from continuing operations before income taxes for the years ended December 31, 2015, 2014, and 2013 is as follows (in thousands): 2015 2014 2013 Income from continuing operations (before-tax) $ 141,430 $ 51,138 $ 90,027 Income tax at the US statutory federal rate (35%) 49,501 17,898 31,509 Increase (decrease) resulting from: Rate differential 5,047 1,145 2,380 State income taxes, net of federal benefit (601 ) (337 ) 271 Dividends paid deduction (57,109 ) (27,873 ) (33,345 ) Change in valuation allowance 6,174 8,988 (697 ) Other items, net (1,509 ) 519 608 Total income tax expense $ 1,503 $ 340 $ 726 We have met the annual REIT distribution requirements by payment of at least 90% of our estimated taxable income in 2015, 2014, and 2013. Earnings and profits, which determine the taxability of such distributions, will differ from net income reported for financial reporting purposes due primarily to differences in cost basis, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes. A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, 2015 2014 2013 Common share distribution $ 0.870000 $ 0.840000 $ 0.800000 Ordinary income 0.769535 0.520692 0.599384 Capital gains(1) — 0.000276 0.046380 Unrecaptured Sec. 1250 gain — 0.000276 0.026512 Return of capital 0.100465 0.319032 0.154236 Allocable to next year — — — (1) Capital gains include unrecaptured Sec. 1250 gains. MPT Operating Partnership, L.P. As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed taxable REIT subsidiaries on behalf of Medical Properties Trust, Inc., which are subject to federal, state and local income taxes at regular corporate rates, and its international subsidiaries are subject to income taxes in the jurisdictions in which they operate. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our taxable REIT subsidiaries and international operations.

Earnings Per Share_Unit

Earnings Per Share/Unit	12 Months Ended
	Dec. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share/Unit	6. Earnings Per Share/Unit Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2015 2014 2013 Numerator: Income from continuing operations $ 139,927 $ 50,798 $ 89,301 Non-controlling interests’ share in continuing operations (329 ) (274 ) (224 ) Participating securities’ share in earnings (1,029 ) (894 ) (729 ) Income from continuing operations, less participating securities’ share in earnings 138,569 49,630 88,348 Income (loss) from discontinued operations attributable to MPT common stockholders — (2 ) 7,914 Net income, less participating securities’ share in earnings $ 138,569 $ 49,628 $ 96,262 Denominator: Basic weighted-average common shares 217,997 169,999 151,439 Dilutive potential common shares 307 541 1,159 Diluted weighted-average common shares 218,304 170,540 152,598 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2015 2014 2013 Numerator: Income from continuing operations $ 139,927 $ 50,798 $ 89,301 Non-controlling interests’ share in continuing operations (329 ) (274 ) (224 ) Participating securities’ share in earnings (1,029 ) (894 ) (729 ) Income from continuing operations, less participating securities’ share in earnings 138,569 49,630 88,348 Income (loss) from discontinued operations attributable to MPT Operating Partnership partners — (2 ) 7,914 Net income, less participating securities’ share in earnings $ 138,569 $ 49,628 $ 96,262 Denominator: Basic weighted-average units 217,997 169,999 151,439 Dilutive potential units 307 541 1,159 Diluted weighted-average units 218,304 170,540 152,598

Stock Awards

Stock Awards	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Awards	7. Stock Awards Stock Awards Our Equity Incentive Plan authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. Our Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 8,196,770 shares of common stock for awards under the Equity Incentive Plan and 5,605,272 shares remain available for future stock awards as of December 31, 2015. The Equity Incentive Plan contains a limit of 5,000,000 shares as the maximum number of shares of common stock that may be awarded to an individual in any fiscal year. Awards under the Equity Incentive Plan are subject to forfeiture due to termination of employment prior to vesting. In the event of a change in control, outstanding and unvested options will immediately vest, unless otherwise provided in the participant’s award or employment agreement, and restricted stock, restricted stock units, deferred stock units and other stock-based awards will vest if so provided in the participant’s award agreement. The term of the awards is set by the Compensation Committee, though Incentive Stock Options may not have terms of more than ten years. Forfeited awards are returned to the Equity Incentive Plan and are then available to be re-issued as future awards. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its Equity Incentive Plan, the Operating Partnership issues a corresponding number of Operating Partnership units. The following awards have been granted pursuant to our Equity Incentive Plan (and its predecessor plan): Restricted Equity Awards These stock-based awards are in the form of service-based awards and performance-based awards. The service-based awards vest as the employee provides the required service (typically three to five years). Service based awards are valued at the average price per share of common stock on the date of grant. In 2015, 2014, and 2013, the Compensation Committee granted performance – based awards to employees which vest based on us achieving certain total shareholder returns or comparisons of our total shareholder returns to peer total return indices. Generally, dividends are not paid on these performance awards until the award is earned. See below for details of such grants: 2015 performance awards — The 2015 performance awards were granted in three parts: 1) Approximately 40% of the 2015 performance awards were based on us achieving a simple 9.0% annual total shareholder return. For the three-year period from January 1, 2015 through December 31, 2017, one-third of the awards will be earned annually if a 9.0% total shareholder return is achieved. If total shareholder return does not reach 9.0% in a particular year, shares for that year can be earned in a future period (during the three-year period) if the cumulative total shareholder return is equal to or greater than a 9.0% annual return for such cumulative period. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.1%; expected volatility of 20%; expected dividend yield of 7.2%; and expected service period of 3 years. 2) Approximately 30% of the 2015 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2015 to December 31, 2017. The minimum total shareholder return needed to earn a portion of this award is 27.0% with 100% of the award earned if our total shareholder return reaches 35.0%. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2017, 2018 and 2019. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.1%; expected volatility of 20%; expected dividend yield of 7.2%; and expected service period of 5 years. 3) The remainder of the 2015 performance awards will be earned if our total shareholder return outpaces that of the MSCI U.S. REIT Index (“Index”) over the cumulative period from January 1, 2015 to December 31, 2017. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 6% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2017, 2018 and 2019. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.1%; expected volatility of 20%; expected dividend yield of 7.2%; and expected service period of 5 years. No 2015 performance awards were earned and vested in 2015; 4,500 performance awards were forfeited in 2015. At December 31, 2015, we have 867,388 of 2015 performance awards remaining to be earned. 2014 performance awards — The 2014 performance awards were granted in three parts: 1) Approximately 40% of the 2014 performance awards were based on us achieving a simple 9.0% annual total shareholder return. For the five-year period from January 1, 2014 through December 31, 2018, one-third of the awards will be earned annually (until the award is fully earned) if a 9.0% total shareholder return is achieved. If total shareholder return does not reach 9.0% in a particular year, shares for that year can be earned in a future period (during the five-year period) if the cumulative total shareholder return is equal to or greater than a 9.0% annual return for such cumulative period. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.7%; expected volatility of 27%; expected dividend yield of 8.0%; and expected service period of 3 years. 2) Approximately 30% of the 2014 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2014 to December 31, 2016. The minimum total shareholder return needed to earn a portion of this award is 27.0% with 100% of the award earned if our total shareholder return reaches 35.0%. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2016, 2017 and 2018. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.8%; expected volatility of 27%; expected dividend yield of 8.0%; and expected service period of 5 years. 3) The remainder of the 2014 performance awards will be earned if our total shareholder return outpaces that of the Index over the cumulative period from January 1, 2014 to December 31, 2016. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 6% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on December 31, 2016, 2017 and 2018. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.8%; expected volatility of 27%; expected dividend yield of 8.0%; and expected service period of 5 years. There were 108,261 of the 2014 performance awards earned and vested in 2014, but none in 2015. At December 31, 2015, we have 771,897 of the 2014 performance awards remaining to be earned. 2013 performance awards — The 2013 performance awards were granted in three parts: 1) Approximately 27% of the 2013 performance awards were based on us achieving a simple 8.5% annual total shareholder return. For the five-year period from January 1, 2013 through December 31, 2017, one-third of the awards will be earned annually (until the award is fully earned) if an 8.5% total shareholder return is achieved. If total shareholder return does not reach 8.5% in a particular year, shares for that year can be earned in a future period (during the five-year period) if the cumulative total shareholder return is equal to or greater than an 8.5% annual return for such cumulative period. None of these shares may be sold for two years after they have vested. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.72%; expected volatility of 27%; expected dividend yield of 8.0%; and expected service period of 3 years. 2) Approximately 36% of the 2013 performance awards were based on us achieving a cumulative total shareholder return from January 1, 2013 to December 31, 2015. The minimum total shareholder return needed to earn a portion of this award is 25.5% with 100% of the award earned if our total shareholder return reaches 33.5%. If any shares were earned from this award, the shares were to vest in equal annual amounts on December 31, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.38%; expected volatility of 28%; expected dividend yield of 8.0%; and expected service period of 5 years. 3) The remainder of the 2013 performance awards were to be earned if our total shareholder return outpaced that of the Index over the cumulative period from January 1, 2013 to December 31, 2015. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 6% to earn 100% of the award. If any shares were earned from this award, the shares would vest in equal annual amounts on December 31, 2015, 2016 and 2017. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 0.38%; expected volatility of 28%; expected dividend yield of 8.0%; and expected service period of 5 years. In 2014 and 2013, 80,293 and 68,086 shares respectively, under the 2013 performance awards were earned and vested. No performance awards were earned in 2015, and 550,000 shares were forfeited as the three-year cumulative hurdle from January 1, 2013 to December 31, 2015 was not met. At December 31, 2015, we have 74,187 of 2013 performance awards remaining to be earned. The following summarizes restricted equity award activity in 2015 and 2014 (which includes awards granted in 2015, 2014, 2013, and any applicable prior years), respectively: For the Year Ended December 31, 2015: Vesting Based on Service Vesting Based on Shares Weighted Average Shares Weighted Average Nonvested awards at beginning of the year 452,263 $ 12.11 2,428,518 $ 5.81 Awarded 407,969 $ 13.94 871,888 $ 6.62 Vested (343,904 ) $ 12.56 (406,970 ) $ 4.94 Forfeited (6,694 ) $ 13.08 (562,284 ) $ 5.33 Nonvested awards at end of year 509,634 $ 13.25 2,331,152 $ 6.38 For the Year Ended December 31, 2014: Vesting Based Vesting Based on Shares Weighted Average Shares Weighted Average Nonvested awards at beginning of the year 325,999 $ 11.36 1,999,179 $ 5.44 Awarded 424,366 $ 12.21 903,134 $ 7.57 Vested (298,102 ) $ 11.43 (473,795 ) $ 7.60 Forfeited — $ — — $ — Nonvested awards at end of year 452,263 $ 12.11 2,428,518 $ 5.81 The value of stock-based awards is charged to compensation expense over the vesting periods. In the years ended December 31, 2015, 2014 and 2013, we recorded $11.1 million, $9.2 million, and $8.8 million, respectively, of non-cash compensation expense. The remaining unrecognized cost from restricted equity awards at December 31, 2015, is $12.8 million and will be recognized over a weighted average period of 2.3 years. Restricted equity awards which vested in 2015, 2014 and 2013 had a value of $10.2 million, $10.2 million, and $9.2 million, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Commitments Operating leases, in which we are the lessee, primarily consist of ground leases on which certain of our facilities or other related property reside along with corporate office and equipment leases. The ground leases are long-term leases (almost all having terms for approximately 30 years or more), some of which contain escalation provisions and one contains a purchase option. Properties subject to these ground leases are subleased to our tenants. Lease and rental expense (which is recorded on the straight-line method) for 2015, 2014 and 2013, respectively, were $4.6 million, $2.3 million, and $2.3 million, which was offset by sublease rental income of $2.3 million, $0.2 million, and $0.5 million for 2015, 2014, and 2013, respectively. Fixed minimum payments due under operating leases with non-cancelable terms of more than one year and amounts to be received in the future from non-cancelable subleases at December 31, 2015 are as follows: (amounts in thousands) Fixed Amounts to Net 2016 $ 5,119 $ (2,477 ) $ 2,642 2017 5,157 (2,502 ) 2,655 2018 5,125 (2,504 ) 2,621 2019 4,803 (2,522 ) 2,281 2020 4,896 (2,621 ) 2,275 Thereafter 140,049 (130,819 ) 9,230 $ 165,149 ($143,445 ) $ 21,704 Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Common Stock_Partner's Capital

Common Stock/Partner's Capital	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Common Stock/Partner's Capital	9. Common Stock/Partner’s Capital Medical Properties Trust, Inc. 2015 Activity On August 11, 2015, we completed an underwritten public offering of 28.75 million shares (including the exercise of the underwriters’ 30-day option to purchase an additional 3.8 million shares) of our common stock, resulting in net proceeds of approximately $337 million, after deducting estimated offering expenses. On August 4, 2015, we filed Articles of Amendment to our charter with the Maryland State Department of Assessments and Taxation increasing the number of authorized shares of common stock, par value $0.001 per share available for issuance from 250,000,000 to 500,000,000. On January 14, 2015, we completed an underwritten public offering of 34.5 million shares (including the exercise of the underwriters’ 30-day option to purchase an additional 4.5 million shares) of our common stock, resulting in net proceeds of approximately $480 million, after deducting estimated offering expenses. 2014 Activity On March 11, 2014, we completed an underwritten public offering of 7.7 million shares of our common stock, resulting in net proceeds of $100.2 million, after deducting estimated offering expenses. We also granted the underwriters a 30-day option to purchase up to an additional 1.2 million shares of common stock. The option, which was exercised in full, closed on April 8, 2014 and resulted in additional net proceeds of approximately $16 million. In January 2014, we put an at-the-market equity offering program in place, giving us the ability to sell up to $250 million of stock with a commission of 1.25%. During 2014, we sold 1.7 million shares of our common stock under our at-the-market equity offering program, at an average price of $13.56 per share resulting in total proceeds, net of commission, of $22.6 million. MPT Operating Partnership, L.P. The Operating Partnership is made up of a general partner, Medical Properties Trust, LLC (“General Partner”) and limited partners, including the Company (which owns 100% of the General Partner) and three other partners. By virtue of its ownership of the General Partner, the Company has a 99.8% ownership interest in Operating Partnership via its ownership of all the common units. The remaining ownership interest is held by the two employees and one director via their ownership of LTIP units. These LTIP units were issued pursuant to the 2007 Multi-Year Incentive Plan, which is now part of the Equity Incentive Plan discussed in Note 7 and once vested in accordance with their award agreement, may be converted to common units per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. (“Operating Partnership Agreement”). In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Operating Partnership Agreement, the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any federal income or excise tax liability imposed by the Internal Revenue Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes. The Operating Partnership’s net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations. Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership’s discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company’s common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company’s common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. In order for LTIP units to be redeemed, they must first be converted to common units and then must wait two years from the issuance of the LTIP units to be redeemed. For each share of common stock issued by Medical Properties Trust, Inc., the Operating Partnership issues a corresponding number of operating partnership units.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	10. Fair Value of Financial Instruments We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes (excluding the 2006 Senior Unsecured Notes), using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facility, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt. Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, December 31, Asset (Liability) Book Fair Book Fair Interest and rent receivables $ 46,939 $ 46,858 $ 41,137 $ 41,005 Loans(1) 508,851 543,859 773,311 803,824 Debt, net(2) (3,322,541 ) (3,372,773 ) (2,174,648 ) (2,258,721 ) (1) Excludes loans related to Ernest and Capella since they are recorded at fair value as discussed below. (2) Includes debt issue costs. Items Measured at Fair Value on a Recurring Basis Our equity interest in Ernest, Capella and related loans, as discussed in Note 2, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans in or prior to 2015. At December 31, 2015, the amounts recorded under the fair value option method were as follows (in thousands): Asset (Liability) Fair Cost Asset Type Mortgage loan $ 310,000 $ 310,000 Mortgage loans Acquisition loans 603,552 603,552 Other loans Equity investment 7,349 7,349 Other assets $ 920,901 $ 920,901 At December 31, 2014, the amounts recorded under the fair value option method were as follows (in thousands): Asset (Liability) Fair Cost Asset Type Mortgage loan $ 100,000 $ 100,000 Mortgage loans Acquisition loans 97,450 97,450 Other loans Equity investment 3,300 3,300 Other assets $ 200,750 $ 200,750 Our mortgage loans with Ernest and Capella are recorded at fair value based on Level 2 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loans and equity investments in Ernest and Capella are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a marketability discount (“DLOM”) on our equity investment of 40% at December 31, 2015. In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest and Capella, respectively. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of their historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry. In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase (Decrease) +100 basis points $(122) - 100 basis points 122 Because the fair value of Ernest and Capella investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during 2015, 2014, or 2013. To date, we have not received any distribution payments from our equity investment in Ernest or Capella.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	11. Discontinued Operations The following table presents the results of discontinued operations, which include the revenue and expenses of facilities disposed of prior to 2014 for the year ended December 31, 2015, 2014, and 2013 (amounts in thousands except per share/unit data): For the Years Ended 2015 2014 2013 Revenues $ — $ — $ 988 Gain on sale — — 7,659 Income (loss) from discontinued operations — (2 ) 7,914 Income from discontinued operations — diluted per share/unit $ — $ — $ 0.05

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2015
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	12. Other Assets The following is a summary of our other assets (in thousands): At December 31, 2015 2014 Debt issue costs, net(1) $ 7,628 $ 8,318 Equity investments 129,337 47,451 Other corporate assets 31,547 28,197 Prepaids and other assets 27,028 11,133 Total other assets $ 195,540 $ 95,099 (1) Relates to revolving credit facility Equity investments have decreased over the prior year primarily due to our new investments in the Italy and Spain joint ventures — see Note 3 for further details. Other corporate assets include leasehold improvements associated with our corporate office space, furniture and fixtures, equipment, software, deposits, etc. Included in prepaids and other assets is prepaid insurance, prepaid taxes, goodwill, and lease inducements made to tenants, among other items.

Quarterly Financial Data (unaud

Quarterly Financial Data (unaudited)	12 Months Ended
	Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Data (unaudited)	13. Quarterly Financial Data (unaudited) Medical Properties Trust, Inc. The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2015 and 2014: (amounts in thousands, except for per share data) For the Three Month Periods in 2015 Ended March 31 June 30 September 30 December 31 Revenues $ 95,961 $ 99,801 $ 114,570 $ 131,546 Income from continuing operations 35,976 22,489 23,123 58,339 Net income 35,976 22,489 23,123 58,339 Net income attributable to MPT common stockholders 35,897 22,407 23,057 58,237 Net income attributable to MPT common stockholders per share — basic $ 0.18 $ 0.11 $ 0.10 $ 0.24 Weighted average shares outstanding — basic 202,958 208,071 223,948 237,011 Net income attributable to MPT common stockholders per share — diluted $ 0.17 $ 0.11 $ 0.10 $ 0.24 Weighted average shares outstanding — diluted 203,615 208,640 223,948 237,011 For the Three Month Periods in 2014 Ended March 31 June 30 September 30 December 31 Revenues $ 73,089 $ 76,560 $ 80,777 $ 82,106 Income (loss) from continuing operations 7,309 (203 ) 28,663 15,029 Income (loss) from discontinued operations (2 ) — — — Net income 7,307 (203 ) 28,663 15,029 Net income attributable to MPT common stockholders 7,241 (203 ) 28,537 14,947 Net income attributable to MPT common stockholders per share — basic $ 0.04 $ — $ 0.16 $ 0.08 Weighted average shares outstanding — basic 163,973 171,718 171,893 172,411 Net income attributable to MPT common stockholders per share — diluted $ 0.04 $ — $ 0.16 $ 0.08 Weighted average shares outstanding — diluted 164,549 171,718 172,639 172,604 MPT Operating Partnership, L.P. The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2015 and 2014: (amounts in thousands, except for per unit data) For the Three Month Periods in 2015 Ended March 31 June 30 September 30 December 31 Revenues $ 95,961 $ 99,801 $ 114,570 $ 131,546 Income from continuing operations 35,976 22,489 23,123 58,339 Net income (loss) 35,976 22,489 23,123 58,339 Net income attributable to MPT Operating Partnership partners 35,897 22,407 23,057 58,237 Net income attributable to MPT Operating Partnership partners per unit — basic $ 0.18 $ 0.11 $ 0.10 $ 0.24 Weighted average units outstanding — basic 202,958 208,071 223,948 237,011 Net income attributable to MPT Operating Partnership partners per unit — diluted $ 0.17 $ 0.11 $ 0.10 $ 0.24 Weighted average units outstanding — diluted 203,615 208,640 223,948 237,011 For the Three Month Periods in 2014 Ended March 31 June 30 September 30 December 31 Revenues $ 73,089 $ 76,560 $ 80,777 $ 82,106 Income (loss) from continuing operations 7,309 (203 ) 28,663 15,029 Income (loss) from discontinued operations (2 ) — — — Net income (loss) 7,307 (203 ) 28,663 15,029 Net income attributable to MPT Operating Partnership partners 7,241 (203 ) 28,537 14,948 Net income attributable to MPT Operating Partnership partners per unit — basic $ 0.04 $ — $ 0.16 $ 0.08 Weighted average units outstanding — basic 163,973 171,718 171,893 172,411 Net income attributable to MPT Operating Partnership partners per unit — diluted $ 0.04 $ — $ 0.16 $ 0.08 Weighted average units outstanding — diluted 164,549 171,718 172,639 172,604

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events On February 22, 2016, we completed a $500 million senior unsecured notes offering, proceeds of which were used to repay borrowings under our Revolving credit facility. Interest on the notes will be payable on March 1 and September 1 of each year, commencing on September 1, 2016. Interest on the notes will be paid in cash at a rate of 6.375% per year. The notes mature on March 1, 2024. We may redeem some or all of the notes at any time prior to March 1, 2019 at a “make whole” redemption price. On or after March 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and upaid interest to the date of purchase.

Schedule II_ Valuation and Qual

Schedule II: Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2015
Valuation and Qualifying Accounts [Abstract]
Schedule II: Valuation and Qualifying Accounts	Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. Schedule II: Valuation and Qualifying Accounts December 31, 2015 Additions Deductions Year Ended December 31, Balance at Charged Net Balance at (In thousands) 2015 $ 20,129 $ 8,205 (6) $ (950 )(4) $ 27,384 2014 $ 41,573 $ 65,512 (2) $ (86,956 )(5) $ 20,129 2013 $ 34,769 $ 9,397 (3) $ (2,593 ) $ 41,573 (1) Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves. (2) Includes the $47 million of impairment charges related to the Monroe property, $9.5 million of rent and interest reserves primarily related to the Monroe property (prior to change in operators — see note 3 to Item 8 of the Form 10-K for further details), and approximately $9 million increase in the valuation allowance to fully reserve our net deferred tax assets. (3) Includes $4.8 million and $2.7 million in rent and interest reserves, respectively, related to our Monroe properties along with $1.9 million to fully reserve for the net deferred tax asset of certain German subsidiaries. (4) Writeoffs of rent and interest reserves related to sale of Healthtrax properties. (5) Writeoffs of loans and other receivables related to the Monroe facility due to change in operators. (6) Includes $1.3 million and $0.2 million of rent and late fee reserves, respectively, related to our Twelve Oaks facility; $0.5 million of rent reserves related to our Healthtrax properties, $0.1 million of interest reserves related to M/C Healthcare loan; and $6.1 million to fully reserve our net deferred tax assets.

SCHEDULE III - REAL ESTATE INVE

SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2015
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION	December 31, 2015 Initial Costs Additions Subsequent to Acquisition Cost at December 31, 2015 Accumulated Date of Date Life on Location Type of Property Land Buildings Improvements Carrying Costs Land Buildings Total Encumbrances (Amounts in thousands) Baden-Wurttemburg, Germany Rehabilitation hospital — 9,459 — — — 9,459 9,459 493 — 1994 November 30, 2013 40 Saxony, Germany Rehabilitation hospital 372 20,515 — — 372 20,515 20,887 1,068 — 1996 November 30, 2013 40 Rhineland-Pflaz, Germany Rehabilitation hospital 3,175 15,008 — — 3,175 15,008 18,183 782 — 1960 November 30, 2013 40 Brandenburg, Germany Rehabilitation hospital 346 17,874 — — 346 17,874 18,220 931 — 1994 November 30, 2013 40 Hesse, Germany Rehabilitation hospital 92 5,236 — — 92 5,236 5,328 273 — 1981 November 30, 2013 40 Hesse, Germany Rehabilitation hospital 3,078 14,804 — — 3,078 14,804 17,882 771 — 1977 November 30, 2013 40 Rhineland-Pflaz, Germany Rehabilitation hospital — 29,701 — — — 29,701 29,701 1,547 — 1992 November 30, 2013 40 Saxony, Germany Rehabilitation hospital 539 14,943 — — 539 14,943 15,482 778 — 1904, 1995 November 30, 2013 40 Rhineland-Pflaz, Germany Rehabilitation hospital 728 6,545 — — 728 6,545 7,273 341 — 1980 November 30, 2013 40 Rhineland-Pflaz, Germany Rehabilitation hospital 5,834 16,109 — — 5,834 16,109 21,943 839 — 1930 November 30, 2013 40 Baden-Wurttemburg, Germany Rehabilitation hospital 3,420 5,827 — — 3,420 5,827 9,247 303 — 1986 November 30, 2013 40 Bavaria, Germany Rehabilitation hospital 2,204 9,294 194 — 2,204 9,488 11,692 257 — 1974 November 19, 2014 40 Thuringia, Germany Rehabilitation hospital 1,605 33,913 — — 1,605 33,913 35,518 989 — 1954, 1992 November 5, 2014 40 Baden-Wurttemburg, Germany Rehabilitation hospital — 11,249 — — — 11,249 11,249 305 — 1988, 1995 December 11, 2014 40 Bath, UK Acute care general hospital 1,747 36,203 — — 1,747 36,203 37,950 1,358 — 2008, 2009 July 1, 2014 40 Ottenhöfen, Germany Rehabilitation hospital 2,254 12,681 108 — 2,362 12,681 15,043 162 — 1956/1957 July 3, 2015 40 Bad Berka, Germany Rehabilitation hospital 3,226 15,046 168 — 3,394 15,046 18,440 161 — 1997 July 22, 2015 40 Wiesbaden, Germany Rehabilitation hospital 1,608 7,457 38 — 1,646 7,457 9,103 94 — 1974 June 30, 2015 40 Bad Lausick, Germany Rehabilitation hospital 1,733 15,674 152 — 1,885 15,674 17,559 201 — 1993 June 30, 2015 40 Bad Sülze, Germany Rehabilitation hospital 2,297 19,814 196 — 2,493 19,814 22,307 254 — 1993 June 30, 2015 40 Kurort Berggießhübel, Germany Rehabilitation hospital 3,199 15,452 — — 3,199 15,452 18,651 165 — 1993 July 21, 2015 40 Braunfels, Germany Acute care general hospital 2,086 13,331 54 — 2,140 13,331 15,471 168 — 1977 June 30, 2015 40 Bernkastel-Kues, Germany Rehabilitation hospital 3,498 15,191 43 — 3,541 15,191 18,732 159 — 1982 July 15, 2015 40 Flechtingen, Germany Rehabilitation hospital 2,781 14,036 146 — 2,927 14,036 16,963 180 — 1993 June 30, 2015 40 Flechtingen, Germany Rehabilitation hospital 2,781 21,989 217 — 2,998 21,989 24,987 282 — 1993-1995 June 30, 2015 40 Nordrach, Germany Rehabilitation hospital 304 2,910 82 — 386 2,910 3,296 39 — 1960 July 7, 2015 40 Bad Gottleuba, Germany Rehabilitation hospital 3,259 14,937 863 — 4,122 14,937 19,059 — — 1913 December 16, 2015 40 Grünheide, Germany Rehabilitation hospital 8,369 40,596 331 — 8,700 40,596 49,296 432 — 1994/2014 July 31, 2015 40 Baden-Baden, Germany Rehabilitation hospital 1,271 8,936 125 — 1,396 8,936 10,332 116 — 1900/2002-2003 June 30, 2015 40 Gyhum, Germany Rehabilitation hospital 3,878 22,165 341 — 4,219 22,165 26,384 288 — 1994 June 30, 2015 40 Hannover, Germany Rehabilitation hospital 4,073 16,293 — — 4,073 16,293 20,366 34 — 1900 December 1, 2015 40 Heiligendamm, Germany Rehabilitation hospital 4,182 26,063 206 — 4,388 26,063 30,451 333 — 1995 June 30, 2015 40 Bad Camberg, Germany Rehabilitation hospital 2,026 15,447 260 — 2,286 15,447 17,733 202 — 1973 June 30, 2015 40 Hoppegarten, Germany Rehabilitation hospital 3,894 24,117 239 — 4,133 24,117 28,250 258 — 1994 July 27, 2015 40 Ban Nauheim, Germany Rehabilitation hospital 3,074 15,529 141 — 3,215 15,529 18,744 199 — 1977 June 30, 2015 40 Kalbe, Germany Rehabilitation hospital 3,400 22,716 163 — 3,563 22,716 26,279 289 — 1995 July 6, 2015 40 Bad Soden-Salmunster, Germany Rehabilitation hospital 934 6,482 120 — 1,054 6,482 7,536 85 — 1974 June 30, 2015 40 Berlin, Germany Rehabilitation hospital 1,157 20,767 184 — 1,341 20,767 22,108 221 — 1998 July 16, 2015 40 Bad Lobenstein, Germany Rehabilitation hospital 3,541 20,079 179 — 3,720 20,079 23,799 257 — 1994 June 30, 2015 40 Bernkastel-Kues, Germany Rehabilitation hospital 782 11,284 130 — 912 11,284 12,196 145 — 1993 July 14, 2015 40 Magdeburg, Germany Rehabilitation hospital 14,387 53,369 250 — 14,637 53,369 68,006 563 — 1999/2014 July 22, 2015 40 Schlangenbad, Germany Rehabilitation hospital 1,048 3,411 266 — 1,314 3,411 4,725 52 — 1973 June 30, 2015 40 Bad Dürrheim, Germany Rehabilitation hospital 1,390 11,400 228 — 1,618 11,400 13,018 125 — 1960-1970 July 24, 2015 40 Bad Krozingen, Germany Rehabilitation hospital 1,472 10,733 114 — 1,586 10,733 12,319 115 — 2008 July 24, 2015 40 Bad Nauheim, Germany Rehabilitation hospital 1,760 9,198 54 — 1,814 9,198 11,012 117 — 1972-1973 June 30, 2015 40 Bad Tennstedt, Germany Rehabilitation hospital 3,677 27,261 201 — 3,878 27,261 31,139 347 — 1993 June 30, 2015 40 Wismar, Germany Rehabilitation hospital 3,465 20,645 195 — 3,660 20,645 24,305 265 — 1996 June 30, 2015 40 Houston, TX Acute care general hospital 3,501 34,530 8,477 15,993 3,274 59,227 62,501 8,018 — 1960 August 10, 2007 40 Allen, TX Freestanding ER 1,550 3,921 — — 1,550 3,921 5,471 147 — 2014 July 14, 2014 40 San Diego, CA Acute care general hospital 12,663 52,432 — — 12,663 52,432 65,095 6,445 — 1973 February 9, 2011 40 Alvin, TX Freestanding ER 105 4,087 — — 105 4,087 4,192 156 — 2014 March 19, 2014 40 Aurora, CO Freestanding ER — 4,860 — — — 4,860 4,860 26 — 2015 September 17, 2015 40 Ft. Worth, TX Freestanding ER — 3,984 — — — 3,984 3,984 75 — 2015 March 27, 2015 40 Bayonne, NJ Acute care general hospital 2,003 51,495 — — 2,003 51,495 53,498 12,658 — 1918 February 4, 2011 20 Bennettsville, SC Acute care general hospital 794 15,772 — — 794 15,772 16,566 3,050 — 1984 April 1, 2008 40 Blue Springs, MO Acute care general hospital 4,347 23,494 — — 4,347 23,494 27,841 566 — 1980 February 13, 2015 40 Bossier City, LA Long term acute care hospital 900 17,818 — — 900 17,818 18,718 3,450 — 1982 April 1, 2008 40 Austin, TX Freestanding ER 1,140 3,853 — — 1,140 3,853 4,993 161 — 2014 May 29, 2014 40 Broomfield, CO Freestanding ER 825 3,895 — — 825 3,895 4,720 146 — 2014 July 3, 2014 40 Carrollton, TX Acute care general hospital 729 34,289 — — 729 34,289 35,018 354 — 2015 July 17, 2015 40 Cedar Hill. TX Freestanding ER 1,122 3,644 — — 1,122 3,644 4,766 137 — 2014 June 23, 2014 40 Spring, TX Freestanding ER 1,310 3,543 — — 1,310 3,543 4,853 133 — 2014 July 15, 2014 40 Chandler, AZ Freestanding ER — 4,244 — — — 4,244 4,244 71 — 2015 April 24, 2015 40 Chandler, AZ Freestanding ER 750 3,214 — — 750 3,214 3,964 19 — 2015 October 7, 2015 40 Cheraw, SC Acute care general hospital 657 19,576 — — 657 19,576 20,233 3,785 — 1982 April 1, 2008 40 Katy, TX Freestanding ER — 3,248 — — — 3,248 3,248 14 — 2015 October 21, 2015 40 Webster, TX Long term acute care hospital 663 33,751 — — 663 33,751 34,414 4,219 — 2004 December 21, 2010 40 Commerce City, TX Freestanding ER 707 4,236 — — 707 4,236 4,943 115 — 2014 December 11, 2014 40 Conroe, TX Freestanding ER 1,338 3,436 — — 1,338 3,436 4,774 35 — 2015 July 29, 2015 40 Converse, TX Freestanding ER 750 4,405 — — 750 4,405 5,155 83 — 2015 April 10, 2015 40 Corinth, TX Long term acute care hospital 1,288 21,175 313 — 1,601 21,175 22,776 2,671 — 2008 January 31, 2011 40 Covington, LA Long term acute care hospital 821 10,238 — 14 821 10,252 11,073 2,712 — 1984 June 9, 2005 40 Dallas, TX Long term acute care hospital 1,000 13,589 — 368 1,421 13,536 14,957 3,158 — 2006 September 5, 2006 40 Denver, CO Freestanding ER — 4,275 — — — 4,275 4,275 56 — 2015 June 8, 2015 40 DeSoto, TX Long term acute care hospital 1,067 10,701 86 8 1,161 10,701 11,862 1,202 — 2008 July 18, 2011 40 Detroit, MI Long term acute care hospital 1,220 8,687 — (365 ) 1,220 8,322 9,542 1,656 — 1956 May 22, 2008 40 Dulles, TX Freestanding ER 1,076 3,784 — — 1,076 3,784 4,860 125 — 2014 September 12, 2014 40 Houston, TX Freestanding ER 1,345 3,678 — — 1,345 3,678 5,023 138 — 2014 June 20, 2014 40 Fairmont, CA Acute care general hospital 1,000 12,301 1,386 — 1,277 13,410 14,687 443 — 1939, 1972, 1985 September 19, 2014 40 Firestone, TX Freestanding ER 495 3,963 — — 495 3,963 4,458 157 — 2014 June 6, 2014 40 Florence, AZ Acute care general hospital 900 28,462 — — 900 28,462 29,362 2,659 — 2012 November 4, 2010 40 Fort Lauderdale, FL Rehabilitation hospital 3,499 21,939 — 1 3,499 21,940 25,439 4,214 — 1985 April 22, 2008 40 Fountain, CO Freestanding ER 1,508 4,131 — — 1,508 4,131 5,639 146 — 2014 July 31, 2014 40 Frisco, TX Freestanding ER — 3,769 — — — 3,769 3,769 15 — 2015 November 13, 2015 40 Frisco, TX Freestanding ER 1,500 3,863 27 — 1,500 3,890 5,390 154 — 2014 June 13, 2014 40 Garden Grove, CA Acute care general hospital 5,502 10,748 — 51 5,502 10,799 16,301 1,925 — 1982 November 25, 2008 40 Garden Grove, CA Medical Office Building 862 7,888 — 28 862 7,916 8,778 1,404 — 1982 November 25, 2008 40 Gilbert, AZ Acute care general hospital 150 15,553 — — 150 15,553 15,703 1,944 — 2005 January 4, 2011 40 Gilbert, AZ Freestanding ER 1,518 4,112 — — 1,518 4,112 5,630 39 — 2015 July 22, 2015 40 Glendale, AZ Freestanding ER — 3,886 — — — 3,886 3,886 50 — 2015 June 5, 2015 40 Hammond, LA Long term acute care hospital 519 8,941 — — 519 8,941 9,460 689 — 2003 December 14, 2012 40 Hausman, TX Acute care general hospital 1,500 8,958 — — 1,500 8,958 10,458 611 — 2013 March 1, 2013 40 Highland Village, TX Freestanding ER — 3,673 — — — 3,673 3,673 21 — 2015 September 22, 2015 40 Hill County, TX Acute care general hospital 1,120 17,882 — — 1,120 17,882 19,002 6,294 — 1980 September 17, 2010 40 Hoboken, NJ Acute care general hospital 1,387 44,351 — — 1,387 44,351 45,738 9,173 — 1863 November 4, 2011 20 Hoover, AL Freestanding ER — 7,581 — — — 7,581 7,581 126 — 2015 May 1, 2015 34 Hoover, AL Medical Office Building — 1,034 — — — 1,034 1,034 17 — 2015 May 1, 2015 34 Hot Springs, AR Acute care general hospital 4,300 66,922 — — 4,300 66,922 71,222 548 — 1985 August 31, 2015 40 Idaho Falls, ID Acute care general hospital 1,822 37,467 — 4,665 1,822 42,132 43,954 8,028 — 2002 April 1, 2008 40 Kansas City, MO Acute care general hospital 10,497 64,419 — — 10,497 64,419 74,916 1,505 — 1978 February 13, 2015 40 Lafayette, IN Rehabilitation hospital 800 14,968 (25 ) — 800 14,943 15,743 1,076 — 2013 February 1, 2013 40 Little Elm, TX Freestanding ER 1,241 3,491 — — 1,241 3,491 4,732 179 — 2013 December 1, 2013 40 Lubbock, TX Rehabilitation hospital — 21,241 — — — 21,241 21,241 260 — 2008 June 16, 2015 40 Lubbock, TX Long term acute care hospital — 10,725 — — — 10,725 10,725 134 — 2008 June 16, 2015 40 McKinney, TX Freestanding ER — 3,991 — — — 3,991 3,991 40 — 2015 July 31, 2015 30 Mesa, AZ Acute care general hospital 4,900 97,980 2,242 — 7,142 97,980 105,122 5,977 — 2007 September 26, 2013 40 Bloomington, IN Acute care general hospital 2,392 28,212 5,000 408 2,392 33,620 36,012 7,544 — 2006 August 8, 2006 40 Montclair, NJ Acute care general hospital 7,900 99,632 585 — 8,477 99,640 108,117 4,623 — 1920-2000 April 1, 2014 40 San Antonio, TX Freestanding ER 351 3,952 — — 351 3,952 4,303 172 — 2014 January 1, 2014 40 Houston, TX Acute care general hospital 4,757 56,238 (37 ) 1,259 5,427 56,790 62,217 12,848 — 2006 December 1, 2006 40 New Braunfels, TX Long term acute care hospital 1,100 7,883 — — 1,100 7,883 8,983 838 — 2007 September 30, 2011 40 Shenandoah, TX Rehabilitation hospital 2,033 21,943 — — 2,033 21,943 23,976 3,017 — 2008 June 17, 2010 40 Colorado Springs, CO Freestanding ER 600 4,231 — — 600 4,231 4,831 168 — 2014 June 5, 2014 40 Northland, MO Long term acute care hospital 834 17,182 — — 834 17,182 18,016 2,112 13,400 2007 February 14, 2011 40 Altoona, WI Acute care general hospital — 29,048 — — — 29,048 29,048 945 — 2014 August 31, 2014 40 Ogden, UT Rehabilitation hospital 1,759 16,414 — — 1,759 16,414 18,173 739 — 2014 March 1, 2014 40 Overlook, TX Acute care general hospital 2,452 9,666 7 — 2,452 9,673 12,125 683 — 2012 February 1, 2013 40 San Diego, CA Acute care general hospital 6,550 15,653 — 77 6,550 15,730 22,280 3,406 — 1964 May 9, 2007 40 Parker, CO Freestanding ER 1,301 4,024 — — 1,301 4,024 5,325 17 — 2015 November 6, 2015 40 Pearland, TX Freestanding ER 1,075 3,577 — — 1,075 3,577 4,652 119 — 2014 September 8, 2014 40 Petersburg, VA Rehabilitation hospital 1,302 9,121 — — 1,302 9,121 10,423 1,710 — 2006 July 1, 2008 40 Poplar Bluff, MO Acute care general hospital 2,659 38,694 — 1 2,660 38,694 41,354 7,431 — 1980 April 22, 2008 40 Port Arthur, TX Acute care general hospital 3,000 72,341 1,062 — 4,062 72,341 76,403 4,246 — 2005 September 26, 2013 40 Port Huron, MI Acute care general hospital 2,000 18,000 — — 2,000 18,000 20,000 — — 1953, 1973-1983 December 31, 2015 40 Portland, OR Long term acute care hospital 3,085 17,859 — 2,559 3,071 20,432 23,503 4,383 — 1964 April 18, 2007 40 Post Falls, ID Rehabilitation hospital 417 12,175 1,905 — 767 13,730 14,497 696 — 2013 December 31, 2013 40 Redding, CA Acute care general hospital 1,555 53,863 — 13 1,555 53,876 55,431 11,346 — 1974 August 10, 2007 40 Redding, CA Long term acute care hospital — 19,952 — 4,360 1,629 22,683 24,312 5,757 — 1991 June 30, 2005 40 Richardson, TX Rehabilitation hospital 2,219 17,419 — — 2,219 17,419 19,638 2,395 — 2008 June 17, 2010 40 Addison, TX Rehabilitation hospital 2,013 22,531 — — 2,013 22,531 24,544 3,098 — 2008 June 17, 2010 40 San Dimas, CA Acute care general hospital 6,160 6,839 — 34 6,160 6,873 13,033 1,218 — 1972 November 25, 2008 40 San Dimas, CA Medical Office Building 1,915 5,085 — 18 1,915 5,103 7,018 905 — 1979 November 25, 2008 40 Sherman, TX Acute care general hospital 4,491 24,802 — — 4,491 24,802 29,293 775 — 1913, 1960-2010 October 31, 2014 40 Sienna, TX Freestanding ER 999 3,591 — — 999 3,591 4,590 120 — 2014 August 20, 2014 40 Spartanburg, SC Rehabilitation hospital 1,135 15,717 — — 1,135 15,717 16,852 931 — 2013 August 1, 2013 40 Houston, TX Freestanding ER 1,423 3,770 — — 1,423 3,770 5,193 79 — 2015 February 18, 2015 40 Thornton, CO Freestanding ER 1,350 4,227 — — 1,350 4,227 5,577 141 — 2014 August 29, 2014 40 Tomball, TX Long term acute care hospital 1,299 23,982 — — 1,299 23,982 25,281 2,998 — 2005 December 21, 2010 40 Victoria, TX Long term acute care hospital 625 7,197 — — 625 7,197 7,822 1,634 — 1998 December 1, 2006 40 Victoria, TX Rehabilitation hospital — 10,412 — — — 10,412 10,412 515 — 2013 December 31, 2013 40 League City, TX Freestanding ER — 3,645 — — — 3,645 3,645 46 — 2015 June 19, 2015 40 Anaheim, CA Acute care general hospital 1,875 21,814 — 10 1,875 21,824 23,699 5,001 — 1964 November 8, 2006 40 West Monroe, LA Acute care general hospital 12,000 69,433 552 — 12,552 69,433 81,985 4,048 — 1962 September 26, 2013 40 San Antonio, TX Acute care general hospital 2,248 5,880 — — 2,248 5,880 8,128 462 — 2012 October 14, 2011 40 West Valley City, UT Acute care general hospital 5,516 58,314 — — 5,516 58,314 63,830 11,198 — 1980 April 22, 2008 40 Wichita, KS Rehabilitation hospital 1,019 18,373 — 1 1,019 18,374 19,393 3,559 — 1992 April 4, 2008 40 $ 302,046 $ 2,632,473 $ 27,568 $ 29,503 $ 315,787 $ 2,675,803 $ 2,991,590 $ 232,675 $ 13,400 The changes in total real estate assets including real estate held for sale but excluding construction in progress, intangible lease asset, investment in direct financing leases, and mortgage loans for the years ended: December 31, 2015 December 31, 2014 December 31, 2013 COST Balance at beginning of period $ 2,040,727 $ 1,733,194 $ 1,189,552 Acquisitions 975,239 263,811 480,503 Transfers from construction in progress 23,163 41,772 81,347 Additions 7,376 84,831 7,749 Dispositions (24,701 ) (56,590 ) (28,616 ) Other (30,214 ) (26,291 ) 2,659 Balance at end of period $ 2,991,590 $ 2,040,727 $ 1,733,194 The changes in accumulated depreciation including real estate assets held for sale for the years ended: December 31, 2015 December 31, 2014 December 31, 2013 ACCUMULATED DEPRECIATION Balance at beginning of period $ 181,441 $ 144,235 $ 114,399 Depreciation 60,796 46,935 33,349 Depreciation on disposed property (8,887 ) (9,213 ) (3,513 ) Other (675 ) (516 ) — Balance at end of period $ 232,675 $ 181,441 $ 144,235

SCHEDULE IV - MORTGAGE LOANS ON

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2015
Mortgage Loans on Real Estate [Abstract]
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV — MORTGAGE LOANS ON REAL ESTATE MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P. Column A Column B Column C Column D Column E Column F Column G(3) Column H Description Interest Final Periodic Payment Prior Face Carrying Principal (Dollar amounts in thousands) Long-term first mortgage loan: Payable in monthly Desert Valley Hospital 11.0 % 2022 (1 ) $ 70,000 $ 70,000 (2 ) Desert Valley Hospital 11.6 % 2022 (1 ) 20,000 20,000 (2 ) Desert Valley Hospital 11.0 % 2017 (1 ) 12,500 12,500 (2 ) Chino Valley Medical Center 11.0 % 2022 (1 ) 50,000 50,000 (2 ) Paradise Valley Hospital 10.6 % 2022 (1 ) 25,000 25,000 (2 ) Ernest Mortgage Loan(4) 9.6 % 2032 (1 ) 100,000 100,000 (2 ) Centinela Hospital Medical Center 11.0 % 2022 (1 ) 100,000 100,000 (2 ) Olympia Medical Center 11.2 % 2024 (1 ) 20,000 20,000 (2 ) St. Joseph Medical Center 8.5 % 2025 (1 ) 30,000 30,000 (2 ) St. Mary’s Medical Center 8.5 % 2025 (1 ) 10,000 10,000 (2 ) Lake Huron Medical Center 8.5 % 2020 (1 ) 10,000 10,000 (2 ) St. Clare’s Hospital(4) 8.5 % 2020 (1 ) 100,000 100,000 (2 ) Capella Mortgage Loan(6) 8.0 % 2030 (1 ) 210,000 210,000 (2 ) $ 757,500 $ 757,500 (5 ) (1) There were no prior liens on loans as of December 31, 2015. (2) The mortgage loan was not delinquent with respect to principal or interest. (3) The aggregate cost for federal income tax purposes is $757,500. (4) Mortgage loans covering four properties. (5) Excludes unamortized loan issue costs of $0.1 million at December 31, 2015. (6) Mortgage loans covering two properties. Changes in mortgage loans (excluding unamortized loan issue costs) for the years ended December 31, 2015, 2014, and 2013 are summarized as follows: Year Ended December 31, 2015 2014 2013 (Dollar amounts in thousands) Balance at beginning of year $ 397,500 $ 388,650 $ 368,650 Additions during year: New mortgage loans and additional advances on existing loans 380,000 12,500 20,000 777,500 401,150 388,650 Deductions during year: Collection of principal (20,000 ) (3,650 ) — (20,000 ) (3,650 ) — Balance at end of year $ 757,500 $ 397,500 $ 388,650

Summary of Significant Accoun27

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates:
Principles of Consolidation	Principles of Consolidation: We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity (“VIE”). If we determine that we have a variable interest in a VIE, we then evaluate if we are the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a VIE that most significantly impact the entity’s economic performance. We consolidate each VIE in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2015, we had loans and/or equity investments in certain VIEs, which are also tenants of our facilities (including but not limited to Ernest, Capella and Vibra). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2015 (in thousands): VIE Type Maximum Loss Asset Type Carrying Amount(2) Loans, net $ 984,512 Mortgage and other loans $ 921,930 Equity investments $ 54,033 Other assets $ 6,232 (1) Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities. (2) Carrying amount reflects the net book value of our loan or equity interest only in the VIE. For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of December 31, 2015, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls). Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower. See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.
Investments in Unconsolidated Entities	Investments in Unconsolidated Entities:
Cash and Cash Equivalents	Cash and Cash Equivalents:
Revenue Recognition	Revenue Recognition: Certain leases may provide for additional rents contingent upon a percentage of the tenant’s revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index or when the consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as rent billed revenue in the period earned. We use DFL accounting to record rent on certain leases deemed to be financing leases, per accounting rules, rather than operating leases. For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income. In instances where we have a profits or equity interest in our tenant’s operations, we record income equal to our percentage interest of the tenant’s profits, as defined in the lease or tenant’s operating agreements, once annual thresholds, if any, are met. We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the remaining term of the lease. We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. Tenant payments for certain taxes, insurance, and other operating expenses related to our facilities (most of which are paid directly by our tenants to the government or appropriate third party vendor) are recorded net of the respective expense as generally our leases are “triple-net” leases, with terms requiring such expenses to be paid by our tenants. Failure on the part of our tenants to pay such expense or to pay late would result in a violation of the lease agreement, which could lead to an event of default, if not cured.
Acquired Real Estate Purchase Price Allocation	Acquired Real Estate Purchase Price Allocation: We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of these intangible assets to expense over the initial term of the respective leases. If a lease is terminated, the unamortized portion of the lease intangibles are charged to expense.
Goodwill	Goodwill:
Real Estate and Depreciation	Real Estate and Depreciation: Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2015 are as follows: Buildings and improvements 38.9 years Tenant lease intangibles 25.6 years Leasehold improvements 22.1 years Furniture, equipment and other 9.3 years
Losses from Rent Receivables	Losses from Rent Receivables: Losses from Operating Lease Receivables: Losses on DFL Receivables:
Loans	Loans:
Earnings Per Share/Units	Earnings Per Share/Units: Our unvested restricted stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit.
Income Taxes	Income Taxes: Our financial statements include the operations of taxable REIT subsidiaries (“TRS”), including MPT Development Services, Inc. (“MDS”) and MPT Covington TRS, Inc. (“CVT”), along with many other entities, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. Our TRS entities are not entitled to a dividends paid deduction and are subject to federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and they make loans to and/or investments in our lessees. With the property acquisitions and investments in Europe, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes in the United States as such income from our international properties will flow through our REIT income tax returns. For our TRS and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax receivables/liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is reflected in our tax provision when such changes occur.
Stock-Based Compensation	Stock-Based Compensation:
Deferred Costs	Deferred Costs:
Deferred Financing Costs	Deferred Financing Costs:
Foreign Currency Translation and Transactions	Foreign Currency Translation and Transactions: Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in foreign currency from time to time. Gains or losses resulting from these foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses on our short-term transactions are included in other income in the consolidated statements of income, while the translation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets.
Derivative Financial Investments and Hedging Activities	Derivative Financial Investments and Hedging Activities: To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur.
Fair Value Measurement	Fair Value Measurement: • Level 1 identical • Level 2 similar • Level 3 unobservable We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Monte Carlo valuation models. We also consider our counterparty’s and own credit risk on derivatives and other liabilities measured at their estimated fair value. Fair Value Option Election:
Recent Accounting Developments	Recent Accounting Developments: Presentation of Debt Issuance Costs In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. Also in August 2015, the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated With Line-of-Credit Arrangements” which clarifies the SEC staff’s position not objecting to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing such costs, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. We adopted these standards for the quarter ended December 31, 2015. There were deferred financing costs of $28.4 million and $27.0 million as of December 31, 2015 and 2014, respectively that are now classified within Debt, net on our consolidated balance sheets. Measurement-Period Adjustments for Business Combinations In September 2015, the FASB issued ASU 2015-16, “Simplifying the Accounting for Measurement-Period Adjustments” to simplify the accounting for business combinations, specifically as it relates to measurement-period adjustments. Acquiring entities in a business combination must recognize measurement-period adjustments in the reporting period in which the adjustment amounts are determined. Also, ASU 2015-16 requires entities to present separately on the face of the income statement (or disclose in the notes to the financial statements) the portion of the amount recorded in the current period earnings, by line item, that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. ASU 2015-16 is effective for us beginning in the 2015 fourth quarter and is to be applied prospectively to measurement-period adjustments that occur after the effective date. We do not expect the adoption of this ASU to have a significant impact on our consolidated financial statements. Revenue from Contracts with Customers In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers.” Under the new standard, revenue is recognized at the time a good or service is transferred to a customer for the amount of consideration received for that specific good or service. Entities may use a full retrospective approach or report the cumulative effect as of the date of adoption. On April 1, 2015, the FASB proposed deferring the effective date of this standard by one year to December 15, 2017, for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. We do not expect this standard to have a significant impact on our financial results, as a substantial portion of our revenue consists of rental income from leasing arrangements, which are specifically excluded from ASU No. 2014-09. Amendments to the Consolidation Analysis In February 2015, the FASB issued ASU 2015-02 that modifies the evaluation of whether limited partnerships and similar legal entities are VIEs, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. We do not believe this proposed standard will have a significant impact on us. This ASU is effective for fiscal years beginning after December 15, 2015.
Leases	Leases In February 2016, the FASB issued ASU 2016-02 - Leases

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Carrying Value and Classification of Related Assets and Maximum Exposure to Loss	The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2015 (in thousands): VIE Type Maximum Loss Asset Type Carrying Amount(2) Loans, net $ 984,512 Mortgage and other loans $ 921,930 Equity investments $ 54,033 Other assets $ 6,232 (1) Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities. (2) Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
Weighted Average Useful Lives of Related Real Estate and Other Assets	Depreciation is calculated on the straight-line method over the useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2015 are as follows: Buildings and improvements 38.9 years Tenant lease intangibles 25.6 years Leasehold improvements 22.1 years Furniture, equipment and other 9.3 years

Real Estate and Loans Receiva29

Real Estate and Loans Receivable (Tables)	12 Months Ended
	Dec. 31, 2015
Text Block [Abstract]
Assets Acquired	Acquisitions We acquired the following assets: 2015 2014 2013 Assets Acquired (in thousands) Land $ 126,336 $ 22,569 $ 41,473 Building 758,009 241,242 439,030 Intangible lease assets — subject to amortization (weighted average useful life of 30.4 years in 2015, 18.2 years in 2014 and 21.0 years in 2013) 154,719 22,513 38,589 Net investments in direct financing leases 174,801 — 110,580 Mortgage loans 380,000 — 20,000 Other loans 523,605 447,664 5,250 Equity investments and other assets 101,716 33,708 — Liabilities (317 ) — — Total assets acquired $ 2,218,869 $ 767,696 $ 654,922 Loans repaid(1) (385,851 ) — — Total net assets acquired $ 1,833,018 $ 767,696 $ 654,922 (1) Loans advanced to MEDIAN in 2014 and repaid in 2015 as part of step 2 of the MEDIAN transaction. See below for details.
Schedule of Unaudited Supplemental Pro Forma Operating Data	The following unaudited supplemental pro forma operating data is presented below as if each acquisition was completed on January 1, 2014 and January 1, 2014 for the year ended December 31, 2015 and 2014, respectively. The unaudited supplemental pro forma operating data is not necessarily indicative of what the actual results of operations would have been assuming the transactions had been completed as set forth above, nor do they purport to represent our results of operations for future periods (in thousands, except per share/unit amounts). For the Year Ended December 31, 2015 2014 Total revenues $ 542,763 $ 531,549 Net income 240,783 220,181 Net income per share/unit $ 1.02 $ 0.93
Summary of Status Update on Current Development Projects	See table below for a status update on our current development projects (in thousands): Property Location Property Type Operator Commitment Costs Incurred Estimated First Choice ER — Houston Houston, TX Acute Care Hospital Adeptus Health $ 5,257 $ 2,535 1Q 2016 First Choice ER- Denver Denver, CO Acute Care Hospital Adeptus Health 5,300 2,435 2Q 2016 First Choice ER- Phoenix Phoenix, AZ Acute Care Hospital Adeptus Health 6,728 3,275 2Q 2016 First Choice ER- San Antonio San Antonio, TX Acute Care Hospital Adeptus Health 7,530 3,690 2Q 2016 First Choice ER- Texas Acute Care Hospital Adeptus Health 16,422 3,924 2Q 2016 Rehabilitation Hospital of Northwestern Ohio Toledo, OH Inpatient Rehabilitation Hospital Ernest Health 19,212 13,693 2Q 2016 First Choice ER- Houston Houston, TX Acute Care Hospital Adeptus Health 45,961 19,613 3Q 2016 First Choice Emergency Rooms Various Acute Care Hospital Adeptus Health 200,090 — Various $ 306,500 $ 49,165 (1) Includes three acute care facilities.
Amortization Expense from Existing Lease Intangible Assets	We recorded amortization expense related to intangible lease assets of $9.1 million, $7.0 million, and $4.0 million in 2015, 2014, and 2013, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows: (amounts in thousands) For the Year Ended December 31: 2016 $ 10,204 2017 10,194 2018 10,133 2019 10,085 2020 9,882
Components of Net Investment in Direct Financing Leases	The components of our net investment in DFLs consisted of the following (dollars in thousands): As of December 31, As of December 31, Minimum lease payments receivable $ 2,587,912 $ 1,607,024 Estimated residual values 393,097 211,888 Less unearned income (2,354,013 ) (1,379,396 ) Net investment in direct financing leases $ 626,996 $ 439,516
Minimum Rental Payments Due under Operating Leases with Non-Cancelable Terms	Minimum rental payments due to us in future periods under operating leases and DFLs, which have non-cancelable terms extending beyond one year at December 31, 2015, are as follows: (amounts in thousands) Total Under Total Under Total 2016 $ 295,839 $ 65,097 $ 360,936 2017 297,671 66,399 364,070 2018 299,662 67,727 367,389 2019 301,040 69,081 370,121 2020 301,460 70,463 371,923 Thereafter 4,847,165 2,039,146 6,886,311 $ 6,342,837 $ 2,377,913 $ 8,720,750
Summary of Loans	The following is a summary of our loans ($ amounts in thousands): As of December 31, 2015 As of December 31, 2014 Balance Weighted Average Balance Weighted Average Mortgage loans $ 757,581 9.5 % $ 397,594 10.5 % Acquisition loans 610,469 9.1 % 525,136 9.3 % Working capital and other loans 54,353 10.2 % 48,031 10.4 % $ 1,422,403 $ 970,761
Schedule of Investment and Revenue by Operator	Investments and Revenue by Operator As of December 31, 2015: (Dollar amounts in thousands) Operators Total Assets Percentage of Total Total Percentage of Prime $ 1,032,353 18.4 % $ 104,325 23.6 % Capella 1,015,914 18.1 % 28,567 6.4 % MEDIAN 978,529 17.4 % 78,540 17.8 % Ernest 569,375 10.2 % 61,988 14.0 % As of December 31, 2014: (Dollar amounts in thousands) Operators Total Assets Percentage of Total Total Percentage of Prime $ 749,553 20.1 % $ 84,038 26.9 % MEDIAN 707,437 19.0 % 23,663 7.6 % Ernest 486,758 13.1 % 57,315 18.3 %
Schedule of Investments and Revenue from External Customers by Geographic Areas	Investments and Revenue by U.S. State and Country As of December 31, 2015: (Dollar amounts in thousands) U.S. States and Other Countries Total Assets Percentage of Total Total Percentage of Texas $ 917,314 16.4 % $ 87,541 19.8 % California 547,085 9.8 % 66,120 15.0 % Germany 978,529 17.4 % 78,540 17.8 % Italy, Spain, and the U.K. 152,661 2.7 % 4,476 1.0 % As of December 31, 2014: (Dollar amounts in thousands) U.S. States and Other Countries Total Assets Percentage of Total Total Percentage of Total Texas $ 776,017 20.9 % $ 74,044 23.7 % California 547,098 14.7 % 64,268 20.5 % Germany 707,437 19.0 % 23,663 7.6 % U.K. 44,005 1.2 % 2,322 0.7 %

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Summary of Debt	The following is a summary of debt ($ amounts in thousands): As of December 31, 2015 As of December 31, 2014 Balance Interest Rate Balance Interest Rate Revolving credit facility $ 1,100,000 Variable $ 593,490 Variable 2006 Senior Unsecured Notes 125,000 Various 125,000 Various 2011 Senior Unsecured Notes 450,000 6.875 % 450,000 6.875 % 2012 Senior Unsecured Notes: Principal amount 350,000 6.375 % 350,000 6.375 % Unamortized premium 2,168 2,522 352,168 352,522 2013 Senior Unsecured Notes(A) 217,240 5.75 % 241,960 5.75 % 2014 Senior Unsecured Notes 300,000 5.50 % 300,000 5.50 % 2015 Senior Unsecured Notes(A) 543,100 4.00 % — — Term loans 263,400 Various 138,682 Various $ 3,350,908 $ 2,201,654 Debt issue costs, net (28,367 ) (27,006 ) $ 3,322,541 $ 2,174,648 (A) These notes are Euro-denominated and reflect the exchange rates at December 31, 2015 and 2014, respectively.
Principal Payments Due on Debt	As of December 31, 2015, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows: 2016 $ 125,299 2017 320 2018 1,112,781 2019 250,000 2020 217,240 Thereafter 1,643,100 Total $ 3,348,740

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Income Tax Expense	From our taxable REIT subsidiaries and our foreign operations, we incurred income tax expenses as follows (in thousands): For the years ended December 31, 2015 2014 2013 Current income tax expense: Domestic $ 147 $ 114 $ 358 Foreign 1,614 225 158 1,761 339 516 Deferred income tax (benefit) expense: Domestic (360 ) (23 ) 210 Foreign 102 24 — (258 ) 1 210 Income tax expense $ 1,503 $ 340 $ 726
Schedule of Deferred Tax Assets and Liabilities	At December 31, 2015 and 2014, components of our deferred tax assets and liabilities were as follows (in thousands): 2015 2014 Deferred tax liabilities: Property and equipment $ (1,636 ) $ — Unbilled rent (4,495 ) (2,070 ) Partnership investments (3,362 ) (3,468 ) Other (6,141 ) (3,759 ) Total deferred tax liabilities $ (15,634 ) $ (9,297 ) Deferred tax assets: Operating loss and interest deduction carry forwards $ 19,016 $ 19,546 Property and equipment — 2,373 Other 10,314 3,971 Total deferred tax assets 29,330 25,890 Valuation allowance (23,005 ) (16,831 ) Total net deferred tax assets $ 6,325 $ 9,059 Net deferred tax (liability) $ (9,309 ) $ (238 )
Summary of Reconciliation of the Income Tax Expense at the Statutory Income Tax Rate and the Effective Tax Rate for Income from Continuing Operations before Income Taxes	A reconciliation of the income tax expense at the statutory income tax rate and the effective tax rate for income from continuing operations before income taxes for the years ended December 31, 2015, 2014, and 2013 is as follows (in thousands): 2015 2014 2013 Income from continuing operations (before-tax) $ 141,430 $ 51,138 $ 90,027 Income tax at the US statutory federal rate (35%) 49,501 17,898 31,509 Increase (decrease) resulting from: Rate differential 5,047 1,145 2,380 State income taxes, net of federal benefit (601 ) (337 ) 271 Dividends paid deduction (57,109 ) (27,873 ) (33,345 ) Change in valuation allowance 6,174 8,988 (697 ) Other items, net (1,509 ) 519 608 Total income tax expense $ 1,503 $ 340 $ 726
Schedule of Per Share Distributions to Stockholders	A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, 2015 2014 2013 Common share distribution $ 0.870000 $ 0.840000 $ 0.800000 Ordinary income 0.769535 0.520692 0.599384 Capital gains(1) — 0.000276 0.046380 Unrecaptured Sec. 1250 gain — 0.000276 0.026512 Return of capital 0.100465 0.319032 0.154236 Allocable to next year — — — (1) Capital gains include unrecaptured Sec. 1250 gains.

Earnings Per Share_Unit (Tables

Earnings Per Share/Unit (Tables)	12 Months Ended
	Dec. 31, 2015
Earnings Per Share [Abstract]
Calculation of Earnings Per Share	Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2015 2014 2013 Numerator: Income from continuing operations $ 139,927 $ 50,798 $ 89,301 Non-controlling interests’ share in continuing operations (329 ) (274 ) (224 ) Participating securities’ share in earnings (1,029 ) (894 ) (729 ) Income from continuing operations, less participating securities’ share in earnings 138,569 49,630 88,348 Income (loss) from discontinued operations attributable to MPT common stockholders — (2 ) 7,914 Net income, less participating securities’ share in earnings $ 138,569 $ 49,628 $ 96,262 Denominator: Basic weighted-average common shares 217,997 169,999 151,439 Dilutive potential common shares 307 541 1,159 Diluted weighted-average common shares 218,304 170,540 152,598 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2015 2014 2013 Numerator: Income from continuing operations $ 139,927 $ 50,798 $ 89,301 Non-controlling interests’ share in continuing operations (329 ) (274 ) (224 ) Participating securities’ share in earnings (1,029 ) (894 ) (729 ) Income from continuing operations, less participating securities’ share in earnings 138,569 49,630 88,348 Income (loss) from discontinued operations attributable to MPT Operating Partnership partners — (2 ) 7,914 Net income, less participating securities’ share in earnings $ 138,569 $ 49,628 $ 96,262 Denominator: Basic weighted-average units 217,997 169,999 151,439 Dilutive potential units 307 541 1,159 Diluted weighted-average units 218,304 170,540 152,598

Stock Awards (Tables)

Stock Awards (Tables)	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Restricted Equity Awards Activity	The following summarizes restricted equity award activity in 2015 and 2014 (which includes awards granted in 2015, 2014, 2013, and any applicable prior years), respectively: For the Year Ended December 31, 2015: Vesting Based on Service Vesting Based on Shares Weighted Average Shares Weighted Average Nonvested awards at beginning of the year 452,263 $ 12.11 2,428,518 $ 5.81 Awarded 407,969 $ 13.94 871,888 $ 6.62 Vested (343,904 ) $ 12.56 (406,970 ) $ 4.94 Forfeited (6,694 ) $ 13.08 (562,284 ) $ 5.33 Nonvested awards at end of year 509,634 $ 13.25 2,331,152 $ 6.38 For the Year Ended December 31, 2014: Vesting Based Vesting Based on Shares Weighted Average Shares Weighted Average Nonvested awards at beginning of the year 325,999 $ 11.36 1,999,179 $ 5.44 Awarded 424,366 $ 12.21 903,134 $ 7.57 Vested (298,102 ) $ 11.43 (473,795 ) $ 7.60 Forfeited — $ — — $ — Nonvested awards at end of year 452,263 $ 12.11 2,428,518 $ 5.81

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Fixed Minimum Rental Payable under Operating Leases Sublease Receivable And Net Payments Due with Non-cancelable Terms	Fixed minimum payments due under operating leases with non-cancelable terms of more than one year and amounts to be received in the future from non-cancelable subleases at December 31, 2015 are as follows: (amounts in thousands) Fixed Amounts to Net 2016 $ 5,119 $ (2,477 ) $ 2,642 2017 5,157 (2,502 ) 2,655 2018 5,125 (2,504 ) 2,621 2019 4,803 (2,522 ) 2,281 2020 4,896 (2,621 ) 2,275 Thereafter 140,049 (130,819 ) 9,230 $ 165,149 ($143,445 ) $ 21,704

Fair Value of Financial Instr35

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Summary of Fair Value Information of Financial Instruments	The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, December 31, Asset (Liability) Book Fair Book Fair Interest and rent receivables $ 46,939 $ 46,858 $ 41,137 $ 41,005 Loans(1) 508,851 543,859 773,311 803,824 Debt, net(2) (3,322,541 ) (3,372,773 ) (2,174,648 ) (2,258,721 ) (1) Excludes loans related to Ernest and Capella since they are recorded at fair value as discussed below. (2) Includes debt issue costs.
Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis	At December 31, 2015, the amounts recorded under the fair value option method were as follows (in thousands): Asset (Liability) Fair Cost Asset Type Mortgage loan $ 310,000 $ 310,000 Mortgage loans Acquisition loans 603,552 603,552 Other loans Equity investment 7,349 7,349 Other assets $ 920,901 $ 920,901 At December 31, 2014, the amounts recorded under the fair value option method were as follows (in thousands): Asset (Liability) Fair Cost Asset Type Mortgage loan $ 100,000 $ 100,000 Mortgage loans Acquisition loans 97,450 97,450 Other loans Equity investment 3,300 3,300 Other assets $ 200,750 $ 200,750
Summary Showing Sensitivity Analysis by Using Basis Point Variations	To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase (Decrease) +100 basis points $(122) - 100 basis points 122

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	The following table presents the results of discontinued operations, which include the revenue and expenses of facilities disposed of prior to 2014 for the year ended December 31, 2015, 2014, and 2013 (amounts in thousands except per share/unit data): For the Years Ended 2015 2014 2013 Revenues $ — $ — $ 988 Gain on sale — — 7,659 Income (loss) from discontinued operations — (2 ) 7,914 Income from discontinued operations — diluted per share/unit $ — $ — $ 0.05

Other Assets (Tables)

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2015
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Summary of Other Assets	The following is a summary of our other assets (in thousands): At December 31, 2015 2014 Debt issue costs, net(1) $ 7,628 $ 8,318 Equity investments 129,337 47,451 Other corporate assets 31,547 28,197 Prepaids and other assets 27,028 11,133 Total other assets $ 195,540 $ 95,099 (1) Relates to revolving credit facility

Quarterly Financial Data (una38

Quarterly Financial Data (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2015
Medical Properties Trust, Inc. [Member]
Unaudited Quarterly Financial Information	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2015 and 2014: (amounts in thousands, except for per share data) For the Three Month Periods in 2015 Ended March 31 June 30 September 30 December 31 Revenues $ 95,961 $ 99,801 $ 114,570 $ 131,546 Income from continuing operations 35,976 22,489 23,123 58,339 Net income 35,976 22,489 23,123 58,339 Net income attributable to MPT common stockholders 35,897 22,407 23,057 58,237 Net income attributable to MPT common stockholders per share — basic $ 0.18 $ 0.11 $ 0.10 $ 0.24 Weighted average shares outstanding — basic 202,958 208,071 223,948 237,011 Net income attributable to MPT common stockholders per share — diluted $ 0.17 $ 0.11 $ 0.10 $ 0.24 Weighted average shares outstanding — diluted 203,615 208,640 223,948 237,011 For the Three Month Periods in 2014 Ended March 31 June 30 September 30 December 31 Revenues $ 73,089 $ 76,560 $ 80,777 $ 82,106 Income (loss) from continuing operations 7,309 (203 ) 28,663 15,029 Income (loss) from discontinued operations (2 ) — — — Net income 7,307 (203 ) 28,663 15,029 Net income attributable to MPT common stockholders 7,241 (203 ) 28,537 14,947 Net income attributable to MPT common stockholders per share — basic $ 0.04 $ — $ 0.16 $ 0.08 Weighted average shares outstanding — basic 163,973 171,718 171,893 172,411 Net income attributable to MPT common stockholders per share — diluted $ 0.04 $ — $ 0.16 $ 0.08 Weighted average shares outstanding — diluted 164,549 171,718 172,639 172,604
MPT Operating Partnership, L.P. [Member]
Unaudited Quarterly Financial Information	The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2015 and 2014: (amounts in thousands, except for per unit data) For the Three Month Periods in 2015 Ended March 31 June 30 September 30 December 31 Revenues $ 95,961 $ 99,801 $ 114,570 $ 131,546 Income from continuing operations 35,976 22,489 23,123 58,339 Net income (loss) 35,976 22,489 23,123 58,339 Net income attributable to MPT Operating Partnership partners 35,897 22,407 23,057 58,237 Net income attributable to MPT Operating Partnership partners per unit — basic $ 0.18 $ 0.11 $ 0.10 $ 0.24 Weighted average units outstanding — basic 202,958 208,071 223,948 237,011 Net income attributable to MPT Operating Partnership partners per unit — diluted $ 0.17 $ 0.11 $ 0.10 $ 0.24 Weighted average units outstanding — diluted 203,615 208,640 223,948 237,011 For the Three Month Periods in 2014 Ended March 31 June 30 September 30 December 31 Revenues $ 73,089 $ 76,560 $ 80,777 $ 82,106 Income (loss) from continuing operations 7,309 (203 ) 28,663 15,029 Income (loss) from discontinued operations (2 ) — — — Net income (loss) 7,307 (203 ) 28,663 15,029 Net income attributable to MPT Operating Partnership partners 7,241 (203 ) 28,537 14,948 Net income attributable to MPT Operating Partnership partners per unit — basic $ 0.04 $ — $ 0.16 $ 0.08 Weighted average units outstanding — basic 163,973 171,718 171,893 172,411 Net income attributable to MPT Operating Partnership partners per unit — diluted $ 0.04 $ — $ 0.16 $ 0.08 Weighted average units outstanding — diluted 164,549 171,718 172,639 172,604

Summary of Significant Accoun39

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)mo	Dec. 31, 2014USD ($)	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Expected lease-up periods for estimating lost rentals, in months | mo	6
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%	90.00%	90.00%
Number of years of federal income tax at corporate rates on failure to qualify as REIT	4 years
Deferred financing costs | $	$ 28.4	$ 27
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years	10 years
Consolidated Entities [Member]
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	100.00%
Time-Based Awards [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years	3 years
Market Conditions Based Awards [Member] | Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years	3 years
Market Conditions Based Awards [Member] | Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years	5 years

Summary of Significant Accoun40

Summary of Significant Accounting Policies - Carrying Value and Classification of Related Assets and Maximum Exposure to Loss (Detail)	Dec. 31, 2015USD ($)
Mortgage and other loans [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 921,930,000
Loans, net [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	984,512,000
Other Assets [Member]
Variable Interest Entity [Line Items]
Carrying Amount	6,232,000
Equity investments [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	$ 54,033,000

Summary of Significant Accoun41

Summary of Significant Accounting Policies - Weighted Average Useful Lives of Related Real Estate and Other Assets (Detail)	12 Months Ended
	Dec. 31, 2015
Buildings and improvements [Member]
Property, Plant and Equipment [Line Items]
Weighted average useful lives of related real estate and other assets	38 years 10 months 24 days
Tenant lease intangibles [Member]
Property, Plant and Equipment [Line Items]
Weighted average useful lives of related real estate and other assets	25 years 7 months 6 days
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Weighted average useful lives of related real estate and other assets	22 years 1 month 6 days
Furniture, equipment and other [Member]
Property, Plant and Equipment [Line Items]
Weighted average useful lives of related real estate and other assets	9 years 3 months 18 days

Real Estate and Loans Receiva42

Real Estate and Loans Receivable - Assets Acquired (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Equity investments and other assets	$ 101,716	$ 33,708
Liabilities	(317)
Total assets acquired	2,218,869	767,696	$ 654,922
Loans repaid	(385,851)
Total net assets acquired	1,833,018	767,696	654,922
Land [Member]
Business Acquisition [Line Items]
Total assets acquired	126,336	22,569	41,473
Building [Member]
Business Acquisition [Line Items]
Total assets acquired	758,009	241,242	439,030
Intangible Lease Assets - Subject to Amortization [Member]
Business Acquisition [Line Items]
Total assets acquired	154,719	22,513	38,589
Net Investments in Direct Financing Leases [Member]
Business Acquisition [Line Items]
Total assets acquired	174,801		110,580
Other Loans [Member]
Business Acquisition [Line Items]
Total assets acquired	523,605	$ 447,664	5,250
Mortgage Loans [Member]
Business Acquisition [Line Items]
Total assets acquired	$ 380,000		$ 20,000

Real Estate and Loans Receiva43

Real Estate and Loans Receivable - Assets Acquired (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Intangible Lease Assets - Subject to Amortization [Member]
Business Acquisition [Line Items]
Weighted average useful life of acquired intangible lease assets (in years)	30 years 4 months 24 days	18 years 2 months 12 days	21 years

Real Estate and Loans Receiva44

Real Estate and Loans Receivable - 2015 Activity - Additional Information (Detail)

Dec. 31, 2015USD ($)PropertyHospital

Dec. 03, 2015EUR (€)Bed

Nov. 18, 2015EUR (€)Facility

Oct. 30, 2015USD ($)

Sep. 30, 2015USD ($)HospitalHealth_Center

Sep. 09, 2015EUR (€)

Aug. 31, 2015USD ($)BedInvestment

Jun. 16, 2015USD ($)BedProperty

Apr. 29, 2015EUR (€)Hospital

Feb. 27, 2015USD ($)Leases

Feb. 13, 2015USD ($)RenewalOptionsFacility

Aug. 31, 2015InvestmentPropertyLeases

Jul. 31, 2015USD ($)Investment

Dec. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Dec. 31, 2013USD ($)

Dec. 31, 2015EUR (€)

Business Acquisition [Line Items]

Mortgage financing

$ 380,000,000

$ 12,500,000

$ 20,000,000

Income contributed by the acquired entity

240,783,000

220,181,000

Acquisition related costs

61,342,000

$ 26,389,000

$ 19,494,000

2015 [Member]

Business Acquisition [Line Items]

Loans provided for acquisition

$ 487,700,000

487,700,000

2015 [Member] | Lake Huron Medical Center [Member]

Business Acquisition [Line Items]

Acquisition costs

20,000,000

Mortgage financing

$ 30,000,000

2015 [Member] | Ernest [Member]

Business Acquisition [Line Items]

Acquisition costs

$ 31,500,000

Loans provided for acquisition

$ 12,000,000

Term of lease, years

20 years

Number of properties acquired | Property

2

2015 [Member] | Ernest [Member] | Minimum [Member]

Business Acquisition [Line Items]

Term of lease extension, years

3 years

2015 [Member] | Ernest [Member] | Maximum [Member]

Business Acquisition [Line Items]

Term of lease extension, years

5 years

2015 [Member] | Axa Real Estate [Member]

Business Acquisition [Line Items]

Ownership interest in joint venture under the equity method

50.00%

2015 [Member] | Acute Care Hospital [Member]

Business Acquisition [Line Items]

Number of facilities acquired | Facility

7

Purchase price of acquisition | €

€ 90,000,000

2015 [Member] | Acute Care Hospital [Member] | Kansas [Member]

Business Acquisition [Line Items]

Term of lease, years

10 years

Term of lease extension, years

5 years

Number of facilities acquired | Facility

2

Purchase price of acquisition

$ 110,000,000

Mortgage financing

$ 40,000,000

Mortgage financing term

10 years

Number of lease extension options in current lease contract | RenewalOptions

2

2015 [Member] | Acute Care Hospital [Member] | Ernest [Member]

Business Acquisition [Line Items]

Number of beds acquired | Bed

37

2015 [Member] | Acute Care Hospital [Member] | Axa Real Estate [Member]

Business Acquisition [Line Items]

Ownership interest in joint venture under the equity method

50.00%

Estimated total development cost | €

€ 21,400,000

2015 [Member] | RHM Rehabilitation Clinic [Member] | Germany [Member]

Business Acquisition [Line Items]

Acquisition costs | €

€ 18,700,000

Term of lease, years

25 years

Number of beds acquired | Bed

266

Cumulative increases in the German consumer price index

70.00%

2015 [Member] | RHM Rehabilitation Clinic [Member] | Germany [Member] | From 2015 through 2017 [Member]

Business Acquisition [Line Items]

Rent escalations percentage

2.00%

2015 [Member] | RHM Rehabilitation Clinic [Member] | Germany [Member] | After 2017 [Member]

Business Acquisition [Line Items]

Rent escalations percentage

0.50%

2015 [Member] | General Acute Care Hospital and Healthcare System [Member]

Business Acquisition [Line Items]

Mortgage financing

$ 100,000,000

Number of licensed hospitals | Hospital

3

Number of free-standing emergency department and health center | Health_Center

1

Mortgage financing term

5 years

2015 [Member] | General Acute Care Hospital [Member] | Lake Huron Medical Center [Member]

Business Acquisition [Line Items]

Number of beds acquired | Bed

144

2015 [Member] | Rehabilitation Hospital with Covenant Health System [Member] | Ernest [Member]

Business Acquisition [Line Items]

Number of beds acquired | Bed

60

2015 [Member] | Inpatient Rehabilitation Hospital [Member] | Ernest [Member] | Weslaco Texas [Member]

Business Acquisition [Line Items]

Acquisition costs

$ 10,700,000

Number of lease extension options | Leases

3

Term of lease extension, years

5 years

Payments to fund long-term loans to related parties

$ 5,000,000

Lease remaining term

17 years

2015 [Member] | Median [Member]

Business Acquisition [Line Items]

Ownership interests acquired

5.10%

Acquisition costs | €

€ 688,000,000

Loans provided for acquisition | €

€ 240,000,000

Term of lease, years

27 years

Number of properties closed | Property

31

Number of hospitals acquired | Hospital

32

32

Lease rent increase percentage

70.00%

Value of properties closed | €

€ 646,000,000

Loan amount outstanding | €

€ 0

Real estate transfer tax

$ 37,000,000

37,000,000

2015 [Member] | Capella [Member]

Business Acquisition [Line Items]

Combined purchase price and investment amount

$ 900,000,000

Ownership interests acquired

49.00%

Acquisition costs

$ 25.8

$ 600,000,000

Loans provided for acquisition

$ 9,200,000

$ 290,000,000

Term of lease, years

15 years

Number of lease extension options | Leases

4

Term of lease extension, years

5 years

Number of properties closed | Property

6

Increase in consumer price-index, floor rate

2.00%

Increase in consumer price-index, ceiling rate

4.00%

2015 [Member] | Capella [Member] | MPT Camaro Opco [Member]

Business Acquisition [Line Items]

Ownership interests acquired

49.00%

2015 [Member] | Capella [Member] | Acute Care Hospital [Member]

Business Acquisition [Line Items]

Number of portfolio investments | Investment

7

7

7

Number of investment in form of mortgage loan | Investment

2

2

2

2015 [Member] | Capella [Member] | Joint Venture Partner [Member]

Business Acquisition [Line Items]

Fixed interest rate

8.00%

8.00%

2015 [Member] | Capella [Member] | Joint Venture Partner [Member] | ManageCo [Member]

Business Acquisition [Line Items]

Ownership interests acquired

51.00%

2015 [Member] | Eight Acute Care Hospitals [Member]

Business Acquisition [Line Items]

Loans provided for acquisition

$ 100,000,000

100,000,000

2015 [Member] | Waterland Private Equity Fund [Member] | Median [Member]

Business Acquisition [Line Items]

Ownership interests acquired

94.90%

2015 [Member] | Business Acquisitions [Member]

Business Acquisition [Line Items]

Revenue contributed by the acquired entity

102,400,000

Income contributed by the acquired entity

69,300,000

Acquisition related costs

$ 58,000,000

Real Estate and Loans Receiva45

Real Estate and Loans Receivable - 2014 Activity - Additional Information (Detail) $ in Thousands, € in Millions, £ in Millions

Dec. 15, 2014EUR (€)

Oct. 31, 2014USD ($)Bed

Sep. 19, 2014USD ($)RenewalOptions

Jul. 01, 2014USD ($)

Jul. 01, 2014GBP (£)

Mar. 31, 2014USD ($)

Dec. 31, 2014USD ($)BedFacility

Dec. 31, 2015USD ($)

Dec. 31, 2014USD ($)Bed

Dec. 31, 2013USD ($)

Dec. 31, 2014EUR (€)Bed

Jul. 01, 2014GBP (£)

Business Acquisition [Line Items]

Acquisition related costs

$ 61,342

$ 26,389

$ 19,494

Income contributed by the acquired entity

$ 240,783

220,181

2014 [Member]

Business Acquisition [Line Items]

Acquired percentage of the outstanding equity interest

5.10%

2014 [Member] | Circle Health Ltd. [Member]

Business Acquisition [Line Items]

Acquired facility, carrying value of sale/leaseback transaction

$ 48,000

£ 28.3

Sale/leaseback transaction, initial term period

15 years

15 years

Sale/leaseback transaction, additional term period

15 years

15 years

Percentage change in annual retail price index, floor rate

2.00%

2.00%

Percentage change in annual retail price index, cap rate

5.00%

5.00%

Acquisition related costs

$ 1,900

£ 1.1

2014 [Member] | Acute Care Hospital [Member]

Business Acquisition [Line Items]

Acquisition costs

$ 115,000

Term of lease, years

15 years

Term of lease extension, years

3 years

2014 [Member] | Acute Care Hospital [Member] | Fair value market [Member]

Business Acquisition [Line Items]

Term of lease extension, years

12 years

2014 [Member] | Acute Care Hospital [Member] | Alecto Healthcare Services [Member] | Fairmont West Virginia [Member]

Business Acquisition [Line Items]

Ownership interest, percentage

20.00%

Acquisition costs

$ 15,000

Term of lease, years

15 years

Term of lease extension, years

5 years

Number of lease extension options in current lease contract | RenewalOptions

3

Working capital loan to the tenant

$ 5,000

Additional lease period

5 years

Additional fund committed to the tenant for capital improvements

$ 5,000

2014 [Member] | Median and Waterland [Member]

Business Acquisition [Line Items]

Interim acquisition loans aggregate amount | €

€ 425

Interim acquisition loans advanced | €

€ 349

2014 [Member] | Median [Member] | Waterland [Member]

Business Acquisition [Line Items]

Acquired percentage of the outstanding equity interest

94.90%

2014 [Member] | Business Acquisitions [Member]

Business Acquisition [Line Items]

Acquisition related costs

26,400

Revenue contributed by the acquired entity

12,400

Income contributed by the acquired entity

8,700

Acquisition-related costs on consummated deals

25,200

Acquisition related costs - transfer taxes on consummated deals

5,800

2014 [Member] | Germany [Member] | RHM Rehabilitation Facilities [Member]

Business Acquisition [Line Items]

Purchase price of acquisition

$ 81,000

81,000

63.6

Applicable transfer and other taxes on purchase price

$ 3,600

$ 3,600

€ 3

Number of facilities acquired | Facility

3

2014 [Member] | Germany [Member] | Bad Mergentheim [Member] | RHM Rehabilitation Facilities [Member]

Business Acquisition [Line Items]

Number of beds | Bed

211

211

211

2014 [Member] | Germany [Member] | Bad Tolz [Member] | RHM Rehabilitation Facilities [Member]

Business Acquisition [Line Items]

Number of beds | Bed

248

248

248

2014 [Member] | Germany [Member] | Bad Liebenstein [Member] | RHM Rehabilitation Facilities [Member]

Business Acquisition [Line Items]

Number of beds | Bed

271

271

271

2014 [Member] | Sherman TX [Member]

Business Acquisition [Line Items]

Purchase price of acquisition

$ 32,500

2014 [Member] | Sherman TX [Member] | Alecto Healthcare Services [Member]

Business Acquisition [Line Items]

Working capital loan

$ 7,500

Initial leaseback term

15 years

Ownership interest, percentage

20.00%

2014 [Member] | Sherman TX [Member] | Acute Care Hospital [Member]

Business Acquisition [Line Items]

Number of beds | Bed

237

Real Estate and Loans Receiva46

Real Estate and Loans Receivable - 2013 Activity - Additional Information (Detail) $ in Thousands, € in Millions	Nov. 29, 2013USD ($)Facility	Sep. 26, 2013USD ($)ContractFacility	Jun. 11, 2013USD ($)RenewalOptionsFacility	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)Bed	Dec. 12, 2013USD ($)RenewalOptions	Nov. 29, 2013EUR (€)	Jul. 18, 2013USD ($)
Business Acquisition [Line Items]
Mortgage financing				$ 380,000	$ 12,500	$ 20,000
Income contributed by the acquired entity				240,783	220,181
Acquisition related costs				$ 61,342	$ 26,389	19,494
2013 [Member]
Business Acquisition [Line Items]
Mortgage financing						20,000
2013 [Member] | RHM Portfolio Acquisition [Member]
Business Acquisition [Line Items]
Purchase price of acquisition	$ 237,800							€ 175
Number of facilities acquired | Facility	11
Applicable transfer and other taxes on purchase price | €								€ 9
Term of lease, years				27 years
Cumulative increases in the German consumer price index	70.00%
2013 [Member] | Dallas Medical Center [Member]
Business Acquisition [Line Items]
Purchase price of acquisition							$ 25,000
Term of lease, years				10 years
Number of lease extension options in current lease contract | RenewalOptions							2
Term of lease extension, years				5 years
2013 [Member] | Ernest [Member]
Business Acquisition [Line Items]
Term of lease, years				20 years
2013 [Member] | Term Loans [Member] | Ernest [Member]
Business Acquisition [Line Items]
Loan on property				$ 5,300
2013 [Member] | Corpus Christi Rehabilitation Hospital [Member]
Business Acquisition [Line Items]
Purchase price of acquisition									$ 10,500
2013 [Member] | Corpus Christi Rehabilitation Hospital [Member] | Commitment [Member]
Business Acquisition [Line Items]
Purchase price of acquisition									$ 500
2013 [Member] | Business Acquisitions [Member]
Business Acquisition [Line Items]
Revenue contributed by the acquired entity						13,600
Income contributed by the acquired entity						10,600
Acquisition related costs						19,500
Acquisition-related costs on consummated deals						18,000
Acquisition related costs - transfer taxes on consummated deals						$ 12,000
2013 [Member] | From 2015 through 2017 [Member] | RHM Portfolio Acquisition [Member]
Business Acquisition [Line Items]
Rent escalations percentage	2.00%
2013 [Member] | After 2017 [Member] | RHM Portfolio Acquisition [Member]
Business Acquisition [Line Items]
Rent escalations percentage	0.50%
2013 [Member] | Maximum [Member] | Ernest [Member]
Business Acquisition [Line Items]
Term of lease extension, years				5 years
Maximum rent increase percent				5.00%
2013 [Member] | Minimum [Member] | Ernest [Member]
Business Acquisition [Line Items]
Term of lease extension, years				3 years
Maximum rent increase percent				2.00%
2013 [Member] | Acute Care Hospital [Member] | Kansas [Member]
Business Acquisition [Line Items]
Number of facilities acquired | Facility			2
Term of lease, years				10 years
Number of lease extension options in current lease contract | RenewalOptions			2
Term of lease extension, years				5 years
Maximum rent increase percent			2.00%
Acquisition costs			$ 75,000
2013 [Member] | Acute Care Hospital [Member] | Iasis Healthcare LLC [Member]
Business Acquisition [Line Items]
Purchase price of acquisition		$ 281,300
Number of facilities acquired | Facility		3
Number of lease extension options in current lease contract | Contract		2
Initial leaseback term				15 years
Lease renewal option				5 years
Lease maturity year				2,019
Extended lease maturity year				2,028
2013 [Member] | Acute Care Hospital [Member] | Maximum [Member] | Iasis Healthcare LLC [Member]
Business Acquisition [Line Items]
Maximum rent increase percent				2.50%
2013 [Member] | Olympia Medical Center [Member]
Business Acquisition [Line Items]
Number of beds | Bed						204

Real Estate and Loans Receiva47

Real Estate and Loans Receivable - Schedule of Unaudited Supplemental Pro Forma Operating Data (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Business Acquisition, Pro Forma Information [Abstract]
Total revenues	$ 542,763	$ 531,549
Net income	$ 240,783	$ 220,181
Net income per share/unit	$ 1.02	$ 0.93

Real Estate and Loans Receiva48

Real Estate and Loans Receivable - Development Activities - Additional Information (Detail) $ in Thousands	Apr. 30, 2015USD ($)Leases	Dec. 31, 2015USD ($)RenewalOptionsFacilityProperty	Dec. 31, 2014USD ($)Facility	May. 05, 2015USD ($)
Business Acquisition [Line Items]
Current development project		$ 306,500
Ernest [Member] | Rehabilitation Hospital of Northwestern Ohio [Member] | Inpatient Rehabilitation Hospital [Member] | Toledo, OH [Member]
Business Acquisition [Line Items]
Current development project		$ 19,212
Development Activities [Member] | Oakleaf Surgical Hospital [Member] | Acute Care Hospital [Member] | Altoona, WI [Member] | National Surgical Hospitals [Member]
Business Acquisition [Line Items]
Term of lease, years		15 years
Number of lease extension options in current lease contract | RenewalOptions		2
Term of lease extension, years		5 years
Current development project		$ 30,000
Development Activities [Member] | First Choice [Member]
Business Acquisition [Line Items]
Number of facilities leased | Facility			17
Number of property leased | Property		3
Estimated total development cost			$ 83,000
Development Activities [Member] | First Choice [Member] | 2015 Master Lease [Member]
Business Acquisition [Line Items]
Number of facilities leased | Facility		17
Estimated total development cost		$ 102,600
Development Activities [Member] | First Choice [Member] | 2014 Master Lease [Member]
Business Acquisition [Line Items]
Number of facilities leased | Facility		14
Development Activities [Member] | UAB Medical West [Member]
Business Acquisition [Line Items]
Estimated total development cost		$ 8,600
Term of lease, years		15 years
Number of lease extension options in current lease contract | RenewalOptions		4
Term of lease extension, years		5 years
Lease rent increase percentage		2.00%
Development Activities [Member] | Ernest [Member] | Rehabilitation Hospital of Northwestern Ohio [Member] | Inpatient Rehabilitation Hospital [Member] | Toledo, OH [Member]
Business Acquisition [Line Items]
Current development project				$ 19,200
Development Activities [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Term of lease extension, years	5 years
Aggregate commitment amount	$ 250,000	$ 500,000
Lease agreement term	15 years
Number of lease extension options | Leases	3
Percentage of increase in annual rent	2.00%
Commitment amount, funded		$ 217,500
Number of facilities completed | Facility		35
Number of facilities under construction | Facility		8
Development Activities [Member] | Northern Utah Rehabilitation Hospital [Member]
Business Acquisition [Line Items]
Estimated total development cost		$ 19,000

Real Estate and Loans Receiva49

Real Estate and Loans Receivable - Summary of Status Update on Current Development Projects (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Business Acquisition [Line Items]
Commitment	$ 306,500
Costs Incurred as 12/31/15	49,165
First Choice ER- Houston [Member] | Houston, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	5,257
Costs Incurred as 12/31/15	$ 2,535
Estimated Completion Date	1Q 2016
First Choice ER- Denver [Member] | Denver, CO [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 5,300
Costs Incurred as 12/31/15	$ 2,435
Estimated Completion Date	2Q 2016
First Choice ER- Phoenix [Member] | Phoenix, AZ [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 6,728
Costs Incurred as 12/31/15	$ 3,275
Estimated Completion Date	2Q 2016
First Choice ER- San Antonio [Member] | San Antonio, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 7,530
Costs Incurred as 12/31/15	$ 3,690
Estimated Completion Date	2Q 2016
First Choice ER - Texas [Member] | Texas [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 16,422
Costs Incurred as 12/31/15	$ 3,924
Estimated Completion Date	2Q 2016
Rehabilitation Hospital of Northwestern Ohio [Member] | Toledo, OH [Member] | Inpatient Rehabilitation Hospital [Member] | Ernest [Member]
Business Acquisition [Line Items]
Commitment	$ 19,212
Costs Incurred as 12/31/15	$ 13,693
Estimated Completion Date	2Q 2016
First Choice ER- Houston [Member] | Houston, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 45,961
Costs Incurred as 12/31/15	$ 19,613
Estimated Completion Date	3Q 2016
First Choice Emergency Rooms [Member] | Various [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	$ 200,090
Estimated Completion Date	Various

Real Estate and Loans Receiva50

Real Estate and Loans Receivable - Disposals - Additional Information (Detail) $ in Thousands	Aug. 05, 2015USD ($)Hospital	Jul. 30, 2015USD ($)	May. 20, 2014USD ($)	Nov. 27, 2013USD ($)	Apr. 17, 2013USD ($)Hospital	Sep. 30, 2015USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Debt Instrument [Line Items]
Proceeds from sale of real estate							$ 19,175	$ 34,649	$ 32,409
Texas [Member]
Debt Instrument [Line Items]
Proceeds from sale of real estate		$ 9,700
Gain (loss) on sale of real estate		1,500
Straight line rent receivables write-off		$ 900
United States [Member]
Debt Instrument [Line Items]
Proceeds from sale of real estate	$ 9,500
Number of hospitals sold | Hospital	6
Gain (loss) on sale of real estate	$ 1,700
Consideration received as note receivable	1,500
Billed rent receivables write-off	$ 900
Amortization of the related lease intangible asset						$ 700
Disposals [Member]
Debt Instrument [Line Items]
Acquisition costs			$ 35,000
Real estate impairment charge			$ 3,100
Disposals [Member] | La Palma Facility [Member]
Debt Instrument [Line Items]
Proceeds from sale of real estate								12,500
Gain (loss) on sale of real estate								2,900
Straight line rent receivables write-off								$ 1,300
Disposals [Member] | San Antonio, TX [Member]
Debt Instrument [Line Items]
Proceeds from sale of real estate				$ 14,000
Gain (loss) on sale of real estate				$ 5,600
Disposals [Member] | Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas [Member]
Debt Instrument [Line Items]
Proceeds from sale of real estate					$ 18,500
Number of hospitals sold | Hospital					2
Gain (loss) on sale of real estate					$ 2,100

Real Estate and Loans Receiva51

Real Estate and Loans Receivable - Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Intangible lease assets	$ 256,950	$ 108,885
Intangible Assets [Member]
Debt Instrument [Line Items]
Intangible lease assets	257,000	108,900
Accumulated amortization, net	231,700	87,700
Amortization expense related to intangible lease assets	$ 9,100	$ 7,000	$ 4,000
Capitalized lease intangibles, weighted average life (in years)	24 years

Real Estate and Loans Receiva52

Real Estate and Loans Receivable - Amortization Expense from Existing Lease Intangible Assets (Detail) $ in Thousands	Dec. 31, 2015USD ($)
Business Combinations [Abstract]
2,016	$ 10,204
2,017	10,194
2,018	10,133
2,019	10,085
2,020	$ 9,882

Real Estate and Loans Receiva53

Real Estate and Loans Receivable - Leasing Operations - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2015Leases
Capella [Member]
Business Acquisition [Line Items]
Number of direct financing leases	4
Ernest [Member]
Business Acquisition [Line Items]
Number of direct financing leases	15
Prime Facilities [Member]
Business Acquisition [Line Items]
Number of direct financing leases	5

Real Estate and Loans Receiva54

Real Estate and Loans Receivable - Components of Net Investment in Direct Financing Leases (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Business Combinations [Abstract]
Minimum lease payments receivable	$ 2,587,912	$ 1,607,024
Estimated residual values	393,097	211,888
Less unearned income	(2,354,013)	(1,379,396)
Net investment in direct financing leases	$ 626,996	$ 439,516

Real Estate and Loans Receiva55

Real Estate and Loans Receivable - Minimum Rental Payments Due under Operating Leases with Non-Cancelable Terms (Detail) $ in Thousands	Dec. 31, 2015USD ($)
Leases User Charges And Commitments [Line Items]
2,016	$ 5,119
2,017	5,157
2,018	5,125
2,019	4,803
2,020	4,896
Thereafter	140,049
Minimum rental payments, total	165,149
Minimum Rental Payments [Member]
Leases User Charges And Commitments [Line Items]
2,016	360,936
2,017	364,070
2,018	367,389
2,019	370,121
2,020	371,923
Thereafter	6,886,311
Minimum rental payments, total	8,720,750
Minimum Rental Payments [Member] | Operating Leases [Member]
Leases User Charges And Commitments [Line Items]
2,016	295,839
2,017	297,671
2,018	299,662
2,019	301,040
2,020	301,460
Thereafter	4,847,165
Minimum rental payments, total	6,342,837
Minimum Rental Payments [Member] | Direct Financing Leases [Member]
Leases User Charges And Commitments [Line Items]
2,016	65,097
2,017	66,399
2,018	67,727
2,019	69,081
2,020	70,463
Thereafter	2,039,146
Minimum rental payments, total	$ 2,377,913

Real Estate and Loans Receiva56

Real Estate and Loans Receivable - Hoboken Facility - Additional Information (Detail) - Hoboken Facility [Member] $ in Millions	Sep. 30, 2015USD ($)
Business Acquisition [Line Items]
Percentage of ownership in subsidiary	10.00%
Real estate investment	$ 5

Real Estate and Loans Receiva57

Real Estate and Loans Receivable - Twelve Oaks facility - Additional Information (Detail) - Twelve Oaks Facility [Member] - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2015
Business Acquisition [Line Items]
Amortization of the related lease intangible asset	$ 1.9
Straight line rent receivables write-off		$ 0.5
Outstanding amount receivable from tenant		1
Letter of credit outstanding		0.5
Amount received from tenants		$ 0.8

Real Estate and Loans Receiva58

Real Estate and Loans Receivable - Monroe Facility - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Impairment charges		$ 50,128
Monroe Properties [Member]
Business Acquisition [Line Items]
Impairment charges		47,000
Amount paid in settlement of bankruptcy claims		$ 2,500
Net investment	$ 36,000

Real Estate and Loans Receiva59

Real Estate and Loans Receivable - Florence Facility - Additional Information (Detail) - Florence Acute Care Facility [Member] $ in Millions	Dec. 31, 2015USD ($)
Business Acquisition [Line Items]
Real estate investment	$ 26.7
Outstanding rent receivables	0.9
Letter of credit outstanding	$ 1.2

Real Estate and Loans Receiva60

Real Estate and Loans Receivable - Summary of Loans (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Loans [Line Items]
Loans, Balance	$ 1,422,403	$ 970,761
Mortgage Loans [Member]
Loans [Line Items]
Loans, Balance	$ 757,581	$ 397,594
Loans, Weighted Average Interest Rate	9.50%	10.50%
Acquisition loans [Member]
Loans [Line Items]
Loans, Balance	$ 610,469	$ 525,136
Loans, Weighted Average Interest Rate	9.10%	9.30%
Working capital and other loans [Member]
Loans [Line Items]
Loans, Balance	$ 54,353	$ 48,031
Loans, Weighted Average Interest Rate	10.20%	10.40%

Real Estate and Loans Receiva61

Real Estate and Loans Receivable - Loans - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 01, 2012	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition [Line Items]
Existing mortgage loans		$ 757,500	$ 397,500	$ 388,650	$ 368,650
Amount of convertible note converted into equity interest	$ 1,700
Convertible note	$ 5,000
Percentage of equity shares from convertible debt	9.90%	15.10%
Remaining convertible debt after conversion of part of debt		$ 3,300
Ernest Transaction and Other Acquisitions [Member]
Business Acquisition [Line Items]
Existing mortgage loans		114,400
Capella [Member]
Business Acquisition [Line Items]
Increase in mortgage loans		210,000
Existing mortgage loans		$ 487,700

Real Estate and Loans Receiva62

Real Estate and Loans Receivable - Schedule of Investment and Revenue by Operator (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investment And Revenue From External Customers [Line Items]
Total Assets	$ 5,609,351				$ 3,720,330				$ 5,609,351	$ 3,720,330
Revenue	131,546	$ 114,570	$ 99,801	$ 95,961	82,106	$ 80,777	$ 76,560	$ 73,089	441,878	312,532	$ 242,523
Assets, Total [Member] | Credit Concentration Risk [Member] | Prime [Member]
Investment And Revenue From External Customers [Line Items]
Total Assets	1,032,353				749,553				$ 1,032,353	$ 749,553
Assets									18.40%	20.10%
Assets, Total [Member] | Credit Concentration Risk [Member] | Capella [Member]
Investment And Revenue From External Customers [Line Items]
Total Assets	1,015,914								$ 1,015,914
Assets									18.10%
Assets, Total [Member] | Credit Concentration Risk [Member] | Median [Member]
Investment And Revenue From External Customers [Line Items]
Total Assets	978,529				707,437				$ 978,529	$ 707,437
Assets									17.40%	19.00%
Assets, Total [Member] | Credit Concentration Risk [Member] | Ernest [Member]
Investment And Revenue From External Customers [Line Items]
Total Assets	$ 569,375				$ 486,758				$ 569,375	$ 486,758
Assets									10.20%	13.10%
Revenue [Member] | Credit Concentration Risk [Member] | Prime [Member]
Investment And Revenue From External Customers [Line Items]
Revenue									$ 104,325	$ 84,038
Assets									23.60%	26.90%
Revenue [Member] | Credit Concentration Risk [Member] | Capella [Member]
Investment And Revenue From External Customers [Line Items]
Revenue									$ 28,567
Assets									6.40%
Revenue [Member] | Credit Concentration Risk [Member] | Median [Member]
Investment And Revenue From External Customers [Line Items]
Revenue									$ 78,540	$ 23,663
Assets									17.80%	7.60%
Revenue [Member] | Credit Concentration Risk [Member] | Ernest [Member]
Investment And Revenue From External Customers [Line Items]
Revenue									$ 61,988	$ 57,315
Assets									14.00%	18.30%

Real Estate and Loans Receiva63

Real Estate and Loans Receivable - Schedule of Investments and Revenue from External Customers by Geographic Areas (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets	$ 5,609,351				$ 3,720,330				$ 5,609,351	$ 3,720,330
Revenue	131,546	$ 114,570	$ 99,801	$ 95,961	82,106	$ 80,777	$ 76,560	$ 73,089	441,878	312,532	$ 242,523
Assets, Total [Member] | Texas [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets	917,314				776,017				$ 917,314	$ 776,017
Assets									16.40%	20.90%
Assets, Total [Member] | California [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets	547,085				547,098				$ 547,085	$ 547,098
Assets									9.80%	14.70%
Assets, Total [Member] | Germany [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets	978,529				707,437				$ 978,529	$ 707,437
Assets									17.40%	19.00%
Assets, Total [Member] | Italy Spain and United Kingdom [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets	$ 152,661								$ 152,661
Assets									2.70%
Assets, Total [Member] | United Kingdom [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Total Assets					$ 44,005					$ 44,005
Assets										1.20%
Revenue [Member] | Texas [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Revenue									$ 87,541	$ 74,044
Assets									19.80%	23.70%
Revenue [Member] | California [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Revenue									$ 66,120	$ 64,268
Assets									15.00%	20.50%
Revenue [Member] | Germany [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Revenue									$ 78,540	$ 23,663
Assets									17.80%	7.60%
Revenue [Member] | Italy Spain and United Kingdom [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Revenue									$ 4,476
Assets									1.00%
Revenue [Member] | United Kingdom [Member] | Credit Concentration Risk [Member]
Investment And Revenue From External Customers By Geographic Area [Line Items]
Revenue										$ 2,322
Assets										0.70%

Real Estate and Loans Receiva64

Real Estate and Loans Receivable - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015USD ($)Investment	Sep. 30, 2015USD ($)	Jun. 30, 2015USD ($)	Mar. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Sep. 30, 2014USD ($)	Jun. 30, 2014USD ($)	Mar. 31, 2014USD ($)	Dec. 31, 2015USD ($)Investment	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Business Acquisition [Line Items]
Revenues	$ 131,546	$ 114,570	$ 99,801	$ 95,961	$ 82,106	$ 80,777	$ 76,560	$ 73,089	$ 441,878	$ 312,532	$ 242,523
European [Member]
Business Acquisition [Line Items]
Revenues									83,000	26,000
Related Party Transactions [Member]
Business Acquisition [Line Items]
Lease and interest revenue earned from tenants									$ 215,400	$ 101,800	$ 70,000
Assets, Total [Member] | Customer Concentration Risk [Member]
Business Acquisition [Line Items]
Number of investment in property | Investment	0								0
Maximum percentage of entity's total assets invested on single property	2.00%								2.00%
Assets, Total [Member] | Geographic Concentration Risk [Member] | United States [Member]
Business Acquisition [Line Items]
Percentage of total assets accounted									80.00%
Assets, Total [Member] | Geographic Concentration Risk [Member] | European [Member]
Business Acquisition [Line Items]
Percentage of total assets accounted									20.00%

Debt - Summary of Debt (Detail)

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Aug. 19, 2015	Oct. 10, 2013
Debt Instrument [Line Items]
Principal amount	$ 3,348,740
Debt issue costs, net	(28,367)	$ (27,006)
Debt	$ 3,322,541	$ 2,174,648
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.875%	6.875%
Debt	$ 450,000	$ 450,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate	Variable	Variable
Debt	$ 1,100,000	$ 593,490
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 125,000	$ 125,000
2012 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 350,000	$ 350,000
Senior unsecured notes, interest rate	6.375%	6.375%
Unamortized premium	$ 2,168	$ 2,522
Debt	$ 352,168	$ 352,522
2013 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.75%	5.75%		5.75%
Debt	$ 217,240	$ 241,960
2014 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.50%	5.50%
Debt	$ 300,000	$ 300,000
2015 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	4.00%		4.00%
Debt	$ 543,100
Term Loans [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 263,400	$ 138,682
Senior Unsecured Debt [Member]
Debt Instrument [Line Items]
Debt	$ 3,350,908	$ 2,201,654

Debt - Principal Payments Due f

Debt - Principal Payments Due for Debt (Detail) $ in Thousands	Dec. 31, 2015USD ($)
Debt Disclosure [Abstract]
2,016	$ 125,299
2,017	320
2,018	1,112,781
2,019	250,000
2,020	217,240
Thereafter	1,643,100
Total	$ 3,348,740

Debt - Revolving Credit Facilit

Debt - Revolving Credit Facility - Additional Information (Detail) - USD ($)	Jun. 19, 2014	Sep. 30, 2015	Nov. 30, 2014	Dec. 31, 2015	Aug. 04, 2015	Dec. 31, 2014	Oct. 17, 2014	Jun. 30, 2014
Debt Instrument [Line Items]
Aggregate committed amount of credit facility		$ 1,950,000,000
Credit facility, amendment fees incurred		100,000
Term Loans [Member]
Debt Instrument [Line Items]
Aggregate committed amount of credit facility		250,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amount of senior unsecured credit facility paid off	$ 900,000,000
Accordion to credit facility		400,000,000					$ 250,000,000
Aggregate committed amount of credit facility		$ 1,300,000,000			$ 1,250,000,000		1,150,000,000
Revolving Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Accordion to credit facility							$ 400,000,000
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amount of senior unsecured debt	775,000,000
Credit facilities, amount outstanding				$ 1,100,000,000		$ 593,500,000
Refinancing charge								$ 300,000
Aggregate committed amount of credit facility				$ 200,000,000
Debt instrument, basis spread of interest rate			0.40%
Credit facilities, percentage of commitment fee on unused capacity			0.30%
Credit facilities, weighted average interest rate				1.70%		2.20%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.50%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Euro Dollar Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.00%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.40%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding	400,000,000
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding	100,000,000
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				0.50%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Euro Dollar Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				1.00%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				0.70%
Credit facilities, percentage of commitment fee on unused capacity				0.25%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Minimum [Member] | London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				1.70%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				1.25%
Credit facilities, percentage of commitment fee on unused capacity				0.35%
Revolving Credit Facility [Member] | Unsecured Revolving Credit Facility [Member] | Revolving Credit Facility Matures in June 2018 [Member] | Maximum [Member] | London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate				2.25%
Revolving Credit Facility [Member] | Term Loans [Member]
Debt Instrument [Line Items]
Amount of senior unsecured credit facility paid off	250,000,000
Amount of senior unsecured debt	$ 125,000,000

Debt - 2015 Senior Unsecured No

Debt - 2015 Senior Unsecured Notes - Additional Information (Detail) - EUR (€) € in Millions	Aug. 19, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Senior unsecured notes, payable term		Interest on the notes will be payable on March 1 and September 1 of each year
Senior unsecured notes, redemption description		We may redeem some or all of the notes at any time prior to March 1, 2019 at a “make whole” redemption price. On or after March 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and upaid interest to the date of purchase.
2015 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes face amount	€ 500
Senior unsecured notes, payable term		Interest on the notes will be payable annually on August 19 of each year
Senior unsecured notes commencing date of payment	Aug. 19, 2016
Senior unsecured notes, interest rate	4.00%	4.00%
Senior unsecured notes, maturity date	Aug. 19, 2022
Senior unsecured notes, redemption period	90 days
Senior unsecured notes, redemption price percentage	101.00%
Senior unsecured notes, redemption description		Notes are redeemed prior to 90 days before maturity, the redemption price will be 100% of their principal amount, plus a make-whole premium, plus accrued and unpaid interest to, but excluding, the applicable redemption date. Within the period beginning on or after 90 days before maturity, the Notes may be redeemed, in whole or in part, at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the applicable redemption date. The 2015 Senior Unsecured Notes are fully and unconditionally guaranteed on an unsecured basis by the Company. In the event of a change of control, each holder of the Notes may require us to repurchase some or all of our Notes at a repurchase price equal to 101% of the aggregate principal amount of the Notes plus accrued and unpaid interest to the date of the purchase.
2015 Senior Unsecured Notes [Member] | Redeemed Prior to 90 Days [Member]
Debt Instrument [Line Items]
Senior unsecured notes, redemption price percentage	100.00%
2015 Senior Unsecured Notes [Member] | Redeemed Beginning on or After 90 Days [Member]
Debt Instrument [Line Items]
Senior unsecured notes, redemption price percentage	100.00%

Debt - 2014 Senior Unsecured No

Debt - 2014 Senior Unsecured Notes - Additional Information (Detail) - USD ($) $ in Millions	Apr. 17, 2014	Dec. 31, 2015
Debt Instrument [Line Items]
Senior notes frequency of periodic payment		Interest on the notes will be payable on March 1 and September 1 of each year
2014 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, value of offering	$ 300
Senior notes frequency of periodic payment		Semi-annually
Senior unsecured notes, interest rate	5.50%
Debt instrument, maturity date	May 1, 2014
Senior notes, earliest redemption date	May 1, 2019
Senior unsecured notes, redemption percentage on principal amount	35.00%
Senior unsecured notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%

Debt - 2013 Senior Unsecured No

Debt - 2013 Senior Unsecured Notes - Additional Information (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2015	Oct. 10, 2013	Dec. 31, 2014
Debt Instrument [Line Items]
Senior notes frequency of periodic payment	Interest on the notes will be payable on March 1 and September 1 of each year
2013 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, value of offering		€ 200
Senior unsecured notes, interest rate	5.75%	5.75%	5.75%
Senior notes frequency of periodic payment		Semi-annually
Debt instrument, maturity date		Oct. 1, 2020
Senior notes, earliest redemption date		Oct. 1, 2016
Senior unsecured notes, redemption percentage on principal amount		35.00%
Senior unsecured notes, repurchase price percentage on principal amount plus accrued and unpaid interest		101.00%

Debt - 2012 Senior Unsecured No

Debt - 2012 Senior Unsecured Notes - Additional Information (Detail) - USD ($) $ in Millions	Aug. 20, 2013	Feb. 17, 2012	Dec. 31, 2015
Debt Instrument [Line Items]
Senior notes frequency of periodic payment			Interest on the notes will be payable on March 1 and September 1 of each year
2012 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, value of offering	$ 150	$ 200
Senior unsecured notes, interest rate		6.375%
Debt instrument, maturity date		Feb. 15, 2022
Senior notes frequency of periodic payment			Semi-annually
Net proceeds, after underwriting discount	$ 150.4	$ 196.5
Senior notes, earliest redemption date		Feb. 15, 2017
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest		101.00%
Debt instrument redemption price	102.00%
Debt instrument effective rate	5.998%

Debt - 2011 Senior Unsecured No

Debt - 2011 Senior Unsecured Notes - Additional Information (Detail) - USD ($) $ in Millions	Apr. 26, 2011	Dec. 31, 2015
Debt Instrument [Line Items]
Senior notes frequency of periodic payment		Interest on the notes will be payable on March 1 and September 1 of each year
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Debt instrument face amount	$ 450
Senior notes frequency of periodic payment		Semi-annually
Senior notes, earliest redemption date	May 1, 2016
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%

Debt - 2006 Senior Unsecured No

Debt - 2006 Senior Unsecured Notes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2006
Debt Instrument [Line Items]
Senior notes frequency of periodic payment	Interest on the notes will be payable on March 1 and September 1 of each year
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, value of offering		$ 125
Credit facilities, periodic payments of interest		$ 65
Senior notes frequency of periodic payment	Quarterly
Unsecured senior notes, year of maturity		2016-07
2006 Senior Unsecured Notes [Member] | London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate		2.30%

Debt - Interest Rate Swap - Add

Debt - Interest Rate Swap - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2011	Jun. 30, 2010	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Hedge ineffectiveness and income statement effect in period			$ 0	$ 0	$ 0
Other assets, collateral			1,700,000	3,300,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount		$ 65,000,000
2006 Senior Unsecured Notes [Member] | Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps			$ 2,900,000	$ 6,000,000
2006 Senior Unsecured Notes [Member] | Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument		5.507%
Maturity date of interest rate swap			2016-07
2006 Senior Unsecured Notes [Member] | Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Maturity date of interest rate swap			2016-07
Interest rate swap, amount fixed	$ 60,000,000
Interest rate of derivative instrument	5.675%

Debt - Term Loans - Additional

Debt - Term Loans - Additional Information (Detail) - USD ($)	Feb. 14, 2011	Jun. 30, 2014	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Aggregate committed amount of credit facility				$ 1,950,000,000
2014 Term Loan [Member]
Debt Instrument [Line Items]
Paid off term loan		$ 125,000,000
Aggregate committed amount of credit facility				$ 250,000,000
Debt instrument, maturity date			Jun. 30, 2019
Interest rate at end of period			2.05%		1.82%
2014 Term Loan [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.60%
2014 Term Loan [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.20%
2014 Term Loan [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate		0.50%	0.50%
2014 Term Loan [Member] | Eurodollar Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate		1.00%	1.00%
2014 Term Loan [Member] | Initial Spread [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.65%
2014 Term Loan [Member] | London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.65%
2014 Term Loan [Member] | London Interbank Offered Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.60%
2014 Term Loan [Member] | London Interbank Offered Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			2.20%
Mortgage Loans [Member] | Northland LTACH Hospital [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date			Jan. 1, 2018
Liabilities acquired	$ 14,600,000
Amortization period			30 years
Interest rate			6.20%
Debt instrument earliest prepayment date			Jan. 1, 2013
Collateralized real estate property			$ 16,900,000		$ 17,500,000
Term Loans [Member]
Debt Instrument [Line Items]
Debt instrument face amount			$ 13,400,000

Debt - Other Financing - Additi

Debt - Other Financing - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jul. 27, 2015
Debt Instrument [Line Items]
Aggregate committed amount of credit facility		$ 1,950,000,000
Capella [Member]
Debt Instrument [Line Items]
Underwriting fees	$ 3,900,000
Capella [Member] | Bridge Loan [Member]
Debt Instrument [Line Items]
Aggregate committed amount of credit facility			$ 1,000,000,000

Debt - Covenants - Additional I

Debt - Covenants - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2015
Debt Instrument [Line Items]
Percentage of dividends which could be paid from adjusted operating funds	95.00%
Percentage of dividends which could be paid from operation funds	95.00%
Maximum percentage of total unencumbered assets	150.00%
Leverage ratio	70.00%
Unsecured Notes [Member]
Debt Instrument [Line Items]
Leverage ratio	77.50%
Two Thousand Sixteen June Unsecured Notes [Member]
Debt Instrument [Line Items]
Leverage ratio	60.00%
Two Thousand Sixteen September Unsecured Notes [Member]
Debt Instrument [Line Items]
Leverage ratio	65.00%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%	90.00%	90.00%
Percentage of taxable income to be distributed for federal income tax assumption	100.00%
Amount of foreign loss before income taxes	$ 29,400,000	$ 7,500,000	$ 12,900,000
Amount of domestic income (loss) before income taxes	7,100,000	$ 20,900,000	$ 7,600,000
U.S federal NOLs	41,400,000
U.S. state NOLs	107,700,000
Foreign NOLs	$ 10,800,000
U.S. federal and state NOLs, expiration period	2021 through 2034
U.S federal alternative minimum tax credits carry forward	$ 300,000
Foreign tax credit	$ 600,000
Foreign tax credit, expiration date	2,025
Increase in valuation allowance	$ 6,200,000

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Current income tax expense:
Domestic	$ 147	$ 114	$ 358
Foreign	1,614	225	158
Total income tax expense	1,761	339	516
Deferred income tax (benefit) expense:
Domestic	(360)	(23)	210
Foreign	102	24
Total income tax expense	(258)	1	210
Income tax expense	$ 1,503	$ 340	$ 726

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax liabilities:
Property and equipment	$ (1,636)
Unbilled rent	(4,495)	$ (2,070)
Partnership investments	(3,362)	(3,468)
Other	(6,141)	(3,759)
Total deferred tax liabilities	(15,634)	(9,297)
Deferred tax assets:
Operating loss and interest deduction carry forwards	19,016	19,546
Property and equipment		2,373
Other	10,314	3,971
Total deferred tax assets	29,330	25,890
Valuation allowance	(23,005)	(16,831)
Total net deferred tax assets	6,325	9,059
Net deferred tax (liability)	$ (9,309)	$ (238)

Income Taxes - Summary of Recon

Income Taxes - Summary of Reconciliation of the Income Tax Expense at the Statutory Income Tax Rate and the Effective Tax Rate for Income from Continuing Operations before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Income from continuing operations (before-tax)	$ 141,430	$ 51,138	$ 90,027
Income tax at the US statutory federal rate (35%)	49,501	17,898	31,509
Increase (decrease) resulting from:
Rate differential	5,047	1,145	2,380
State income taxes, net of federal benefit	(601)	(337)	271
Dividends paid deduction	(57,109)	(27,873)	(33,345)
Change in valuation allowance	6,174	8,988	(697)
Other items, net	(1,509)	519	608
Income tax expense	$ 1,503	$ 340	$ 726

Income Taxes - Summary of Rec82

Income Taxes - Summary of Reconciliation of the Income Tax Expense at the Statutory Income Tax Rate and the Effective Tax Rate for Income from Continuing Operations before Income Taxes (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Income tax at the US statutory federal rate	35.00%	35.00%	35.00%

Income Taxes - Schedule of Per

Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Common share distribution	$ 0.870000	$ 0.840000	$ 0.800000
Ordinary income	0.769535	0.520692	0.599384
Capital gains		0.000276	0.046380
Unrecaptured Sec. 1250 gain		0.000276	0.026512
Return of capital	0.100465	$ 0.319032	$ 0.154236
Allocable to next year	$ 0

Earnings Per Share_Unit - Calcu

Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 58,339	$ 23,123	$ 22,489	$ 35,976	$ 15,029	$ 28,663	$ (203)	$ 7,309	$ 139,927	$ 50,798	$ 89,301
Non-controlling interests' share in continuing operations									(329)	(274)	(224)
Participating securities' share in earnings									(1,029)	(894)	(729)
Income from continuing operations, less participating securities' share in earnings									138,569	49,630	88,348
Income (loss) from discontinued operations attributable to MPT common stockholders										(2)	7,914
Net income, less participating securities' share in earnings									$ 138,569	$ 49,628	$ 96,262
Basic weighted-average common shares	237,011	223,948	208,071	202,958	172,411	171,893	171,718	163,973	217,997	169,999	151,439
Dilutive potential common shares									307	541	1,159
Diluted weighted-average common shares	237,011	223,948	208,640	203,615	172,604	172,639	171,718	164,549	218,304	170,540	152,598
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 58,339	$ 23,123	$ 22,489	$ 35,976	$ 15,029	$ 28,663	$ (203)	$ 7,309	$ 139,927	$ 50,798	$ 89,301
Non-controlling interests' share in continuing operations									(329)	(274)	(224)
Participating securities' share in earnings									(1,029)	(894)	(729)
Income from continuing operations, less participating securities' share in earnings									138,569	49,630	88,348
Income (loss) from discontinued operations attributable to MPT common stockholders										(2)	7,914
Net income, less participating securities' share in earnings									$ 138,569	$ 49,628	$ 96,262
Basic weighted-average common shares	237,011	223,948	208,071	202,958	172,411	171,893	171,718	163,973	217,997	169,999	151,439
Dilutive potential common shares									307	541	1,159
Diluted weighted-average common shares	237,011	223,948	208,640	203,615	172,604	172,639	171,718	164,549	218,304	170,540	152,598

Stock Awards - Additional Infor

Stock Awards - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 11.1	$ 9.2	$ 8.8
Stock-based compensation expense, unrecognized cost	$ 12.8
Stock-based compensation expense, unrecognized cost, reorganization period (in years)	2 years 3 months 18 days
Restricted equity awards, fair value	$ 10.2	$ 10.2	$ 9.2
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance award vesting period in years	10 years
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	8,196,770
Common stock remaining for future stock awards transferred to the equity incentive plan	5,605,272
Maximum number of shares of common stock that may be awarded	5,000,000
Service-Based Awards [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)	5 years
Service-Based Awards [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)	3 years
40% Of 2015 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)	3 years
Share based payment award, expected volatility rate	40.00%
Stock-based awards expiration date	Dec. 31, 2017
Share based payment award, weighted average risk-free rate of return	1.10%
Common stock options awarded, dividend yield	7.20%
Percentage of performance award grant in period	20.00%
Percentage of shareholder return annually	9.00%
Annual total shareholder return (in years)	3 years
30% of 2015 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)	5 years
Share based payment award, expected volatility rate	27.00%
Share based payment award, weighted average risk-free rate of return	1.10%
Common stock options awarded, dividend yield	7.20%
Percentage of performance award grant in period	30.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%
30% of 2015 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2017, 2018 and 2019.
30% of 2015 Performance Awards [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned	35.00%
30% of 2015 Performance Awards [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned	20.00%
Remaining % of 2015 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)	5 years
Share based payment award, expected volatility rate	20.00%
Share based payment award, weighted average risk-free rate of return	1.10%
Common stock options awarded, dividend yield	7.20%
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%
Percentage of shareholder return to be earned	6.00%
Remaining % of 2015 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2017, 2018 and 2019.
2015 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of performance awards forfeited	4,500
Number of performance awards earned and vested	0
Number of performance awards to be earned	867,388
40% of 2014 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)		3 years
Share based payment award, expected volatility rate		40.00%
Stock-based awards expiration date		Dec. 31, 2018
Share based payment award, weighted average risk-free rate of return		1.70%
Common stock options awarded, dividend yield		8.00%
Percentage of performance award grant in period		27.00%
Percentage of shareholder return annually		9.00%
Annual total shareholder return (in years)		5 years
30% of 2014 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)		5 years
Share based payment award, expected volatility rate		27.00%
Share based payment award, weighted average risk-free rate of return		0.80%
Common stock options awarded, dividend yield		8.00%
Percentage of performance award grant in period		30.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit		100.00%
30% of 2014 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2016, 2017 and 2018.
30% of 2014 Performance Awards [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned		35.00%
30% of 2014 Performance Awards [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned		27.00%
Remaining % of 2014 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)		5 years
Share based payment award, expected volatility rate		27.00%
Share based payment award, weighted average risk-free rate of return		0.80%
Common stock options awarded, dividend yield		8.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit		100.00%
Percentage of shareholder return to be earned		6.00%
Remaining % of 2014 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2016, 2017 and 2018
2014 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of performance awards earned and vested		108,261
Number of performance awards to be earned		771,897
27% of 2013 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance award vesting period in years			2 years
Share-based compensation arrangement by share based payment award, expected service period (in years)			3 years
Share based payment award, expected volatility rate			27.00%
Stock-based awards expiration date			Dec. 31, 2017
Share based payment award, weighted average risk-free rate of return			0.72%
Common stock options awarded, dividend yield			8.00%
Percentage of performance award grant in period			27.00%
Percentage of shareholder return annually			8.50%
Annual total shareholder return (in years)			5 years
Number of shares sold under performance awards			0
36% of 2013 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)			5 years
Share based payment award, expected volatility rate			28.00%
Share based payment award, weighted average risk-free rate of return			0.38%
Common stock options awarded, dividend yield			8.00%
Percentage of performance award grant in period			36.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit			100.00%
36% of 2013 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2015, 2016 and 2017
36% of 2013 Performance Awards [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned			33.50%
36% of 2013 Performance Awards [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned			25.50%
Remaining % of 2013 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share based payment award, expected service period (in years)			5 years
Share based payment award, expected volatility rate			28.00%
Share based payment award, weighted average risk-free rate of return			0.38%
Common stock options awarded, dividend yield			8.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit			100.00%
Percentage of shareholder return to be earned			6.00%
Remaining % of 2013 Performance Awards [Member] | If Any Shares Are Earned From This Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award vesting rights	Vest in equal annual amounts on December 31, 2015, 2016 and 2017
2013 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of performance awards earned and vested		80,293	68,086
Number of performance awards to be earned	74,187
Number of performance awards forfeited	550,000
Number of performance awards earned and vested	0

Stock Awards - Restricted Equit

Stock Awards - Restricted Equity Awards Activity (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Vesting Based on Service [Member]
Employee Restricted Equity Awards Vesting Activity [Line Items]
Nonvested awards at beginning of the year, Shares	452,263	325,999
Awarded, Shares	407,969	424,366
Vested, Shares	(343,904)	(298,102)
Forfeited, Shares	(6,694)
Nonvested awards at end of year, Shares	509,634	452,263
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 12.11	$ 11.36
Awarded, Weighted Average Value at Award Date	13.94	12.21
Vested, Weighted Average Value at Award Date	12.56	11.43
Forfeited, Weighted Average Value at Award Date	13.08
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 13.25	$ 12.11
Vesting Based on Market/Performance Conditions [Member]
Employee Restricted Equity Awards Vesting Activity [Line Items]
Nonvested awards at beginning of the year, Shares	2,428,518	1,999,179
Awarded, Shares	871,888	903,134
Vested, Shares	(406,970)	(473,795)
Forfeited, Shares	(562,284)
Nonvested awards at end of year, Shares	2,331,152	2,428,518
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 5.81	$ 5.44
Awarded, Weighted Average Value at Award Date	6.62	7.57
Vested, Weighted Average Value at Award Date	4.94	7.60
Forfeited, Weighted Average Value at Award Date	5.33
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 6.38	$ 5.81

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
Term of lease period	30 years or more
Lease and Rental Expenses	$ 4.6	$ 2.3	$ 2.3
Sublease rental income	$ 23	$ 0.2	$ 0.5

Commitments and Contingencies88

Commitments and Contingencies - Fixed Minimum Rental Payments Due under Operating Leases with Non-Cancelable Terms (Detail) $ in Thousands	Dec. 31, 2015USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,016	$ 5,119
2,017	5,157
2,018	5,125
2,019	4,803
2,020	4,896
Thereafter	140,049
Minimum rental payments, total	165,149
2,016	(2,477)
2,017	(2,502)
2,018	(2,504)
2,019	(2,522)
2,020	(2,621)
Thereafter	(130,819)
Sub lease minimum rental payments receivable, total	(143,445)
2,016	2,642
2,017	2,655
2,018	2,621
2,019	2,281
2,020	2,275
Thereafter	9,230
Minimum rental payments, total	$ 21,704

Common Stock_Partner's Capital

Common Stock/Partner's Capital - Additional Information (Detail) $ / shares in Units, $ in Thousands	Aug. 11, 2015USD ($)shares	Jan. 14, 2015USD ($)shares	Mar. 11, 2014USD ($)shares	Jan. 31, 2014USD ($)	Dec. 31, 2015USD ($)DirectorEmployeePartner$ / sharesshares	Dec. 31, 2014USD ($)$ / sharesshares	Dec. 31, 2013USD ($)	Aug. 04, 2015$ / sharesshares	Jun. 30, 2015$ / sharesshares
Class of Stock [Line Items]
Common stock, shares issued | shares					236,744,000	172,743,000
Proceeds from sale of common shares / units, net of offering costs					$ 817,389	$ 138,173	$ 313,330
Common stock, shares authorized | shares					500,000,000	500,000,000		500,000,000	250,000,000
Common stock, par value | $ / shares					$ 0.001	$ 0.001		$ 0.001	$ 0.001
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Proceeds from sale of common shares / units, net of offering costs					$ 817,389	$ 138,173	$ 313,330
Percentage of ownership of general partner					100.00%
Ownership interest in equity					99.80%
Number of other partners | Partner					3
Market Equity Offering Program [Member]
Class of Stock [Line Items]
Common stock, shares issued | shares						1,700,000
Proceeds from sale of common shares / units, net of offering costs						$ 22,600
Sales commission percentage				1.25%
Market Equity Offering Program [Member] | IPO [Member]
Class of Stock [Line Items]
Public offering price for common stock per share | $ / shares						$ 13.56
Market Equity Offering Program [Member] | Maximum [Member]
Class of Stock [Line Items]
Number of shares can be sold out				$ 250,000
Employee [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage | Employee					2
Director [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage | Director					1
Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued | shares	28,750,000	34,500,000	7,700,000
Additional shares purchased by underwriters | shares	3,800,000	4,500,000	1,200,000
Proceeds from sale of common shares / units, net of offering costs	$ 337,000	$ 480,000	$ 100,200
Time granted to underwriters to purchase shares					30 days
Net proceeds from additional issuance of shares			$ 16,000

Fair Value of Financial Instr90

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Interest and rent receivables, Book value	$ 46,939	$ 41,137
Loans, Book value	508,851	773,311
Debt, net Book value	(3,322,541)	(2,174,648)
Interest and rent receivables, Fair value	46,858	41,005
Loans, Fair value	543,859	803,824
Debt, net Fair value	$ (3,372,773)	$ (2,258,721)

Fair Value of Financial Instr91

Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	$ 920,901	$ 200,750
Cost	920,901	200,750
Fair Value Measurements, Recurring [Member] | Equity investments [Member] | Other Assets [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	7,349	3,300
Cost	7,349	3,300
Fair Value Measurements, Recurring [Member] | Acquisition loans [Member] | Other Loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	603,552	97,450
Cost	603,552	97,450
Fair Value Measurements, Recurring [Member] | Mortgage Loans [Member] | Mortgage loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	310,000	100,000
Cost	$ 310,000	$ 100,000

Fair Value of Financial Instr92

Fair Value of Financial Instruments - Additional information (Detail)	12 Months Ended
	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Adjustment for marketability discount	40.00%

Fair Value of Financial Instr93

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
+100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ (122)
- 100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ 122

Discontinued Operations - Disco

Discontinued Operations - Discontinued Operations (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]
Revenues			$ 988
Gain on sale			7,659
Income (loss) from discontinued operations	$ (2)	$ (2)	$ 7,914
Income from discontinued operations - diluted per share/unit			$ 0.05

Other Assets - Summary of Other

Other Assets - Summary of Other Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Other Assets [Abstract]
Debt issue costs, net	$ 7,628	$ 8,318
Equity investments	129,337	47,451
Other corporate assets	31,547	28,197
Prepaids and other assets	27,028	11,133
Total other assets	$ 195,540	$ 95,099

Quarterly Financial Data (Una96

Quarterly Financial Data (Unaudited) - Unaudited Quarterly Financial Information (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information [Line Items]
Revenues	$ 131,546	$ 114,570	$ 99,801	$ 95,961	$ 82,106	$ 80,777	$ 76,560	$ 73,089	$ 441,878	$ 312,532	$ 242,523
Income (loss) from continuing operations	58,339	23,123	22,489	35,976	15,029	28,663	(203)	7,309	139,927	50,798	89,301
Income (loss) from discontinued operations								(2)		(2)	7,914
Net income	58,339	23,123	22,489	35,976	15,029	28,663	(203)	7,307	139,927	50,796	97,215
Net income attributable to MPT common stockholders	$ 58,237	$ 23,057	$ 22,407	$ 35,897	$ 14,947	$ 28,537	$ (203)	$ 7,241	$ 139,598	$ 50,522	$ 96,991
Net income attributable to MPT common stockholders per share - basic	$ 0.24	$ 0.10	$ 0.11	$ 0.18	$ 0.08	$ 0.16		$ 0.04	$ 0.64	$ 0.29	$ 0.64
Weighted average shares outstanding - basic	237,011	223,948	208,071	202,958	172,411	171,893	171,718	163,973	217,997	169,999	151,439
Net income attributable to MPT common stockholders per share - diluted	$ 0.24	$ 0.10	$ 0.11	$ 0.17	$ 0.08	$ 0.16		$ 0.04	$ 0.63	$ 0.29	$ 0.63
Weighted average shares outstanding - diluted	237,011	223,948	208,640	203,615	172,604	172,639	171,718	164,549	218,304	170,540	152,598
MPT Operating Partnership, L.P. [Member]
Quarterly Financial Information [Line Items]
Revenues	$ 131,546	$ 114,570	$ 99,801	$ 95,961	$ 82,106	$ 80,777	$ 76,560	$ 73,089	$ 441,878	$ 312,532	$ 242,523
Income (loss) from continuing operations	58,339	23,123	22,489	35,976	15,029	28,663	(203)	7,309	139,927	50,798	89,301
Income (loss) from discontinued operations								(2)		(2)	7,914
Net income	58,339	23,123	22,489	35,976	15,029	28,663	(203)	7,307	139,927	50,796	97,215
Net income attributable to MPT common stockholders	$ 58,237	$ 23,057	$ 22,407	$ 35,897	$ 14,948	$ 28,537	$ (203)	$ 7,241	$ 139,598	$ 50,522	$ 96,991
Net income attributable to MPT common stockholders per share - basic	$ 0.24	$ 0.10	$ 0.11	$ 0.18	$ 0.08	$ 0.16		$ 0.04	$ 0.64	$ 0.29	$ 0.64
Weighted average shares outstanding - basic	237,011	223,948	208,071	202,958	172,411	171,893	171,718	163,973	217,997	169,999	151,439
Net income attributable to MPT common stockholders per share - diluted	$ 0.24	$ 0.10	$ 0.11	$ 0.17	$ 0.08	$ 0.16		$ 0.04	$ 0.63	$ 0.29	$ 0.63
Weighted average shares outstanding - diluted	237,011	223,948	208,640	203,615	172,604	172,639	171,718	164,549	218,304	170,540	152,598

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($) $ in Millions	Feb. 22, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Senior unsecured notes, payable term		Interest on the notes will be payable on March 1 and September 1 of each year
Senior unsecured notes, redemption description		We may redeem some or all of the notes at any time prior to March 1, 2019 at a “make whole” redemption price. On or after March 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time prior to March 1, 2019, we may redeem up to 35% of the notes at a redemption price equal to 106.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon, using proceeds from one or more equity offerings. In the event of a change in control, each holder of the notes may require us to repurchase some or all of the notes at a repurchase price equal to 101% of the aggregate principal amount of the notes plus accrued and upaid interest to the date of purchase.
Subsequent Event [Member]
Subsequent Event [Line Items]
Senior unsecured notes face amount	$ 500
Senior unsecured notes commencing date of payment	Sep. 1, 2016
Senior unsecured notes, interest rate	6.375%
Debt instrument, maturity date	Mar. 1, 2024
Senior notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%
Senior notes, earliest redemption date	Mar. 1, 2019
Debt instrument, redemption price percentage	106.375%
Subsequent Event [Member] | Maximum [Member]
Subsequent Event [Line Items]
Senior unsecured notes, redemption price percentage	35.00%

Schedule II - Schedule of Valua

Schedule II - Schedule of Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]
Balance at Beginning of Year	$ 20,129	$ 41,573	$ 34,769
Additions charged against operations	8,205	65,512	9,397
Deductions,Net recoveries/write offs	(950)	(86,956)	(2,593)
Balance at end of year	$ 27,384	$ 20,129	$ 41,573

Schedule II - Schedule of Val99

Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2013
Impairment charges	$ 50,128
Net deferred tax assets reserve		$ 6,100
Monroe Properties [Member]
Impairment charges	47,000
Rent & interest reserves	9,500
Increase in valuation allowance	$ 9,000
Monroe Properties [Member]
Rent & interest reserves			$ 4,800
Interest reserves			2,700
Twelve Oaks Facility [Member]
Rent & interest reserves		1,300
Late fee reserves		200
Healthtrax Properties [Member]
Rent & interest reserves		500
M/C Healthcare Loan [Member]
Interest reserves		$ 100
Germany [Member]
Full reserve for net deferred tax asset			$ 1,900

Schedule III - Real Estate I100

Schedule III - Real Estate Investments and Accumulated Depreciation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,400
Initial costs, land	302,046
Initial costs, buildings	2,632,473
Additions subsequent to acquisition, Improvements	27,568
Additions subsequent to acquisition, carrying costs	29,503
Land at cost	315,787
Buildings at cost	2,675,803
Total at cost	2,991,590	$ 2,040,727	$ 1,733,194	$ 1,189,552
Accumulated Depreciation	$ 232,675	$ 181,441	$ 144,235	$ 114,399
Baden-Wurttemburg, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 11,249
Buildings at cost	11,249
Total at cost	11,249
Accumulated Depreciation	$ 305
Date of Construction	1,995
Date Acquired	Dec. 11, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Saxony, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 539
Initial costs, buildings	14,943
Land at cost	539
Buildings at cost	14,943
Total at cost	15,482
Accumulated Depreciation	$ 778
Date of Construction	1,995
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Rhineland-Pflaz, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 5,834
Initial costs, buildings	16,109
Land at cost	5,834
Buildings at cost	16,109
Total at cost	21,943
Accumulated Depreciation	$ 839
Date of Construction	1,930
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Brandenburg, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 346
Initial costs, buildings	17,874
Land at cost	346
Buildings at cost	17,874
Total at cost	18,220
Accumulated Depreciation	$ 931
Date of Construction	1,994
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Hesse, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,078
Initial costs, buildings	14,804
Land at cost	3,078
Buildings at cost	14,804
Total at cost	17,882
Accumulated Depreciation	$ 771
Date of Construction	1,977
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Bavaria Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,204
Initial costs, buildings	9,294
Additions subsequent to acquisition, Improvements	194
Land at cost	2,204
Buildings at cost	9,488
Total at cost	11,692
Accumulated Depreciation	$ 257
Date of Construction	1,974
Date Acquired	Nov. 19, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Thuringia Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,605
Initial costs, buildings	33,913
Land at cost	1,605
Buildings at cost	33,913
Total at cost	35,518
Accumulated Depreciation	$ 989
Date of Construction	1,992
Date Acquired	Nov. 5, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Bath, UK [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,747
Initial costs, buildings	36,203
Land at cost	1,747
Buildings at cost	36,203
Total at cost	37,950
Accumulated Depreciation	$ 1,358
Date of Construction	2,009
Date Acquired	Jul. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Ottenhofen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,254
Initial costs, buildings	12,681
Additions subsequent to acquisition, Improvements	108
Land at cost	2,362
Buildings at cost	12,681
Total at cost	15,043
Accumulated Depreciation	$ 162
Date of Construction	1,957
Date Acquired	Jul. 3, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Berka Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,226
Initial costs, buildings	15,046
Additions subsequent to acquisition, Improvements	168
Land at cost	3,394
Buildings at cost	15,046
Total at cost	18,440
Accumulated Depreciation	$ 161
Date of Construction	1,997
Date Acquired	Jul. 22, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Wiesbaden Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,608
Initial costs, buildings	7,457
Additions subsequent to acquisition, Improvements	38
Land at cost	1,646
Buildings at cost	7,457
Total at cost	9,103
Accumulated Depreciation	$ 94
Date of Construction	1,974
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Lausick Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,733
Initial costs, buildings	15,674
Additions subsequent to acquisition, Improvements	152
Land at cost	1,885
Buildings at cost	15,674
Total at cost	17,559
Accumulated Depreciation	$ 201
Date of Construction	1,993
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Sulze Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,297
Initial costs, buildings	19,814
Additions subsequent to acquisition, Improvements	196
Land at cost	2,493
Buildings at cost	19,814
Total at cost	22,307
Accumulated Depreciation	$ 254
Date of Construction	1,993
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Kurort Berggiebhubel Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,199
Initial costs, buildings	15,452
Land at cost	3,199
Buildings at cost	15,452
Total at cost	18,651
Accumulated Depreciation	$ 165
Date of Construction	1,993
Date Acquired	Jul. 21, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Braunfels Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,086
Initial costs, buildings	13,331
Additions subsequent to acquisition, Improvements	54
Land at cost	2,140
Buildings at cost	13,331
Total at cost	15,471
Accumulated Depreciation	$ 168
Date of Construction	1,977
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bernkastel-Kues Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,498
Initial costs, buildings	15,191
Additions subsequent to acquisition, Improvements	43
Land at cost	3,541
Buildings at cost	15,191
Total at cost	18,732
Accumulated Depreciation	$ 159
Date of Construction	1,982
Date Acquired	Jul. 15, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Flechtingen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,781
Initial costs, buildings	21,989
Additions subsequent to acquisition, Improvements	217
Land at cost	2,998
Buildings at cost	21,989
Total at cost	24,987
Accumulated Depreciation	$ 282
Date of Construction	1,993
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Nordrach Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 304
Initial costs, buildings	2,910
Additions subsequent to acquisition, Improvements	82
Land at cost	386
Buildings at cost	2,910
Total at cost	3,296
Accumulated Depreciation	$ 39
Date of Construction	1,960
Date Acquired	Jul. 7, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Gottleuba Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,259
Initial costs, buildings	14,937
Additions subsequent to acquisition, Improvements	863
Land at cost	4,122
Buildings at cost	14,937
Total at cost	$ 19,059
Date of Construction	1,913
Date Acquired	Dec. 16, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Grunheide, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 8,369
Initial costs, buildings	40,596
Additions subsequent to acquisition, Improvements	331
Land at cost	8,700
Buildings at cost	40,596
Total at cost	49,296
Accumulated Depreciation	$ 432
Date of Construction	2,014
Date Acquired	Jul. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Baden-Baden Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,271
Initial costs, buildings	8,936
Additions subsequent to acquisition, Improvements	125
Land at cost	1,396
Buildings at cost	8,936
Total at cost	10,332
Accumulated Depreciation	$ 116
Date of Construction	2,003
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Gyhum Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,878
Initial costs, buildings	22,165
Additions subsequent to acquisition, Improvements	341
Land at cost	4,219
Buildings at cost	22,165
Total at cost	26,384
Accumulated Depreciation	$ 288
Date of Construction	1,994
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hannover Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 4,073
Initial costs, buildings	16,293
Land at cost	4,073
Buildings at cost	16,293
Total at cost	20,366
Accumulated Depreciation	$ 34
Date of Construction	1,900
Date Acquired	Dec. 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Heiligendamm Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 4,182
Initial costs, buildings	26,063
Additions subsequent to acquisition, Improvements	206
Land at cost	4,388
Buildings at cost	26,063
Total at cost	30,451
Accumulated Depreciation	$ 333
Date of Construction	1,995
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Camberg Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,026
Initial costs, buildings	15,447
Additions subsequent to acquisition, Improvements	260
Land at cost	2,286
Buildings at cost	15,447
Total at cost	17,733
Accumulated Depreciation	$ 202
Date of Construction	1,973
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hoppegarten Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,894
Initial costs, buildings	24,117
Additions subsequent to acquisition, Improvements	239
Land at cost	4,133
Buildings at cost	24,117
Total at cost	28,250
Accumulated Depreciation	$ 258
Date of Construction	1,994
Date Acquired	Jul. 27, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Ban Nauheim Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,074
Initial costs, buildings	15,529
Additions subsequent to acquisition, Improvements	141
Land at cost	3,215
Buildings at cost	15,529
Total at cost	18,744
Accumulated Depreciation	$ 199
Date of Construction	1,977
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Kalbe Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,400
Initial costs, buildings	22,716
Additions subsequent to acquisition, Improvements	163
Land at cost	3,563
Buildings at cost	22,716
Total at cost	26,279
Accumulated Depreciation	$ 289
Date of Construction	1,995
Date Acquired	Jul. 6, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Soden-Salmunster, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 934
Initial costs, buildings	6,482
Additions subsequent to acquisition, Improvements	120
Land at cost	1,054
Buildings at cost	6,482
Total at cost	7,536
Accumulated Depreciation	$ 85
Date of Construction	1,974
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Berlin Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,157
Initial costs, buildings	20,767
Additions subsequent to acquisition, Improvements	184
Land at cost	1,341
Buildings at cost	20,767
Total at cost	22,108
Accumulated Depreciation	$ 221
Date of Construction	1,998
Date Acquired	Jul. 16, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Lobenstein Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,541
Initial costs, buildings	20,079
Additions subsequent to acquisition, Improvements	179
Land at cost	3,720
Buildings at cost	20,079
Total at cost	23,799
Accumulated Depreciation	$ 257
Date of Construction	1,994
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Magdeburg Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 14,387
Initial costs, buildings	53,369
Additions subsequent to acquisition, Improvements	250
Land at cost	14,637
Buildings at cost	53,369
Total at cost	68,006
Accumulated Depreciation	$ 563
Date of Construction	2,014
Date Acquired	Jul. 22, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Schlangenbad Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,048
Initial costs, buildings	3,411
Additions subsequent to acquisition, Improvements	266
Land at cost	1,314
Buildings at cost	3,411
Total at cost	4,725
Accumulated Depreciation	$ 52
Date of Construction	1,973
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Durrheim Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,390
Initial costs, buildings	11,400
Additions subsequent to acquisition, Improvements	228
Land at cost	1,618
Buildings at cost	11,400
Total at cost	13,018
Accumulated Depreciation	$ 125
Date of Construction	1,970
Date Acquired	Jul. 24, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Krozingen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,472
Initial costs, buildings	10,733
Additions subsequent to acquisition, Improvements	114
Land at cost	1,586
Buildings at cost	10,733
Total at cost	12,319
Accumulated Depreciation	$ 115
Date of Construction	2,008
Date Acquired	Jul. 24, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Nauheim Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,760
Initial costs, buildings	9,198
Additions subsequent to acquisition, Improvements	54
Land at cost	1,814
Buildings at cost	9,198
Total at cost	11,012
Accumulated Depreciation	$ 117
Date of Construction	1,973
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bad Tennstedt Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,677
Initial costs, buildings	27,261
Additions subsequent to acquisition, Improvements	201
Land at cost	3,878
Buildings at cost	27,261
Total at cost	31,139
Accumulated Depreciation	$ 347
Date of Construction	1,993
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Wismar Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,465
Initial costs, buildings	20,645
Additions subsequent to acquisition, Improvements	195
Land at cost	3,660
Buildings at cost	20,645
Total at cost	24,305
Accumulated Depreciation	$ 265
Date of Construction	1,996
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Houston, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,423
Initial costs, buildings	3,770
Land at cost	1,423
Buildings at cost	3,770
Total at cost	5,193
Accumulated Depreciation	$ 79
Date of Construction	2,015
Date Acquired	Feb. 18, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Allen TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,550
Initial costs, buildings	3,921
Land at cost	1,550
Buildings at cost	3,921
Total at cost	5,471
Accumulated Depreciation	$ 147
Date of Construction	2,014
Date Acquired	Jul. 14, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
San Diego, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 6,550
Initial costs, buildings	15,653
Additions subsequent to acquisition, carrying costs	77
Land at cost	6,550
Buildings at cost	15,730
Total at cost	22,280
Accumulated Depreciation	$ 3,406
Date of Construction	1,964
Date Acquired	May 9, 2007
Life on which depreciation in latest income statements is computed (Years)	40 years
Alvin TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 105
Initial costs, buildings	4,087
Land at cost	105
Buildings at cost	4,087
Total at cost	4,192
Accumulated Depreciation	$ 156
Date of Construction	2,014
Date Acquired	Mar. 19, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Aurora, CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 4,860
Buildings at cost	4,860
Total at cost	4,860
Accumulated Depreciation	$ 26
Date of Construction	2,015
Date Acquired	Sep. 17, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Ft Worth, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,984
Buildings at cost	3,984
Total at cost	3,984
Accumulated Depreciation	$ 75
Date of Construction	2,015
Date Acquired	Mar. 27, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bayonne, NJ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,003
Initial costs, buildings	51,495
Land at cost	2,003
Buildings at cost	51,495
Total at cost	53,498
Accumulated Depreciation	$ 12,658
Date of Construction	1,918
Date Acquired	Feb. 4, 2011
Life on which depreciation in latest income statements is computed (Years)	20 years
Bennettsville, SC [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 794
Initial costs, buildings	15,772
Land at cost	794
Buildings at cost	15,772
Total at cost	16,566
Accumulated Depreciation	$ 3,050
Date of Construction	1,984
Date Acquired	Apr. 1, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Blue Springs Mo [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,347
Initial costs, buildings	23,494
Land at cost	4,347
Buildings at cost	23,494
Total at cost	27,841
Accumulated Depreciation	$ 566
Date of Construction	1,980
Date Acquired	Feb. 13, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Bossier City, LA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 900
Initial costs, buildings	17,818
Land at cost	900
Buildings at cost	17,818
Total at cost	18,718
Accumulated Depreciation	$ 3,450
Date of Construction	1,982
Date Acquired	Apr. 1, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Austin TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,140
Initial costs, buildings	3,853
Land at cost	1,140
Buildings at cost	3,853
Total at cost	4,993
Accumulated Depreciation	$ 161
Date of Construction	2,014
Date Acquired	May 29, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Broomfield, CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 825
Initial costs, buildings	3,895
Land at cost	825
Buildings at cost	3,895
Total at cost	4,720
Accumulated Depreciation	$ 146
Date of Construction	2,014
Date Acquired	Jul. 3, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Carrollton, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 729
Initial costs, buildings	34,289
Land at cost	729
Buildings at cost	34,289
Total at cost	35,018
Accumulated Depreciation	$ 354
Date of Construction	2,015
Date Acquired	Jul. 17, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Cedar Hill TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,122
Initial costs, buildings	3,644
Land at cost	1,122
Buildings at cost	3,644
Total at cost	4,766
Accumulated Depreciation	$ 137
Date of Construction	2,014
Date Acquired	Jun. 23, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Spring, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,310
Initial costs, buildings	3,543
Land at cost	1,310
Buildings at cost	3,543
Total at cost	4,853
Accumulated Depreciation	$ 133
Date of Construction	2,014
Date Acquired	Jul. 15, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Chandler, AZ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 4,244
Buildings at cost	4,244
Total at cost	4,244
Accumulated Depreciation	$ 71
Date of Construction	2,015
Date Acquired	Apr. 24, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Chandler Az Two [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 750
Initial costs, buildings	3,214
Land at cost	750
Buildings at cost	3,214
Total at cost	3,964
Accumulated Depreciation	$ 19
Date of Construction	2,015
Date Acquired	Oct. 7, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Cheraw, SC [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 657
Initial costs, buildings	19,576
Land at cost	657
Buildings at cost	19,576
Total at cost	20,233
Accumulated Depreciation	$ 3,785
Date of Construction	1,982
Date Acquired	Apr. 1, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Katy, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,248
Buildings at cost	3,248
Total at cost	3,248
Accumulated Depreciation	$ 14
Date of Construction	2,015
Date Acquired	Oct. 21, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Webster, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 663
Initial costs, buildings	33,751
Land at cost	663
Buildings at cost	33,751
Total at cost	34,414
Accumulated Depreciation	$ 4,219
Date of Construction	2,004
Date Acquired	Dec. 21, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Commerce City TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 707
Initial costs, buildings	4,236
Land at cost	707
Buildings at cost	4,236
Total at cost	4,943
Accumulated Depreciation	$ 115
Date of Construction	2,014
Date Acquired	Dec. 11, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Conroe Tx [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,338
Initial costs, buildings	3,436
Land at cost	1,338
Buildings at cost	3,436
Total at cost	4,774
Accumulated Depreciation	$ 35
Date of Construction	2,015
Date Acquired	Jul. 29, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Converse TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 750
Initial costs, buildings	4,405
Land at cost	750
Buildings at cost	4,405
Total at cost	5,155
Accumulated Depreciation	$ 83
Date of Construction	2,015
Date Acquired	Apr. 10, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Corinth, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,288
Initial costs, buildings	21,175
Additions subsequent to acquisition, Improvements	313
Land at cost	1,601
Buildings at cost	21,175
Total at cost	22,776
Accumulated Depreciation	$ 2,671
Date of Construction	2,008
Date Acquired	Jan. 31, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
Covington, LA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 821
Initial costs, buildings	10,238
Additions subsequent to acquisition, carrying costs	14
Land at cost	821
Buildings at cost	10,252
Total at cost	11,073
Accumulated Depreciation	$ 2,712
Date of Construction	1,984
Date Acquired	Jun. 9, 2005
Life on which depreciation in latest income statements is computed (Years)	40 years
Dallas, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,000
Initial costs, buildings	13,589
Additions subsequent to acquisition, carrying costs	368
Land at cost	1,421
Buildings at cost	13,536
Total at cost	14,957
Accumulated Depreciation	$ 3,158
Date of Construction	2,006
Date Acquired	Sep. 5, 2006
Life on which depreciation in latest income statements is computed (Years)	40 years
Denver, CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 4,275
Buildings at cost	4,275
Total at cost	4,275
Accumulated Depreciation	$ 56
Date of Construction	2,015
Date Acquired	Jun. 8, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
DeSoto, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,067
Initial costs, buildings	10,701
Additions subsequent to acquisition, Improvements	86
Additions subsequent to acquisition, carrying costs	8
Land at cost	1,161
Buildings at cost	10,701
Total at cost	11,862
Accumulated Depreciation	$ 1,202
Date of Construction	2,008
Date Acquired	Jul. 18, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
Detroit, MI [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,220
Initial costs, buildings	8,687
Additions subsequent to acquisition, carrying costs	(365)
Land at cost	1,220
Buildings at cost	8,322
Total at cost	9,542
Accumulated Depreciation	$ 1,656
Date of Construction	1,956
Date Acquired	May 22, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Dulles TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,076
Initial costs, buildings	3,784
Land at cost	1,076
Buildings at cost	3,784
Total at cost	4,860
Accumulated Depreciation	$ 125
Date of Construction	2,014
Date Acquired	Sep. 12, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Fairmont CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,000
Initial costs, buildings	12,301
Additions subsequent to acquisition, Improvements	1,386
Land at cost	1,277
Buildings at cost	13,410
Total at cost	14,687
Accumulated Depreciation	$ 443
Date of Construction	1,985
Date Acquired	Sep. 19, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Firestone TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 495
Initial costs, buildings	3,963
Land at cost	495
Buildings at cost	3,963
Total at cost	4,458
Accumulated Depreciation	$ 157
Date of Construction	2,014
Date Acquired	Jun. 6, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Florence, AZ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 900
Initial costs, buildings	28,462
Land at cost	900
Buildings at cost	28,462
Total at cost	29,362
Accumulated Depreciation	$ 2,659
Date of Construction	2,012
Date Acquired	Nov. 4, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Fort Lauderdale, FL [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,499
Initial costs, buildings	21,939
Additions subsequent to acquisition, carrying costs	1
Land at cost	3,499
Buildings at cost	21,940
Total at cost	25,439
Accumulated Depreciation	$ 4,214
Date of Construction	1,985
Date Acquired	Apr. 22, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Fountain, CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,508
Initial costs, buildings	4,131
Land at cost	1,508
Buildings at cost	4,131
Total at cost	5,639
Accumulated Depreciation	$ 146
Date of Construction	2,014
Date Acquired	Jul. 31, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Frisco TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,769
Buildings at cost	3,769
Total at cost	3,769
Accumulated Depreciation	$ 15
Date of Construction	2,015
Date Acquired	Nov. 13, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Garden Grove, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 5,502
Initial costs, buildings	10,748
Additions subsequent to acquisition, carrying costs	51
Land at cost	5,502
Buildings at cost	10,799
Total at cost	16,301
Accumulated Depreciation	$ 1,925
Date of Construction	1,982
Date Acquired	Nov. 25, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Garden Grove, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Medical Office Building
Initial costs, land	$ 862
Initial costs, buildings	7,888
Additions subsequent to acquisition, carrying costs	28
Land at cost	862
Buildings at cost	7,916
Total at cost	8,778
Accumulated Depreciation	$ 1,404
Date of Construction	1,982
Date Acquired	Nov. 25, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Gilbert, AZ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 150
Initial costs, buildings	15,553
Land at cost	150
Buildings at cost	15,553
Total at cost	15,703
Accumulated Depreciation	$ 1,944
Date of Construction	2,005
Date Acquired	Jan. 4, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
Gilbert Arizona Two [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,518
Initial costs, buildings	4,112
Land at cost	1,518
Buildings at cost	4,112
Total at cost	5,630
Accumulated Depreciation	$ 39
Date of Construction	2,015
Date Acquired	Jul. 22, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Glendale Az [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,886
Buildings at cost	3,886
Total at cost	3,886
Accumulated Depreciation	$ 50
Date of Construction	2,015
Date Acquired	Jun. 5, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hammond LA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 519
Initial costs, buildings	8,941
Land at cost	519
Buildings at cost	8,941
Total at cost	9,460
Accumulated Depreciation	$ 689
Date of Construction	2,003
Date Acquired	Dec. 14, 2012
Life on which depreciation in latest income statements is computed (Years)	40 years
Hausman, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,500
Initial costs, buildings	8,958
Land at cost	1,500
Buildings at cost	8,958
Total at cost	10,458
Accumulated Depreciation	$ 611
Date of Construction	2,013
Date Acquired	Mar. 1, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Highland Village, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,673
Buildings at cost	3,673
Total at cost	3,673
Accumulated Depreciation	$ 21
Date of Construction	2,015
Date Acquired	Sep. 22, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hill County, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,120
Initial costs, buildings	17,882
Land at cost	1,120
Buildings at cost	17,882
Total at cost	19,002
Accumulated Depreciation	$ 6,294
Date of Construction	1,980
Date Acquired	Sep. 17, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Hoboken, NJ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,387
Initial costs, buildings	44,351
Land at cost	1,387
Buildings at cost	44,351
Total at cost	45,738
Accumulated Depreciation	$ 9,173
Date of Construction	1,863
Date Acquired	Nov. 4, 2011
Life on which depreciation in latest income statements is computed (Years)	20 years
Hoover AL [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 7,581
Buildings at cost	7,581
Total at cost	7,581
Accumulated Depreciation	$ 126
Date of Construction	2,015
Date Acquired	May 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hoover Al Two [Member ]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Medical Office Building
Initial costs, buildings	$ 1,034
Buildings at cost	1,034
Total at cost	1,034
Accumulated Depreciation	$ 17
Date of Construction	2,015
Date Acquired	May 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Hot Springs, AR [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,300
Initial costs, buildings	66,922
Land at cost	4,300
Buildings at cost	66,922
Total at cost	71,222
Accumulated Depreciation	$ 548
Date of Construction	1,985
Date Acquired	Aug. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Idaho Falls Id [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,822
Initial costs, buildings	37,467
Additions subsequent to acquisition, carrying costs	4,665
Land at cost	1,822
Buildings at cost	42,132
Total at cost	43,954
Accumulated Depreciation	$ 8,028
Date of Construction	2,002
Date Acquired	Apr. 1, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Kansas City Mo [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 10,497
Initial costs, buildings	64,419
Land at cost	10,497
Buildings at cost	64,419
Total at cost	74,916
Accumulated Depreciation	$ 1,505
Date of Construction	1,978
Date Acquired	Feb. 13, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Lafayette, IN [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 800
Initial costs, buildings	14,968
Additions subsequent to acquisition, Improvements	(25)
Land at cost	800
Buildings at cost	14,943
Total at cost	15,743
Accumulated Depreciation	$ 1,076
Date of Construction	2,013
Date Acquired	Feb. 1, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Little Elm, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,241
Initial costs, buildings	3,491
Land at cost	1,241
Buildings at cost	3,491
Total at cost	4,732
Accumulated Depreciation	$ 179
Date of Construction	2,013
Date Acquired	Dec. 1, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Lubbock Tx [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 21,241
Buildings at cost	21,241
Total at cost	21,241
Accumulated Depreciation	$ 260
Date of Construction	2,008
Date Acquired	Jun. 16, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Lubbock Tx Two [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, buildings	$ 10,725
Buildings at cost	10,725
Total at cost	10,725
Accumulated Depreciation	$ 134
Date of Construction	2,008
Date Acquired	Jun. 16, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
McKinney, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,991
Buildings at cost	3,991
Total at cost	3,991
Accumulated Depreciation	$ 40
Date of Construction	2,015
Date Acquired	Jul. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Mesa - AZ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,900
Initial costs, buildings	97,980
Additions subsequent to acquisition, Improvements	2,242
Land at cost	7,142
Buildings at cost	97,980
Total at cost	105,122
Accumulated Depreciation	$ 5,977
Date of Construction	2,007
Date Acquired	Sep. 26, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Bloomington, IN
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,392
Initial costs, buildings	28,212
Additions subsequent to acquisition, Improvements	5,000
Additions subsequent to acquisition, carrying costs	408
Land at cost	2,392
Buildings at cost	33,620
Total at cost	36,012
Accumulated Depreciation	$ 7,544
Date of Construction	2,006
Date Acquired	Aug. 8, 2006
Life on which depreciation in latest income statements is computed (Years)	40 years
Montclair NJ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 7,900
Initial costs, buildings	99,632
Additions subsequent to acquisition, Improvements	585
Land at cost	8,477
Buildings at cost	99,640
Total at cost	108,117
Accumulated Depreciation	$ 4,623
Date of Construction	2,000
Date Acquired	Apr. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
San Antonio, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 351
Initial costs, buildings	3,952
Land at cost	351
Buildings at cost	3,952
Total at cost	4,303
Accumulated Depreciation	$ 172
Date of Construction	2,014
Date Acquired	Jan. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
New Braunfels, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,100
Initial costs, buildings	7,883
Land at cost	1,100
Buildings at cost	7,883
Total at cost	8,983
Accumulated Depreciation	$ 838
Date of Construction	2,007
Date Acquired	Sep. 30, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
Shenandoah, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,033
Initial costs, buildings	21,943
Land at cost	2,033
Buildings at cost	21,943
Total at cost	23,976
Accumulated Depreciation	$ 3,017
Date of Construction	2,008
Date Acquired	Jun. 17, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Colorado Springs CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 600
Initial costs, buildings	4,231
Land at cost	600
Buildings at cost	4,231
Total at cost	4,831
Accumulated Depreciation	$ 168
Date of Construction	2,014
Date Acquired	Jun. 5, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Northland, MO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 13,400
Type of property	Long term acute care hospital
Initial costs, land	$ 834
Initial costs, buildings	17,182
Land at cost	834
Buildings at cost	17,182
Total at cost	18,016
Accumulated Depreciation	$ 2,112
Date of Construction	2,007
Date Acquired	Feb. 14, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
Altoona, WI [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, buildings	$ 29,048
Buildings at cost	29,048
Total at cost	29,048
Accumulated Depreciation	$ 945
Date of Construction	2,014
Date Acquired	Aug. 31, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Ogden UT [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,759
Initial costs, buildings	16,414
Land at cost	1,759
Buildings at cost	16,414
Total at cost	18,173
Accumulated Depreciation	$ 739
Date of Construction	2,014
Date Acquired	Mar. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Overlook, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,452
Initial costs, buildings	9,666
Additions subsequent to acquisition, Improvements	7
Land at cost	2,452
Buildings at cost	9,673
Total at cost	12,125
Accumulated Depreciation	$ 683
Date of Construction	2,012
Date Acquired	Feb. 1, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Parker, CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,301
Initial costs, buildings	4,024
Land at cost	1,301
Buildings at cost	4,024
Total at cost	5,325
Accumulated Depreciation	$ 17
Date of Construction	2,015
Date Acquired	Nov. 6, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Pearland, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,075
Initial costs, buildings	3,577
Land at cost	1,075
Buildings at cost	3,577
Total at cost	4,652
Accumulated Depreciation	$ 119
Date of Construction	2,014
Date Acquired	Sep. 8, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Petersburg, VA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,302
Initial costs, buildings	9,121
Land at cost	1,302
Buildings at cost	9,121
Total at cost	10,423
Accumulated Depreciation	$ 1,710
Date of Construction	2,006
Date Acquired	Jul. 1, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Poplar Bluff, MO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,659
Initial costs, buildings	38,694
Additions subsequent to acquisition, carrying costs	1
Land at cost	2,660
Buildings at cost	38,694
Total at cost	41,354
Accumulated Depreciation	$ 7,431
Date of Construction	1,980
Date Acquired	Apr. 22, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Port Arthur, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 3,000
Initial costs, buildings	72,341
Additions subsequent to acquisition, Improvements	1,062
Land at cost	4,062
Buildings at cost	72,341
Total at cost	76,403
Accumulated Depreciation	$ 4,246
Date of Construction	2,005
Date Acquired	Sep. 26, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Port Huron Mi [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,000
Initial costs, buildings	18,000
Land at cost	2,000
Buildings at cost	18,000
Total at cost	$ 20,000
Date of Construction	1,983
Date Acquired	Dec. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Portland, OR [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 3,085
Initial costs, buildings	17,859
Additions subsequent to acquisition, carrying costs	2,559
Land at cost	3,071
Buildings at cost	20,432
Total at cost	23,503
Accumulated Depreciation	$ 4,383
Date of Construction	1,964
Date Acquired	Apr. 18, 2007
Life on which depreciation in latest income statements is computed (Years)	40 years
Post Falls, ID [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 417
Initial costs, buildings	12,175
Additions subsequent to acquisition, Improvements	1,905
Land at cost	767
Buildings at cost	13,730
Total at cost	14,497
Accumulated Depreciation	$ 696
Date of Construction	2,013
Date Acquired	Dec. 31, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Redding, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, buildings	$ 19,952
Additions subsequent to acquisition, carrying costs	4,360
Land at cost	1,629
Buildings at cost	22,683
Total at cost	24,312
Accumulated Depreciation	$ 5,757
Date of Construction	1,991
Date Acquired	Jun. 30, 2005
Life on which depreciation in latest income statements is computed (Years)	40 years
Richardson, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,219
Initial costs, buildings	17,419
Land at cost	2,219
Buildings at cost	17,419
Total at cost	19,638
Accumulated Depreciation	$ 2,395
Date of Construction	2,008
Date Acquired	Jun. 17, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Addison, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,013
Initial costs, buildings	22,531
Land at cost	2,013
Buildings at cost	22,531
Total at cost	24,544
Accumulated Depreciation	$ 3,098
Date of Construction	2,008
Date Acquired	Jun. 17, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
San Dimas, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Medical Office Building
Initial costs, land	$ 1,915
Initial costs, buildings	5,085
Additions subsequent to acquisition, carrying costs	18
Land at cost	1,915
Buildings at cost	5,103
Total at cost	7,018
Accumulated Depreciation	$ 905
Date of Construction	1,979
Date Acquired	Nov. 25, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Sherman TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,491
Initial costs, buildings	24,802
Land at cost	4,491
Buildings at cost	24,802
Total at cost	29,293
Accumulated Depreciation	$ 775
Date of Construction	2,010
Date Acquired	Oct. 31, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Sienna, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 999
Initial costs, buildings	3,591
Land at cost	999
Buildings at cost	3,591
Total at cost	4,590
Accumulated Depreciation	$ 120
Date of Construction	2,014
Date Acquired	Aug. 20, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Spartanburg, SC [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,135
Initial costs, buildings	15,717
Land at cost	1,135
Buildings at cost	15,717
Total at cost	16,852
Accumulated Depreciation	$ 931
Date of Construction	2,013
Date Acquired	Aug. 1, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
Thornton CO [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,350
Initial costs, buildings	4,227
Land at cost	1,350
Buildings at cost	4,227
Total at cost	5,577
Accumulated Depreciation	$ 141
Date of Construction	2,014
Date Acquired	Aug. 29, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
Tomball, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 1,299
Initial costs, buildings	23,982
Land at cost	1,299
Buildings at cost	23,982
Total at cost	25,281
Accumulated Depreciation	$ 2,998
Date of Construction	2,005
Date Acquired	Dec. 21, 2010
Life on which depreciation in latest income statements is computed (Years)	40 years
Victoria, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Long term acute care hospital
Initial costs, land	$ 625
Initial costs, buildings	7,197
Land at cost	625
Buildings at cost	7,197
Total at cost	7,822
Accumulated Depreciation	$ 1,634
Date of Construction	1,998
Date Acquired	Dec. 1, 2006
Life on which depreciation in latest income statements is computed (Years)	40 years
League City TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, buildings	$ 3,645
Buildings at cost	3,645
Total at cost	3,645
Accumulated Depreciation	$ 46
Date of Construction	2,015
Date Acquired	Jun. 19, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Anaheim, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,875
Initial costs, buildings	21,814
Additions subsequent to acquisition, carrying costs	10
Land at cost	1,875
Buildings at cost	21,824
Total at cost	23,699
Accumulated Depreciation	$ 5,001
Date of Construction	1,964
Date Acquired	Nov. 8, 2006
Life on which depreciation in latest income statements is computed (Years)	40 years
West Monroe, LA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 12,000
Initial costs, buildings	69,433
Additions subsequent to acquisition, Improvements	552
Land at cost	12,552
Buildings at cost	69,433
Total at cost	81,985
Accumulated Depreciation	$ 4,048
Date of Construction	1,962
Date Acquired	Sep. 26, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
West Valley City, UT [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 5,516
Initial costs, buildings	58,314
Land at cost	5,516
Buildings at cost	58,314
Total at cost	63,830
Accumulated Depreciation	$ 11,198
Date of Construction	1,980
Date Acquired	Apr. 22, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
Wichita, KS [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,019
Initial costs, buildings	18,373
Additions subsequent to acquisition, carrying costs	1
Land at cost	1,019
Buildings at cost	18,374
Total at cost	19,393
Accumulated Depreciation	$ 3,559
Date of Construction	1,992
Date Acquired	Apr. 4, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
1994 [Member] | Baden-Wurttemburg, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 9,459
Buildings at cost	9,459
Total at cost	9,459
Accumulated Depreciation	$ 493
Date of Construction	1,994
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1994 [Member] | Grunheide, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 8,369
Initial costs, buildings	40,596
Additions subsequent to acquisition, Improvements	331
Land at cost	8,700
Buildings at cost	40,596
Total at cost	49,296
Accumulated Depreciation	$ 432
Date of Construction	1,994
Date Acquired	Jul. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1996 [Member] | Saxony, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 372
Initial costs, buildings	20,515
Land at cost	372
Buildings at cost	20,515
Total at cost	20,887
Accumulated Depreciation	$ 1,068
Date of Construction	1,996
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1960 [Member] | Rhineland-Pflaz, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,175
Initial costs, buildings	15,008
Land at cost	3,175
Buildings at cost	15,008
Total at cost	18,183
Accumulated Depreciation	$ 782
Date of Construction	1,960
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1960 [Member] | Bad Durrheim Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,390
Initial costs, buildings	11,400
Additions subsequent to acquisition, Improvements	228
Land at cost	1,618
Buildings at cost	11,400
Total at cost	13,018
Accumulated Depreciation	$ 125
Date of Construction	1,960
Date Acquired	Jul. 24, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1960 [Member] | Houston, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 3,501
Initial costs, buildings	34,530
Additions subsequent to acquisition, Improvements	8,477
Additions subsequent to acquisition, carrying costs	15,993
Land at cost	3,274
Buildings at cost	59,227
Total at cost	62,501
Accumulated Depreciation	$ 8,018
Date of Construction	1,960
Date Acquired	Aug. 10, 2007
Life on which depreciation in latest income statements is computed (Years)	40 years
1960 [Member] | Sherman TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,491
Initial costs, buildings	24,802
Land at cost	4,491
Buildings at cost	24,802
Total at cost	29,293
Accumulated Depreciation	$ 775
Date of Construction	1,960
Date Acquired	Oct. 31, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1981 [Member] | Hesse, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 92
Initial costs, buildings	5,236
Land at cost	92
Buildings at cost	5,236
Total at cost	5,328
Accumulated Depreciation	$ 273
Date of Construction	1,981
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1992 [Member] | Rhineland-Pflaz, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 29,701
Buildings at cost	29,701
Total at cost	29,701
Accumulated Depreciation	$ 1,547
Date of Construction	1,992
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1904 [Member] | Saxony, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 539
Initial costs, buildings	14,943
Land at cost	539
Buildings at cost	14,943
Total at cost	15,482
Accumulated Depreciation	$ 778
Date of Construction	1,904
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1980 [Member] | Rhineland-Pflaz, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 728
Initial costs, buildings	6,545
Land at cost	728
Buildings at cost	6,545
Total at cost	7,273
Accumulated Depreciation	$ 341
Date of Construction	1,980
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1986 [Member] | Baden-Wurttemburg, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 3,420
Initial costs, buildings	5,827
Land at cost	3,420
Buildings at cost	5,827
Total at cost	9,247
Accumulated Depreciation	$ 303
Date of Construction	1,986
Date Acquired	Nov. 30, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
1954 [Member] | Thuringia Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,605
Initial costs, buildings	33,913
Land at cost	1,605
Buildings at cost	33,913
Total at cost	35,518
Accumulated Depreciation	$ 989
Date of Construction	1,954
Date Acquired	Nov. 5, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1988 [Member] | Baden-Wurttemburg, Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 11,249
Buildings at cost	11,249
Total at cost	11,249
Accumulated Depreciation	$ 305
Date of Construction	1,988
Date Acquired	Dec. 11, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
2008 [Member] | Bath, UK [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,747
Initial costs, buildings	36,203
Land at cost	1,747
Buildings at cost	36,203
Total at cost	37,950
Accumulated Depreciation	$ 1,358
Date of Construction	2,008
Date Acquired	Jul. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1956 [Member] | Ottenhofen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,254
Initial costs, buildings	12,681
Additions subsequent to acquisition, Improvements	108
Land at cost	2,362
Buildings at cost	12,681
Total at cost	15,043
Accumulated Depreciation	$ 162
Date of Construction	1,956
Date Acquired	Jul. 3, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1993 [Member] | Bernkastel-Kues Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 782
Initial costs, buildings	11,284
Additions subsequent to acquisition, Improvements	130
Land at cost	912
Buildings at cost	11,284
Total at cost	12,196
Accumulated Depreciation	$ 145
Date of Construction	1,993
Date Acquired	Jul. 14, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1993 [Member] | Flechtingen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,781
Initial costs, buildings	14,036
Additions subsequent to acquisition, Improvements	146
Land at cost	2,927
Buildings at cost	14,036
Total at cost	16,963
Accumulated Depreciation	$ 180
Date of Construction	1,993
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1995 [Member] | Flechtingen Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 2,781
Initial costs, buildings	21,989
Additions subsequent to acquisition, Improvements	217
Land at cost	2,998
Buildings at cost	21,989
Total at cost	24,987
Accumulated Depreciation	$ 282
Date of Construction	1,995
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1900 [Member] | Baden-Baden Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,271
Initial costs, buildings	8,936
Additions subsequent to acquisition, Improvements	125
Land at cost	1,396
Buildings at cost	8,936
Total at cost	10,332
Accumulated Depreciation	$ 116
Date of Construction	1,900
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
2002 [Member] | Baden-Baden Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,271
Initial costs, buildings	8,936
Additions subsequent to acquisition, Improvements	125
Land at cost	1,396
Buildings at cost	8,936
Total at cost	10,332
Accumulated Depreciation	$ 116
Date of Construction	2,002
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Renovations in 1997 [Member] | Hannover Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 4,073
Initial costs, buildings	16,293
Land at cost	4,073
Buildings at cost	16,293
Total at cost	20,366
Accumulated Depreciation	$ 34
Date of Construction	1,997
Date Acquired	Dec. 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Renovations in 2000 [Member] | Hannover Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 4,073
Initial costs, buildings	16,293
Land at cost	4,073
Buildings at cost	16,293
Total at cost	20,366
Accumulated Depreciation	$ 34
Date of Construction	2,000
Date Acquired	Dec. 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
Renovations in 2009 [Member] | Hannover Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 4,073
Initial costs, buildings	16,293
Land at cost	4,073
Buildings at cost	16,293
Total at cost	20,366
Accumulated Depreciation	$ 34
Date of Construction	2,009
Date Acquired	Dec. 1, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1999 [Member] | Magdeburg Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 14,387
Initial costs, buildings	53,369
Additions subsequent to acquisition, Improvements	250
Land at cost	14,637
Buildings at cost	53,369
Total at cost	68,006
Accumulated Depreciation	$ 563
Date of Construction	1,999
Date Acquired	Jul. 22, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1972 [Member] | Bad Nauheim Germany [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, land	$ 1,760
Initial costs, buildings	9,198
Additions subsequent to acquisition, Improvements	54
Land at cost	1,814
Buildings at cost	9,198
Total at cost	11,012
Accumulated Depreciation	$ 117
Date of Construction	1,972
Date Acquired	Jun. 30, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1972 [Member] | Fairmont CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,000
Initial costs, buildings	12,301
Additions subsequent to acquisition, Improvements	1,386
Land at cost	1,277
Buildings at cost	13,410
Total at cost	14,687
Accumulated Depreciation	$ 443
Date of Construction	1,972
Date Acquired	Sep. 19, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1972 [Member] | San Dimas, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 6,160
Initial costs, buildings	6,839
Additions subsequent to acquisition, carrying costs	34
Land at cost	6,160
Buildings at cost	6,873
Total at cost	13,033
Accumulated Depreciation	$ 1,218
Date of Construction	1,972
Date Acquired	Nov. 25, 2008
Life on which depreciation in latest income statements is computed (Years)	40 years
1973 [Member] | San Diego, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 12,663
Initial costs, buildings	52,432
Land at cost	12,663
Buildings at cost	52,432
Total at cost	65,095
Accumulated Depreciation	$ 6,445
Date of Construction	1,973
Date Acquired	Feb. 9, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years
1973 [Member] | Port Huron Mi [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,000
Initial costs, buildings	18,000
Land at cost	2,000
Buildings at cost	18,000
Total at cost	$ 20,000
Date of Construction	1,973
Date Acquired	Dec. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
2014 [Member] | Houston, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,345
Initial costs, buildings	3,678
Land at cost	1,345
Buildings at cost	3,678
Total at cost	5,023
Accumulated Depreciation	$ 138
Date of Construction	2,014
Date Acquired	Jun. 20, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
2014 [Member] | Frisco TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Freestanding ER
Initial costs, land	$ 1,500
Initial costs, buildings	3,863
Additions subsequent to acquisition, Improvements	27
Land at cost	1,500
Buildings at cost	3,890
Total at cost	5,390
Accumulated Depreciation	$ 154
Date of Construction	2,014
Date Acquired	Jun. 13, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1939 [Member] | Fairmont CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,000
Initial costs, buildings	12,301
Additions subsequent to acquisition, Improvements	1,386
Land at cost	1,277
Buildings at cost	13,410
Total at cost	14,687
Accumulated Depreciation	$ 443
Date of Construction	1,939
Date Acquired	Sep. 19, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
1920 [Member] | Montclair NJ [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 7,900
Initial costs, buildings	99,632
Additions subsequent to acquisition, Improvements	585
Land at cost	8,477
Buildings at cost	99,640
Total at cost	108,117
Accumulated Depreciation	$ 4,623
Date of Construction	1,920
Date Acquired	Apr. 1, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
2006 [Member] | Houston, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,757
Initial costs, buildings	56,238
Additions subsequent to acquisition, Improvements	(37)
Additions subsequent to acquisition, carrying costs	1,259
Land at cost	5,427
Buildings at cost	56,790
Total at cost	62,217
Accumulated Depreciation	$ 12,848
Date of Construction	2,006
Date Acquired	Dec. 1, 2006
Life on which depreciation in latest income statements is computed (Years)	40 years
1953 [Member] | Port Huron Mi [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,000
Initial costs, buildings	18,000
Land at cost	2,000
Buildings at cost	18,000
Total at cost	$ 20,000
Date of Construction	1,953
Date Acquired	Dec. 31, 2015
Life on which depreciation in latest income statements is computed (Years)	40 years
1974 [Member] | Redding, CA [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 1,555
Initial costs, buildings	53,863
Additions subsequent to acquisition, carrying costs	13
Land at cost	1,555
Buildings at cost	53,876
Total at cost	55,431
Accumulated Depreciation	$ 11,346
Date of Construction	1,974
Date Acquired	Aug. 10, 2007
Life on which depreciation in latest income statements is computed (Years)	40 years
1913 [Member] | Sherman TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 4,491
Initial costs, buildings	24,802
Land at cost	4,491
Buildings at cost	24,802
Total at cost	29,293
Accumulated Depreciation	$ 775
Date of Construction	1,913
Date Acquired	Oct. 31, 2014
Life on which depreciation in latest income statements is computed (Years)	40 years
2013 [Member] | Victoria, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Rehabilitation hospital
Initial costs, buildings	$ 10,412
Buildings at cost	10,412
Total at cost	10,412
Accumulated Depreciation	$ 515
Date of Construction	2,013
Date Acquired	Dec. 31, 2013
Life on which depreciation in latest income statements is computed (Years)	40 years
2012 [Member] | San Antonio, TX [Member]
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Type of property	Acute care general hospital
Initial costs, land	$ 2,248
Initial costs, buildings	5,880
Land at cost	2,248
Buildings at cost	5,880
Total at cost	8,128
Accumulated Depreciation	$ 462
Date of Construction	2,012
Date Acquired	Oct. 14, 2011
Life on which depreciation in latest income statements is computed (Years)	40 years

Schedule III - Changes in Total

Schedule III - Changes in Total Real Estate Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
Balance at beginning of period	$ 2,040,727	$ 1,733,194	$ 1,189,552
Acquisitions	975,239	263,811	480,503
Transfers from construction in progress	23,163	41,772	81,347
Additions	7,376	84,831	7,749
Dispositions	(24,701)	(56,590)	(28,616)
Other	(30,214)	(26,291)	2,659
Balance at end of period	$ 2,991,590	$ 2,040,727	$ 1,733,194

Schedule III - Changes in Accum

Schedule III - Changes in Accumulated Depreciation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
Balance at beginning of period	$ 181,441	$ 144,235	$ 114,399
Depreciation	60,796	46,935	33,349
Depreciation on disposed property	(8,887)	(9,213)	(3,513)
Other	(675)	(516)
Balance at end of period	$ 232,675	$ 181,441	$ 144,235

Schedule IV - Schedule of Mortg

Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail)	12 Months Ended
	Dec. 31, 2015USD ($)
Mortgage Loans on Real Estate [Line Items]
Prior Liens	$ 0
Face Amount of Mortgages	757,500,000
Carrying Amount of Mortgages	757,500,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Periodic Payment Terms	Payable in monthly installments of interest plus principal payable in full at maturity
Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.00%
Final Maturity Date	2,022
Face Amount of Mortgages	$ 70,000,000
Carrying Amount of Mortgages	70,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.60%
Final Maturity Date	2,022
Face Amount of Mortgages	$ 20,000,000
Carrying Amount of Mortgages	20,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.00%
Final Maturity Date	2,017
Face Amount of Mortgages	$ 12,500,000
Carrying Amount of Mortgages	12,500,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Chino Valley Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.00%
Final Maturity Date	2,022
Face Amount of Mortgages	$ 50,000,000
Carrying Amount of Mortgages	50,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Paradise Valley Hospital [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	10.60%
Final Maturity Date	2,022
Face Amount of Mortgages	$ 25,000,000
Carrying Amount of Mortgages	25,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Ernest Mortgage Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	9.60%
Final Maturity Date	2,032
Face Amount of Mortgages	$ 100,000,000
Carrying Amount of Mortgages	100,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Centinela Hospital Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.00%
Final Maturity Date	2,022
Face Amount of Mortgages	$ 100,000,000
Carrying Amount of Mortgages	100,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Olympia Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	11.20%
Final Maturity Date	2,024
Face Amount of Mortgages	$ 20,000,000
Carrying Amount of Mortgages	20,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | St. Joseph Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	8.50%
Final Maturity Date	2,025
Face Amount of Mortgages	$ 30,000,000
Carrying Amount of Mortgages	30,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | St Marys Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	8.50%
Final Maturity Date	2,025
Face Amount of Mortgages	$ 10,000,000
Carrying Amount of Mortgages	10,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Lake Huron Medical Center [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	8.50%
Final Maturity Date	2,020
Face Amount of Mortgages	$ 10,000,000
Carrying Amount of Mortgages	10,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | St. Clare's Hospital [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	8.50%
Final Maturity Date	2,020
Face Amount of Mortgages	$ 100,000,000
Carrying Amount of Mortgages	100,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Long-Term First Mortgage Loan [Member] | Capella Mortgage Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Interest rate	8.00%
Final Maturity Date	2,030
Face Amount of Mortgages	$ 210,000,000
Carrying Amount of Mortgages	210,000,000
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0

Schedule IV - Schedule of Mo104

Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail)	Dec. 31, 2015USD ($)Property
Mortgage Loans on Real Estate [Line Items]
Prior Liens	$ 0
Carrying amount of mortgages, federal income tax purposes	757,500,000
Unamortized loan issue costs	$ 100,000
Long-Term First Mortgage Loan [Member] | Ernest Mortgage Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Number of properties | Property	4
Long-Term First Mortgage Loan [Member] | Capella Mortgage Loan [Member]
Mortgage Loans on Real Estate [Line Items]
Number of properties | Property	2

Schedule IV - Changes in Mortga

Schedule IV - Changes in Mortgage Loans Excluding Unamortized Loan Issue Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Mortgage Loans on Real Estate [Abstract]
Balance at beginning of year	$ 397,500	$ 388,650	$ 368,650
New mortgage loans and additional advances on existing loans	380,000	12,500	20,000
Mortgage loans on real estate including additions during year	777,500	401,150	388,650
Collection of principal	(20,000)	(3,650)
Deductions during year	(20,000)	(3,650)
Balance at end of year	$ 757,500	$ 397,500	$ 388,650